Interim / Quarterly Report • Aug 7, 2025
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
Classification: internal


| PREFACE 4 |
|---|
| INTERIM MANAGEMENT REPORT AS AT 30 JUNE 2025 5 |
| HIGHLIGHTS 6 |
| ALTERNATIVE PERFORMANCE MEASURES 8 |
| SHAREHOLDER INFORMATION 16 |
| RECLASSIFIED CONSOLIDATED INCOME STATEMENT 18 |
| RECLASSIFIED CONSOLIDATED BALANCE SHEET 20 |
| CONDENSED RECLASSIFIED CONSOLIDATED CASH FLOW STATEMENT22 |
| INCOME STATEMENT REVIEW 23 |
| BALANCE SHEET REVIEW 48 |
| ACQUISITION OF COMPANIES AND BUSINESSES 60 |
| OUTLOOK 61 |
| CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS AT 30 JUNE 2025 62 |
| CONSOLIDATED STATEMENT OF FINANCIAL POSITION63 |
| CONSOLIDATED INCOME STATEMENT 65 |
| STATEMENT OF CONSOLIDATED COMPREHENSIVE INCOME 66 |
| STATEMENT OF CHANGES IN CONSOLIDATION EQUITY67 |
| STATEMENT OF CONSOLIDATED CASH FLOWS 69 |
| SUPPLEMENTARY INFORMATION TO THE STATEMENT OF CONSOLIDATED CASH FLOWS 70 |
| NOTES71 |
| 1. General Information71 |
| 2. Impacts of trade tariffs, conflict in Middle East, Ukraine and climate change on the Group's performance and financial position 72 |

| 3. | Acquisitions and goodwill 73 |
|
|---|---|---|
| 4. | Intangible fixed assets with finite useful life76 | |
| 5. | Property, plant, and equipment78 | |
| 6. | Right-of-use assets80 | |
| 7. | Other non-current assets81 | |
| 8. | Share capital and treasury shares82 | |
| 9. | Net financial indebtedness83 | |
| 10. | Financial liabilities86 | |
| 11. | Provision for risks and charges88 | |
| 12. | Lease liabilities 88 |
|
| 13. | Revenues from sales and services89 | |
| 14. | Operating costs, depreciation and impairment, financial income-expenses and taxes 89 |
|
| 15. | Performance stock grants90 | |
| 16. | Earnings (loss) per share 92 |
|
| 17. | Transactions with parents and other related parties 93 |
|
| 18. | Contingent liabilities 94 |
|
| 19. | Financial risk management 94 |
|
| 20. | Translation of foreign companies' financial statements95 | |
| 21. | Segment Reporting96 | |
| 22. | Accounting policies 101 |
|
| 23. | Subsequent events104 | |
| ANNEXES | 105 |
|
| Consolidation scope 105 Declaration in respect of the Consolidated Financial Statements pursuant to Article 154- bis of Legislative Decree no. 58/98 110 |
||
| INDEPENDENT AUDITOR'S REPORT ON REVIEW OF CONDENSED INTERIM CONSOLIDATED | ||
| FINANCIAL STATEMENTS AS AT 30 JUNE 2025 111 |
||
This report contains forward looking statements ("Outlook") relating to future events and the Amplifon Group's operating, economic and financial results. These forecasts, by definition, contain elements of risk and uncertainty, insofar as they are linked to the occurrence of future events and developments. The actual results may be very different with respect to the original forecast due to several factors, the majority of which are out of the Group's control.

This Interim Financial Report as at 30 June 2025 was prepared in accordance with the International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB) endorsed by the European Union and should be read together with the Group's consolidated financial statements as at and for the year ended 31 December 2024 that includes additional information on the risks and uncertainties that could impact the Group's operating results or its financial position.
Starting from 2025, in order to facilitate the understanding of the Group's economicfinancial performance and in line with market practice, a change was made to the representation of Alternative Performance Measures (APM) used by the Top management to monitor the Group's economic, financial and operating performance. The Group reports certain indicators as "adjusted" in order to present the Group's operating performance net of items (income and expenses) that are unusual, infrequent or not related to the operating performance. This will allow an analysis of the strictly operational performance of the Group. The Group also determined the same indicators for the comparison period in the same way.
For more information on the Alternative Performance Measures identified by the Group and the way the latter are determined, please refer to the section "Alternative Performance Measures" in this Interim Financial Report.


In the first six months of 2025 Amplifon, with the acquisition made, recorded revenue growth despite a particularly challenging comparison base and a weak market which was impacted by macroeconomic and geopolitical factors.
| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Economic figures: | ||
| Revenues from sales and services | 1,180,490 | 1,177,251 |
| Gross operating profit (loss) (EBITDA) | 286,981 | 293,773 |
| Gross operating profit (loss) (EBITDA) Adjusted (*) | 287,645 | 297,058 |
| Operating profit (loss) (EBIT) | 128,986 | 148,947 |
| Operating profit (loss) (EBIT) Adjusted (*) | 156,328 | 176,795 |
| Profit (loss) before tax | 98,280 | 121,432 |
| Profit (loss) before tax Adjusted (*) | 124,946 | 148,974 |
| Net profit (loss) | 68,219 | 87,874 |
| Net profit (loss) Adjusted (*) | 90,561 | 107,909 |
| Net profit (loss) attributable to the Group | 68,120 | 87,793 |
| Net profit (loss) attributable to the Group Adjusted (*) | 90,462 | 107,828 |
(*) For details on the Alternative Performance Measures identified by the Group and how they were determined refer to the specific sections of the Preface and the Alternative Performance Measures in this Interim Financial Report.
| (€ thousands) | 06/30/2025 | 12/31/2024 | Change |
|---|---|---|---|
| Financial figures: | |||
| Non-current assets | 3,105,626 | 3,185,747 | (80,121) |
| Net invested capital | 2,623,382 | 2,626,366 | (2,984) |
| Group net equity | 1,013,559 | 1,150,002 | (136,443) |
| Total net equity | 1,013,831 | 1,150,224 | (136,393) |
| Net financial indebtedness excluding lease liabilities | 1,108,956 | 961,805 | 147,151 |
| Lease liabilities | 500,595 | 514,337 | (13,742) |
| Net financial indebtedness | 1,609,551 | 1,476,142 | 133,409 |
| (€ thousands) | First six months 2025 | First six months 2024 |
|---|---|---|
| Free cash flow | 37,476 | 46,822 |
| Cash flow generated from (absorbed by) business combinations | (54,493) | (142,737) |
| Cash flow provided by (used in) financing activities | (121,762) | (59,899) |
| Net cash flow from the period | (138,779) | (155,814) |
| Effect of exchange rate fluctuations on the net financial position | (8,298) | (1,341) |
| Effect of discontinued operations on the net financial position | (74) | - |
| Net cash flow from the period with changes for exchange rate fluctuations and discontinued operations |
(147,151) | (157,155) |

The first six months of the current year closed with:
Net financial debt, excluding lease liabilities, amounted to €1,108,956 thousand as at 30 June 2025, an increase of €147,151 thousand compared to 31 December 2024 which reflects the significant outlays for the payment of dividends and share buybacks. In the first half of 2025, free cash flow reached a positive €37,476 thousand (€46,822 thousand as at 30 June 2024) after €64,433 thousand in capital expenditure (€65,338 thousand in the comparison period).
Net cash-outs for acquisitions (which amounted to €54,493 thousand versus €142,737 thousand in the first half of 2024), along with the purchase of treasury shares (€55,228 thousand) and the payment of dividends (€65,302 thousand versus €65,593 thousand in the comparison period), brought cash flow for the reporting period to negative €138,779 thousand versus negative €155,814 thousand in the first half of 2024.
As a result of the repayments made in the second quarter of 2025, the Group no longer has any financing subject to financial covenants.

| (€ thousands) | 06/30/2025 | 12/31/2024 | 06/30/2024 |
|---|---|---|---|
| Gross operating profit (loss) (EBITDA) | 286,981 | 561,090 | 293,773 |
| Gross operating profit (loss) (EBITDA) Adjusted | 287,645 | 566,051 | 297,058 |
| Operating profit (loss) (EBIT) | 128,986 | 256,814 | 148,947 |
| Operating profit (loss) (EBIT) Adjusted | 156,328 | 313,845 | 176,795 |
| Profit (loss) before tax | 98,280 | 196,780 | 121,432 |
| Profit (loss) before tax Adjusted | 124,946 | 254,670 | 148,974 |
| Net profit (loss) | 68,219 | 145,570 | 87,874 |
| Net profit (loss) Adjusted | 90,561 | 188,329 | 107,909 |
| Net profit (loss) attributable to the Group | 68,120 | 145,374 | 87,793 |
| Net profit (loss) attributable to the Group Adjusted | 90,462 | 188,133 | 107,828 |
| Net financial indebtedness excluding lease liabilities | 1,108,956 | 961,805 | 1,009,285 |
| Lease liabilities | 500,595 | 514,337 | 512,361 |
| Net financial indebtedness | 1,609,551 | 1,476,142 | 1,521,646 |
| Total Net Equity | 1,013,831 | 1,150,224 | 1,138,588 |
| Group Net Equity | 1,013,559 | 1,150,002 | 1,138,354 |
| Net financial indebtedness excluding lease liabilities/Net Equity (€) | 1.09 | 0.84 | 0.89 |
| Net financial indebtedness excluding lease liabilities /Group Net Equity (€) | 1.09 | 0.84 | 0.89 |
| Net financial indebtedness excluding lease liabilities/EBITDA for the leverage calculation (€) |
1.93 | 1.63 | 1.70 |
| Earnings per share (EPS) (€) | 0.30300 | 0.64384 | 0.38850 |
| Diluted EPS (€) | 0.30090 | 0.64214 | 0.38547 |
| EPS Adjusted (€) | 0.40238 | 0.83321 | 0.47716 |
| Group Net Equity per share (€) | 4.548 | 5.104 | 5.034 |
| Period-end price (€) | 19.930 | 24.850 | 33.240 |
| Highest price in period (€) | 27.140 | 35.140 | 35.140 |
| Lowest price in period (€) | 15.620 | 22.890 | 29.180 |
| Share price/net equity per share (€) | 4.382 | 4.869 | 6.603 |
| Market capitalization (€ millions) | 4,420.93 | 5,599.21 | 7,518.35 |
| Number of shares outstanding | 222,854,231 | 225,320,371 | 226,183,821 |
| Weighted average number of shares outstanding in the year | 224,820,026 | 225,791,949 | 225,979,292 |
| Weighted average number of shares potentially subject to options in the period |
226,388,620 | 226,388,620 | 226,388,620 |

The main economic and financial indicators used by Top management to monitor the Group's economic and financial performance as alternatives to the indicators defined or specified in the applicable financial reporting framework are reported in this section. In order to facilitate understanding of the Group's economic and financial performance, the directors identified certain Alternative Performance Measures (APMs). The following information is provided with a view to a correct interpretation of these APMs:
This document contains certain indicators defined as "Adjusted", in order to represent the Group's operating performance net of unusual, infrequent or unrelated elements (income or expenses) and thus allow an analysis of the Group's strictly operating performance.
These "Adjusted" components can be grouped into the following categories, as identified by the top management:

The Alternative Performance Measures identified by the Group can be defined as follows:
The reconciliation of the Net profit (loss) attributable to the Group with EBITDA and the EBITDA Adjusted is shown below.
| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Net profit (loss) attributable to the Group | 68,120 | 87,793 |
| Profit (loss) of minority interests | 99 | 81 |
| Net profit (loss) | 68,219 | 87,874 |
| Current and deferred income tax | 30,061 | 33,558 |
| Financial income, expenses and value adjustments to financial assets | 30,706 | 27,515 |
| Amortization, depreciation and impairment | 157,995 | 144,826 |
| Gross operating profit (EBITDA) | 286,981 | 293,773 |
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out (1) | (827) | 233 |
| Charges and write-off related to back-office and network reorganization, as well as other efficiency projects and changes in Top management (2) |
1,441 | 2,456 |
| Gain and loss on disposal of assets and/or businesses, write-off and revaluation of fixed assets (3) | 50 | (324) |
| Other unusual, infrequent or unrelated income and expenses above an amount of €1m in a quarter, or above €2m across multiple quarters (4) |
- | 920 |
| Total adjustments | 664 | 3,285 |
| Gross operating profit (EBITDA) Adjusted | 287,645 | 297,058 |
(4) The positive adjustment of €920 thousand in the comparison period refers to the notional cost of the assignment of Amplifon shares made by the shareholder Ampliter to the Chief Executive Officer.

The reconciliation of the Net profit (loss) attributable to the Group with EBIT and the EBIT Adjusted is shown below.
| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Net profit (loss) attributable to the Group | 68,120 | 87,793 |
| Profit (loss) of minority interests | 99 | 81 |
| Net profit (loss) | 68,219 | 87,874 |
| Current and deferred income tax | 30,061 | 33,558 |
| Financial income, expenses and value adjustments to financial assets | 30,706 | 27,515 |
| Operating profit (loss) (EBIT) | 128,986 | 148,947 |
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out (1) | (827) | 233 |
| Charges and write-off related to back-office and network reorganization, as well as other efficiency projects and changes in Top management (2) |
2,794 | 2,456 |
| Gain and loss on disposal of assets and/or businesses, write-off and revaluation of fixed assets (3) | 123 | 321 |
| Amortization of fixed assets accounted in phase of Purchase Price Allocation (4) | 25,252 | 23,918 |
| Other unusual, infrequent or unrelated income and expenses above an amount of €1m in a quarter, or above €2m across multiple quarters (5) |
- | 920 |
| Total adjustments | 27,342 | 27,848 |
| Operating profit (loss) (EBIT) Adjusted | 156,328 | 176,796 |
(1), (5) The adjustments are listed in the section on Adjusted EBITDA;
-
(2) €1,353 thousand in costs for the write-down of property, plant and equipment, intangible assets and goodwill related to company and network reorganization and other efficiency projects are added to the adjustments listed in the section on Adjusted EBITDA (entirely related to APAC);
(3) €73 thousand (€645 thousand in the comparison period) in costs for the write-down of property, plant and equipment, intangible assets and goodwill are added to the adjustments listed in the section on Adjusted EBITDA;
(4) The positive adjustment of €25,252 thousand at 30 June 2025 (by geographic area: EMEA for €16,929 thousand, Americas for €2,482 thousand and APAC for €5,841 thousand) refers to the amortization of client lists, trademarks, licenses and non-compete agreements allocated as a result of business combinations ("PPA"). In the comparison period the positive adjustment was for €23,918 thousand (by geographic area: EMEA for €15,761 thousand, Americas for €2,133 thousand and APAC for €6,024 thousand);

The reconciliation of the Profit (loss) before tax with Profit (loss) before tax Adjusted is shown below.
| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Net profit (loss) attributable to the Group | 68,120 | 87,793 |
| Profit (loss) of minority interests | 99 | 81 |
| Net profit (loss) | 68,219 | 87,874 |
| Current and deferred income tax | 30,061 | 33,558 |
| Profit (loss) before tax | 98,280 | 121,432 |
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out (1) | (827) | 233 |
| Charges and write-off related to back-office and network reorganization, as well as other efficiency projects and changes in Top management (2) |
2,794 | 2,456 |
| Gain and loss on disposal of assets and/or businesses, write-off and revaluation of fixed assets (3) | 123 | 321 |
| Amortization of fixed assets accounted in phase of Purchase Price Allocation (4) | 25,252 | 23,918 |
| Financial income (loss) related to inflation accounting (IAS 29) and Fair Value changes resulting from modifications and/or non-cash accretion of financial liabilities (IFRS 9) (5) |
1,161 | 2,079 |
| Other unusual, infrequent or unrelated income and expenses above an amount of €1m in a quarter, or above €2m across multiple quarters (6) |
(1,837) | (1,465) |
| Total adjustments | 26,666 | 27,542 |
| Profit (loss) before tax Adjusted | 124,946 | 148,974 |
(1), (2), (3), (4) The adjustments are listed in the section on Adjusted EBIT;
(5) The adjustment of €1,161 thousand at 30 June 2025 (€2,079 thousand in the comparison period) refers for €612 thousand (€ 1,660 thousand in the comparison period) to financial expenses stemming from hyperinflation (IAS 29) and for €549 thousand (€420 thousand in the comparison period) to changes in FV following changes in financial liabilities (IFRS 9);
(6) The following should be added to the adjustments referred to in the section on Adjusted EBIT: €1,837 thousand (€2,385 thousand in the comparison period) in financial income relating to tax credits, derived from superbonus discounts, in accordance Articles 119 and 121 of Legislative Decree 34/2020, for further details refer to Note 7 (Other Non-Current Assets) of the explanatory notes;

The reconciliation of the Net profit (loss) with Net profit (loss) Adjusted is shown below.
| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Net profit (loss) attributable to the Group | 68,120 | 87,793 |
| Profit (loss) of minority interests | 99 | 81 |
| Net profit (loss) | 68,219 | 87,874 |
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out (1) | (827) | 233 |
| Charges and write-off related to back-office and network reorganization, as well as other efficiency projects and changes in Top management (2) |
2,794 | 2,456 |
| Gain and loss on disposal of assets and/or businesses, write-off and revaluation of fixed assets (3) | 123 | 321 |
| Amortization of fixed assets accounted in phase of Purchase Price Allocation (4) | 25,252 | 23,918 |
| Financial income (loss) related to inflation accounting (IAS 29) and Fair Value changes resulting from modifications and/or non-cash accretion of financial liabilities (IFRS 9) (5) |
1,161 | 2,079 |
| Other unusual, infrequent or unrelated income and expenses above an amount of €1m in a quarter, or above €2m across multiple quarters (6) |
(1,837) | (1,465) |
| Total adjustments before tax | 26,666 | 27,542 |
| Fiscal effect on adjustments and other fiscal adjustments (7) | (4,324) | (7,507) |
| Total adjustments | 22,342 | 20,035 |
| Net profit (loss) Adjusted | 90,561 | 107,909 |
(1), (2), (3), (4), (5), (6) The adjustments are listed in the section on Adjusted Profit Before Tax;
(7) The adjustment refers to the impact of taxes following the adjustments listed above and the effect of a reassessment of an estimation of deferred tax in Australia that entailed a non-monetary charge for €2,773 thousand.
The reconciliation of the Net profit (loss) attributable to the Group with Net profit (loss) attributable to the Group Adjusted is shown below.
| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Net profit (loss) attributable to the Group | 68,120 | 87,793 |
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out (1) | (827) | 233 |
| Charges and write-off related to back-office and network reorganization, as well as other efficiency projects and changes in Top management (2) |
2,794 | 2,456 |
| Gain and loss on disposal of assets and/or businesses, write-off and revaluation of fixed assets (3) | 123 | 321 |
| Amortization of fixed assets accounted in phase of Purchase Price Allocation (4) | 25,252 | 23,918 |
| Financial income (loss) related to inflation accounting (IAS 29) and Fair Value changes resulting from modifications and/or non-cash accretion of financial liabilities (IFRS 9) (5) |
1,161 | 2,079 |
| Other unusual, infrequent or unrelated income and expenses above an amount of €1m in a quarter, or above €2m across multiple quarters (6) |
(1,837) | (1,465) |
| Total adjustments before tax | 26,666 | 27,542 |
| Fiscal effect on adjustments and other fiscal adjustments (7) | (4,324) | (7,507) |
| Total adjustments | 22,342 | 20,035 |
| Net profit (loss) attributable to the Group Adjusted | 90,462 | 107,830 |
(1), (2), (3), (4), (5), (6), (7) The adjustments are listed in the section on Net profit (loss) Adjusted;

The breakdown of the calculation of the indicator is shown below:
| Value as at | |
|---|---|
| (€ thousands) | 06/30/2025 |
| Group EBITDA first six months 2025 | 286,981 |
| Group EBITDA July – December 2024 | 267,317 |
| Fair value of stock grant assignment | 10,196 |
| EBITDA normalized (from acquisitions and disposals) | 5,929 |
| Items (income and expenses) that are unusual, infrequent or not related to the operating performance July 2024 - June 2025 | 4,752 |
| EBITDA for the leverage calculation | 575,175 |


The main shareholders of Amplifon S.p.A. as at 30 June 2025 are:

| Shareholder | No. of ordinary shares (*) |
% held | % of the total share capital in voting rights |
|---|---|---|---|
| Ampliter S.r.l. | 95,105,392 | 42.01% | 68.36% |
| Treasury shares | 3,534,389 | 1.56% | 0.85% |
| Market | 127,748,839 | 56.43% | 30.79% |
| Total | 226,388,620 | 100.00% | 100.00% |
(*) Number of shares related to the share capital registered with the Company registrar on 30 June 2025.
Pursuant to article 2497 of the Italian Civil Code, Amplifon S.p.A. is not subject to management and coordination either by its direct parent Ampliter S.r.l. or its indirect parent.
The shares of the parent Amplifon S.p.A. have been listed on the screen-based stock market Euronext Milano (EXM) since 27 June 2001 and since 10 September 2008 in the STAR segment. Amplifon is also included in the FTSE MIB index and in the Stoxx Europe 600 index.

The chart shows the performance of the Amplifon share price and its trading volumes from 1st January 2025 to 30th June 2025.

As at 30 June 2025 market capitalization was €4,420.93 million.
Dealings in Amplifon shares in the screen-based stock market Euronext Milano (EXM) during the period 01 January 2025 – 30 June 2025, showed:

| (€ thousands) | First Half 2025 |
% on sales |
First Half 2024 |
% on sales |
Change % |
|---|---|---|---|---|---|
| Revenues from sales and services | 1,180,490 | 100.0% | 1,177,251 | 100.0% | 0.3% |
| Operating costs | (896,155) | -75.9% | (887,685) | -75.4% | -1.0% |
| Other income and costs | 2,646 | 0.2% | 4,207 | 0.4% | -37.1% |
| Gross operating profit (loss) (EBITDA) | 286,981 | 24.3% | 293,773 | 25.0% | -2.3% |
| Gross operating profit (loss) (EBITDA) Adjusted (*) | 287,645 | 24.4% | 297,058 | 25.2% | -3.2% |
| Depreciation, amortization and impairment losses on non-current assets |
(64,074) | -5.4% | (56,855) | -4.8% | -12.7% |
| Right-of-use depreciation | (68,670) | -5.9% | (64,053) | -5.4% | -7.2% |
| PPA related depreciation, amortization and impairment | (25,251) | -2.1% | (23,918) | -2.1% | -5.6% |
| Operating profit (loss) (EBIT) | 128,986 | 10.9% | 148,947 | 12.7% | -13.4% |
| Operating profit (loss) (EBIT) Adjusted (*) | 156,328 | 13.2% | 176,795 | 15.0% | -11.6% |
| Income, expenses, valuation and adjustments of financial assets | 90 | 0.0% | 283 | 0.0% | -68.2% |
| Net financial expenses | (28,854) | -2.4% | (26,340) | -2.3% | -9.5% |
| Exchange differences, inflation accounting and Fair Value valuation | (1,942) | -0.2% | (1,458) | -0.1% | -33.2% |
| Profit (loss) before tax | 98,280 | 8.3% | 121,432 | 10.3% | -19.1% |
| Profit (loss) before tax Adjusted (*) | 124,946 | 10.6% | 148,974 | 12.7% | -16.1% |
| Tax | (30,061) | -2.5% | (33,558) | -2.8% | 10.4% |
| Net profit (loss) | 68,219 | 5.8% | 87,874 | 7.5% | -22.4% |
| Net profit (loss) Adjusted (*) | 90,561 | 7.7% | 107,909 | 9.2% | -16.1% |
| Profit (loss) of minority interests | 99 | 0.0% | 81 | 0.0% | 22.2% |
| Net profit (loss) attributable to the Group | 68,120 | 5.8% | 87,793 | 7.5% | -22.4% |
| Net profit (loss) attributable to the Group Adjusted (*) | 90,462 | 7.7% | 107,828 | 9.2% | -16.1% |
(*) For details on the Alternative Performance Measures identified by the Group and how they were determined refer to the specific sections of the Preface and the Alternative Performance Measures in this Interim Financial Report.

| (€ thousands) | Second Quarter 2025 |
% on sales |
Second Quarter 2024 |
% on sales |
Change % |
|---|---|---|---|---|---|
| Revenues from sales and services | 592,700 | 100.0% | 604,143 | 100.0% | -1.9% |
| Operating costs | (446,384) | -75.4% | (446,995) | -74.0% | 0.1% |
| Other income and costs | (131) | 0.1% | 930 | 0.2% | -114.1% |
| Gross operating profit (loss) (EBITDA) | 146,185 | 24.7% | 158,078 | 26.2% | -7.5% |
| Gross operating profit (loss) (EBITDA) Adjusted (*) | 147,289 | 24.9% | 161,330 | 26.7% | -8.7% |
| Depreciation, amortization and impairment losses on non-current assets |
(31,911) | -5.6% | (28,815) | -4.6% | -10.7% |
| Right-of-use depreciation | (34,170) | -5.8% | (32,828) | -5.5% | -4.1% |
| PPA related depreciation, amortization and impairment | (12,558) | -1.9% | (12,121) | -2.1% | -3.6% |
| Operating profit (loss) (EBIT) | 67,546 | 11.4% | 84,314 | 14.0% | -19.9% |
| Operating profit (loss) (EBIT) Adjusted (*) | 82,543 | 13.9% | 99,814 | 16.5% | -17.3% |
| Income, expenses, valuation and adjustments of financial assets | 90 | - | 282 | - | -68.1% |
| Net financial expenses | (14,706) | -2.5% | (12,629) | -2.1% | -16.4% |
| Exchange differences, inflation accounting and Fair Value valuation |
(1,384) | -0.2% | (713) | -0.1% | -94.1% |
| Profit (loss) before tax | 51,546 | 8.7% | 71,254 | 11.8% | -27.7% |
| Profit (loss) before tax Adjusted (*) | 66,222 | 11.2% | 86,124 | 14.3% | -23.1% |
| Tax | (16,262) | -2.7% | (18,708) | -3.1% | 13.1% |
| Net profit (loss) | 35,284 | 6.0% | 52,546 | 8.7% | -32.9% |
| Net profit (loss) Adjusted (*) | 48,872 | 8.2% | 63,389 | 10.5% | -22.9% |
| Profit (loss) of minority interests | 48 | - | (383) | -0.1% | 112.5% |
| Net profit (loss) attributable to the Group | 35,236 | 5.9% | 52,929 | 8.8% | -33.4% |
| Net profit (loss) attributable to the Group Adjusted (*) | 48,824 | 8.2% | 63,772 | 10.6% | -23.4% |
(*) For details on the Alternative Performance Measures identified by the Group and how they were determined refer to the specific sections of the Preface and the Alternative Performance Measures in this Interim Financial Report.

The reclassified Consolidated Balance Sheet aggregates assets and liabilities according to operating functionality criteria, subdivided by convention into the following three key functions: investments, operations and finance.
| (€ thousands) | 06/30/2025 | 12/31/2024 | Change |
|---|---|---|---|
| Goodwill | 1,919,448 | 1,945,495 | (26,047) |
| Customer lists, non-compete agreements, trademarks and location rights | 244,533 | 259,447 | (14,914) |
| Software, licenses, other int.ass., wip and advances | 159,858 | 168,913 | (9,055) |
| Tangible assets | 252,009 | 253,925 | (1,916) |
| Right of use assets | 476,337 | 492,064 | (15,727) |
| Fixed financial assets (1) | 12,323 | 24,472 | (12,149) |
| Other non-current financial assets (1) | 41,118 | 41,432 | (313) |
| Total fixed assets | 3,105,626 | 3,185,747 | (80,121) |
| Inventories | 93,637 | 93,180 | 457 |
| Trade receivables | 220,330 | 226,754 | (6,424) |
| Other receivables | 122,505 | 115,304 | 7,201 |
| Current assets (A) | 436,472 | 435,238 | 1,234 |
| Total assets | 3,542,098 | 3,620,985 | (78,887) |
| Trade payables | (328,383) | (377,100) | 48,717 |
| Other payables (2) | (351,634) | (374,272) | 22,638 |
| Provisions for risks (current portion) | (3,062) | (2,403) | (659) |
| Short term liabilities (B) | (683,079) | (753,775) | 70,696 |
| Net working capital (A) - (B) | (246,607) | (318,537) | 71,930 |
| Derivative instruments (3) | 1,059 | 3,680 | (2,621) |
| Deferred tax assets | 74,322 | 77,332 | (3,010) |
| Deferred tax liabilities | (99,669) | (99,493) | (176) |
| Provisions for risks (non-current portion) | (16,704) | (20,925) | 4,221 |
| Employee benefits (non-current portion) | (13,527) | (15,457) | 1,930 |
| Loan fees (4) | 3,720 | 3,452 | 268 |
| Other long-term payables | (184,838) | (189,433) | 4,595 |
| NET INVESTED CAPITAL | 2,623,382 | 2,626,366 | (2,984) |
| Shareholders' equity | 1,013,559 | 1,150,002 | (136,443) |
| Third parties' equity | 272 | 222 | 50 |
| Net equity | 1,013,831 | 1,150,224 | (136,393) |
| Long term net financial debt (4) | 1,046,467 | 960,387 | 86,080 |
| Short term net financial debt (4) | 62,489 | 1,418 | 61,071 |
| Total net financial debt | 1,108,956 | 961,805 | 147,151 |
| Lease liabilities | 500,595 | 514,337 | (13,742) |
| Total lease liabilities & net financial debt | 1,609,551 | 1,476,142 | 133,409 |
| NET EQUITY, LEASE LIABILITIES AND NET FINANCIAL DEBT | 2,623,382 | 2,626,366 | (2,984) |

Notes for reconciling the condensed balance sheet with the statutory balance sheet:

The condensed consolidated cash flow statement is a summarized version of the reclassified statement of cash flows set out in the following pages and its purpose is, starting from the EBIT, to detail the cash flows from or used in operating, investing and financing activities.
| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Operating profit (loss) (EBIT) | 128,986 | 148,947 |
| Amortization, depreciation and write-downs | 157,995 | 144,826 |
| Provisions, other non-monetary items and gain/losses from disposals | 3,128 | 9,554 |
| Net financial expenses | (28,138) | (25,134) |
| Taxes paid | (21,386) | (44,208) |
| Changes in net working capital | (71,569) | (58,257) |
| Cash flow provided by (used in) operating activities before repayment of lease liabilities |
169,016 | 175,728 |
| Repayment of lease liabilities | (67,107) | (63,568) |
| Cash flow provided by (used in) operating activities (A) | 101,909 | 112,160 |
| Cash flow provided by (used in) operating investing activities (B) | (64,433) | (65,338) |
| Free Cash Flow (A) + (B) | 37,476 | 46,822 |
| Net cash flow provided by (used in) acquisitions (C) | (54,493) | (142,737) |
| Cash flow provided by (used in) investing activities (B) + (C) | (118,926) | (208,075) |
| Cash flow provided by (used in) operating activities and investing activities | (17,017) | (95,915) |
| Dividends | (65,302) | (65,593) |
| Treasury Shares | (55,228) | - |
| Fees paid on medium/long-term financing | (1,788) | (105) |
| Change in non-current assets | 556 | 5,799 |
| Net cash flow from the period | (138,779) | (155,814) |
| Net financial indebtedness at the beginning of the period excluding lease liabilities |
(961,805) | (852,130) |
| Effect of exchange rate fluctuations on net financial debt | (8,298) | (1,341) |
| Effect of discontinued operations on net financial debt | (74) | - |
| Changes in net financial debt | (138,779) | (155,814) |
| Net financial indebtedness at the end of the period excluding lease liabilities | (1,108,956) | (1,009,285) |
The impact of unusual, infrequent or unrelated items on free cash flow in the period is shown in the following table.
| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Free cash flow | 37,476 | 46,822 |
| Free cash flow generated by unusual, infrequent or unrelated items (see page 60 for details) |
2,542 | 2,005 |
| Free cash flow generated by operating performance | 40,018 | 48,827 |

| (€ thousands) | First Half 2025 | ||||||
|---|---|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |||
| Revenues from sales and services | 765,958 | 243,085 | 171,447 | - | 1,180,490 | ||
| Operating costs | (544,554) | (185,535) | (128,390) | (37,676) | (896,155) | ||
| Other income and costs | 1,544 | 740 | 254 | 108 | 2,646 | ||
| Gross operating profit (loss) (EBITDA) | 222,948 | 58,290 | 43,311 | (37,568) | 286,981 | ||
| Gross operating profit (loss) (EBITDA) Adjusted (*) | 223,114 | 57,090 | 43,641 | (36,200) | 287,645 | ||
| Depreciation, amortization and impairment of non current assets |
(28,950) | (10,344) | (10,404) | (14,376) | (64,074) | ||
| Right-of-use depreciation | (44,484) | (7,718) | (15,239) | (1,229) | (68,670) | ||
| PPA related depreciation, amortization and impairment | (16,928) | (2,265) | (5,841) | (217) | (25,251) | ||
| Operating profit (loss) (EBIT) | 132,586 | 37,963 | 11,827 | (53,390) | 128,986 | ||
| Operating profit (loss) (EBIT) Adjusted (*) | 149,784 | 39,245 | 19,321 | (52,022) | 156,328 | ||
| Income, expenses, valuation and adjustments of financial assets |
90 | ||||||
| Net financial expenses | (28,854) | ||||||
| Exchange differences, inflation accounting and Fair Value valuation |
(1,942) | ||||||
| Profit (loss) before tax | 98,280 | ||||||
| Profit (loss) before tax Adjusted (*) | 124,946 | ||||||
| Tax | (30,061) | ||||||
| Net profit (loss) | 68,219 | ||||||
| Net profit (loss) Adjusted (*) | 90,561 | ||||||
| Profit (loss) of minority interests | 99 | ||||||
| Net profit (loss) attributable to the Group | 68,120 | ||||||
| Net profit (loss) attributable to the Group Adjusted (*) | 90,462 |
(*) For details on the Alternative Performance Measures identified by the Group and how they were determined refer to the specific sections of the Preface and the Alternative Performance Measures in this Interim Financial Report.

Below is a summary reconciliation between EBITDA, EBIT, Profit before Tax, Net profit (loss), and the Net profit (loss) attributable to the Group.
| (€ thousands) | First Half 2025 | ||||||
|---|---|---|---|---|---|---|---|
| EBITDA | EBIT | Profit (loss) before tax |
Net profit (loss) |
Net profit (loss) Attributable to the Group |
|||
| Alternative Performance Measures | 286,981 128,986 | 98,280 | 68,219 | 68,120 | |||
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out |
(827) | (827) | (827) | (827) | (827) | ||
| Charges and write-off related to back-office and network reorganization, as well as other efficiency projects and changes in Top management |
1,441 | 2,794 | 2,794 | 2,794 | 2,794 | ||
| Gain and loss on disposal of assets and/or businesses, write-off and revaluation of fixed assets |
50 | 123 | 123 | 123 | 123 | ||
| Amortization of fixed assets accounted in phase of Purchase Price Allocation | - 25,252 | 25,252 | 25,252 | 25,252 | |||
| Financial income (loss) related to inflation accounting (IAS 29) and Fair Value changes resulting from modifications and/or non-cash accretion of financial liabilities (IFRS 9) |
- | - | 1,161 | 1,161 | 1,161 | ||
| Other unusual, infrequent or unrelated income and expenses above an amount of €1m in a quarter, or above €2m across multiple quarters |
- | - | (1,837) | (1,837) | (1,837) | ||
| Total adjustments before tax | 664 27,342 | 26,666 | 26,666 | 26,666 | |||
| Fiscal effect on adjustments and other fiscal adjustments | (4,324) | (4,324) | |||||
| Total adjustments | 664 27,342 | 26,666 | 22,342 | 22,342 | |||
| Adjusted Alternative Performance Measures | 287,645 156,328 | 124,946 | 90,561 | 90,462 |
Below is a summary reconciliation between EBITDA, EBIT by geographical with the same adjusted indicators.
| (€ thousands) | First Half 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EMEA Americas |
Asia Pacific | Corporate | Total | |||||||
| EBITDA | EBIT | EBITDA | EBIT | EBITDA | EBIT | EBITDA | EBIT | EBITDA | EBIT | |
| Alternative Performance Measures |
222,948 | 132,586 | 58,290 | 37,963 | 43,311 | 11,827 | (37,568) | (53,390) | 286,981 | 128,986 |
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out |
122 | 122 | (1,290) | (1,290) | 211 | 211 | 130 | 130 | (827) | (827) |
| Charges and write-off related to back-office and network reorganization, as well as other efficiency projects and changes in Top management |
(2) | 28 | 90 | 90 | 115 | 1,438 | 1,238 | 1,238 | 1,441 | 2,794 |
| Gain and loss on disposal of assets and/or businesses, write off and revaluation of fixed assets |
46 | 119 | - | - | 4 | 4 | - | - | 50 | 123 |
| Amortization of fixed assets accounted in phase of Purchase Price Allocation |
- | 16,929 | - | 2,482 | - | 5,841 | - | - | - | 25,252 |
| Total adjustments | 166 | 17,198 | (1,200) | 1,282 | 330 | 7,494 | 1,368 | 1,368 | 664 | 27,342 |
| Adjusted Alternative Performance Measures |
223,114 | 149,784 | 57,090 | 39,245 | 43,641 | 19,321 | (36,200) | (52,022) | 287,645 | 156,328 |

| (€ thousands) | First Half 2024 | |||||||
|---|---|---|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | ||||
| Revenues from sales and services | 757,467 | 240,418 | 179,185 | 181 | 1,177,251 | |||
| Operating costs | (533,912) | (180,528) | (131,935) | (41,310) | (887,685) | |||
| Other income and costs | 2,184 | 1,821 | (95) | 297 | 4,207 | |||
| Gross operating profit (loss) (EBITDA) | 225,739 | 61,711 | 47,155 | (40,832) | 293,773 | |||
| Gross operating profit (loss) (EBITDA) Adjusted (*) | 227,407 | 60,530 | 47,294 | (38,173) | 297,058 | |||
| Depreciation, amortization and impairment of non current assets |
(24,957) | (8,942) | (9,502) | (13,454) | (56,855) | |||
| Right-of-use depreciation | (41,455) | (6,985) | (14,437) | (1,176) | (64,053) | |||
| PPA related depreciation, amortization and impairment | (15,761) | (2,133) | (6,024) | - | (23,918) | |||
| Operating profit (loss) (EBIT) | 143,566 | 43,651 | 17,192 | (55,462) | 148,947 | |||
| Operating profit (loss) (EBIT) Adjusted (*) | 161,605 | 44,603 | 23,390 | (52,803) | 176,795 | |||
| Income, expenses, revaluation and adjustments of financial assets |
283 | |||||||
| Net financial expenses | (26,340) | |||||||
| Exchange differences, inflation accounting and Fair Value valuation |
(1,458) | |||||||
| Profit (loss) before tax | 121,432 | |||||||
| Profit (loss) before tax Adjusted (*) | 148,974 | |||||||
| Tax | (33,558) | |||||||
| Net profit (loss) | 87,874 | |||||||
| Net profit (loss) Adjusted (*) | 107,909 | |||||||
| Profit (loss) of minority interests | 81 | |||||||
| Net profit (loss) attributable to the Group | 87,793 | |||||||
| Net profit (loss) attributable to the Group Adjusted (*) | 107,828 |
(*) For details on the Alternative Performance Measures identified by the Group and how they were determined refer to the specific sections of the Preface and the Alternative Performance Measures in this Interim Financial Report.

Below is a summary reconciliation between EBITDA, EBIT, Profit before Tax, Net profit (loss), and the Net profit (loss) attributable to the Group.
| (€ thousands) | First Half 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| EBITDA | EBIT | Profit (loss) before tax |
Net profit (loss) |
Net profit (loss) attributable to the Group |
|||||
| Alternative Performance Measures | 293,773 148,947 | 121,432 | 87,874 | 87,793 | |||||
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out |
233 | 233 | 233 | 233 | 233 | ||||
| Costs relative to corporate and network reorganization, as well as other efficiency projects |
2,456 | 2,456 | 2,456 | 2,456 | 2,456 | ||||
| Gain and loss on disposal of assets and/or businesses, write-off and revaluation of fixed assets |
(324) | 321 | 321 | 321 | 321 | ||||
| Amortization of fixed assets accounted in phase of Purchase Price Allocation | - | 23,918 | 23,918 | 23,918 | 23,918 | ||||
| Financial income (loss) related to inflation accounting (IAS 29) and Fair Value changes resulting from modifications and/or non-cash accretion of financial liabilities (IFRS 9) |
- | - | 2,079 | 2,079 | 2,079 | ||||
| Other unusual, infrequent or unrelated income and expenses above an amount of €1m in a quarter, or above €2m across multiple quarters |
920 | 920 | (1,465) | (1,465) | (1,465) | ||||
| Total adjustments before tax | 3,285 | 27,848 | 27,542 | 27,542 | 27,542 | ||||
| Fiscal effect on adjustments and other fiscal adjustments | (7,507) | (7,507) | |||||||
| Total adjustments | 3,285 | 27,848 | 27,542 | 20,035 | 20,035 | ||||
| Adjusted Alternative Performance Measures | 297,058 176,795 | 148,974 | 107,909 | 107,828 |
Below is a summary reconciliation between EBITDA, EBIT by geographical with the same adjusted indicators.
| (€ thousands) | First Half 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EMEA | Americas Asia Pacific |
Corporate | Total | |||||||
| EBITDA | EBIT | EBITDA | EBIT | EBITDA | EBIT | EBITDA | EBIT | EBITDA | EBIT | |
| Alternative Performance Measures |
225,739 | 143,566 | 61,711 | 43,651 | 47,155 | 17,192 | (40,832) | (55,462) | 293,773 | 148,947 |
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out |
1,157 | 1,157 | (1,191) | (1,191) | 267 | 267 | - | - | 233 | 233 |
| Charges and write-off related to back-office and network reorganization, as well as other efficiency projects and changes in Top management |
718 | 718 | - | - | - | - | 1,738 | 1,738 | 2,456 | 2,456 |
| Gain and loss on disposal of assets and/or businesses, write off and revaluation of fixed assets |
(207) | 403 | 10 | 10 | (128) | (93) | 1 | 1 | (324) | 321 |
| Amortization of fixed assets accounted in phase of Purchase Price Allocation |
- | 15,761 | 2,133 | - | 6,024 | - | - | - | 23,918 | |
| Other unusual, infrequent or unrelated income and expenses above an amount of €1m in a quarter, or above €2m across multiple quarters |
- | - | - | - | - | - | 920 | 920 | 920 | 920 |
| Total adjustments | 1,668 | 18,039 | (1,181) | 952 | 139 | 6,198 | 2,659 | 2,659 | 3,285 | 27,848 |
| Adjusted Alternative Performance Measures |
227,407 | 161,605 | 60,530 | 44,603 | 47,294 | 23,390 | (38,173) | (52,803) | 297,058 | 176,795 |

| (€ thousands) | Second Quarter 2025 | |||||||
|---|---|---|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | ||||
| Revenues from sales and services | 382,394 | 124,646 | 85,660 | - | 592,700 | |||
| Operating costs | (271,005 ) |
(94,353) | (65,817) | (15,209) | (446,384) | |||
| Other income and costs | (682) | 187 | 371 | (7) | (131) | |||
| Gross operating profit (loss) (EBITDA) | 110,707 | 30,480 | 20,214 | (15,216) | 146,185 | |||
| Gross operating profit (loss) (EBITDA) Adjusted (*) | 110,514 | 30,425 | 20,325 | (13,975) | 147,289 | |||
| Depreciation, amortization and impairment of non current assets |
(14,588) | (5,242) | (5,726) | (6,355) | (31,911) | |||
| Right-of-use depreciation | (22,312) | (3,864) | (7,373) | (621) | (34,170) | |||
| PPA related depreciation, amortization and impairment | (8,368) | (1,105) | (2,868) | (217) | (12,558) | |||
| Operating profit (loss) (EBIT) | 65,439 | 20,269 | 4,247 | (22,409) | 67,546 | |||
| Operating profit (loss) (EBIT) Adjusted (*) | 73,626 | 21,537 | 8,548 | (21,168) | 82,543 | |||
| Income, expenses, revaluation and adjustments of financial assets |
90 | |||||||
| Net financial expenses | (14,706) | |||||||
| Exchange differences, inflation accounting and Fair Value valuation |
(1,384) | |||||||
| Profit (loss) before tax | 51,546 | |||||||
| Profit (loss) before tax Adjusted (*) | 66,222 | |||||||
| Tax | (16,262) | |||||||
| Net profit (loss) | 35,284 | |||||||
| Net profit (loss) Adjusted (*) | 48,872 | |||||||
| Profit (loss) of minority interests | 48 | |||||||
| Net profit (loss) attributable to the Group | 35,236 | |||||||
| Net profit (loss) attributable to the Group Adjusted (*) | 48,824 |
(*) For details on the Alternative Performance Measures identified by the Group and how they were determined refer to the specific sections of the Preface and the Alternative Performance Measures in this Interim Financial Report.

Below is a summary reconciliation between EBITDA, EBIT, Profit before Tax, Net profit (loss), and the Net profit (loss) attributable to the Group.
| (€ thousands) | Second Quarter 2025 | ||||||
|---|---|---|---|---|---|---|---|
| EBITDA | EBIT | Profit (loss) before tax |
Net profit (loss) |
Net profit (loss) Attributable to the Group |
|||
| Alternative Performance Measures | 146,185 67,546 | 51,546 | 35,284 | 35,236 | |||
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out |
(394) | (394) | (394) | (394) | (394) | ||
| Costs related to back-office and network reorganization, as well as other efficiency projects and changes in Top management |
1,441 | 2,794 | 2,794 | 2,794 | 2,794 | ||
| Gain and loss on disposal of assets and/or businesses, write-off and revaluation of fixed assets |
57 | 38 | 38 | 38 | 38 | ||
| Amortization of fixed assets accounted in phase of Purchase Price Allocation | - 12,559 | 12,559 | 12,559 | 12,559 | |||
| Financial income (loss) related to inflation accounting (IAS 29) and Fair Value changes resulting from modifications and/or non-cash accretion of financial liabilities (IFRS 9) |
- | - | 640 | 640 | 640 | ||
| Other unusual, infrequent or unrelated income and expenses above an amount of €1m in a quarter, or above €2m across multiple quarters |
- | - | (961) | (961) | (961) | ||
| Total adjustments before tax | 1,104 14,997 | 14,676 | 14,676 | 14,676 | |||
| Fiscal effect on adjustments and other fiscal adjustments | (1,088) | (1,088) | |||||
| Total adjustments | 1,104 14,997 | 14,676 | 13,588 | 13,588 | |||
| Adjusted Alternative Performance Measures | 147,289 82,543 | 66,222 | 48,872 | 48,824 |
Below is a summary reconciliation between EBITDA, EBIT by geographical with the same adjusted indicators.
| (€ thousands) | Second Quarter 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | ||||||
| EBITDA | EBIT | EBITDA | EBIT | EBITDA | EBIT | EBITDA | EBIT | EBITDA | EBIT | |
| Alternative Performance Measures |
110,707 | 65,439 | 30,480 | 20,269 | 20,214 | 4,247 | (15,216) | (22,409) | 146,185 | 67,546 |
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out |
(249) | (249) | (145) | (145) | (3) | (3) | 3 | 3 | (394) | (394) |
| Costs related to back-office and network reorganization, as well as other efficiency projects and changes in Top management |
(2) | 28 | 90 | 90 | 115 | 1,438 | 1,238 | 1,238 | 1,441 | 2,794 |
| Gain and loss on disposal of assets and/or businesses, write-off and revaluation of fixed assets |
58 | 39 | - | - | (1) | (1) | - | - | 57 | 38 |
| Amortization of fixed assets accounted in phase of Purchase Price Allocation |
- | 8,369 | - | 1,323 | - | 2,867 | - | - | - | 12,559 |
| Total adjustments | (193) | 8,187 | (55) | 1,268 | 111 | 4,301 | 1,241 | 1,241 | 1,104 | 14,997 |
| Adjusted Alternative Performance Measures |
110,514 | 73,626 | 30,425 | 21,537 | 20,325 | 8,548 | (13,975) | (21,168) | 147,289 | 82,543 |

| (€ thousands) | Second Quarter 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | ||||||
| Revenues from sales and services | 381,409 | 129,597 | 93,021 | 116 | 604,143 | |||||
| Operating costs | (264,170) | (95,212) | (69,959) | (17,654) | (446,995) | |||||
| Other income and costs | (233) | 1,086 | (69) | 146 | 930 | |||||
| Gross operating profit (loss) (EBITDA) | 117,006 | 35,471 | 22,993 | (17,392) | 158,078 | |||||
| Gross operating profit (loss) (EBITDA) Adjusted (*) | 118,194 | 35,109 | 23,268 | (15,241) | 161,330 | |||||
| Depreciation, amortization and impairment of non current assets |
(12,608) | (4,613) | (4,806) | (6,788) | (28,815) | |||||
| Right-of-use depreciation | (20,907) | (3,615) | (7,712) | (594) | (32,828) | |||||
| PPA related depreciation, amortization and impairment | (7,881) | (1,188) | (3,052) | - | (12,121) | |||||
| Operating profit (loss) (EBIT) | 75,610 | 26,055 | 7,423 | (24,774) | 84,314 | |||||
| Operating profit (loss) (EBIT) Adjusted (*) | 84,790 | 26,881 | 10,766 | (22,623) | 99,814 | |||||
| Income, expenses, revaluation and adjustments of financial assets |
282 | |||||||||
| Net financial expenses | (12,629) | |||||||||
| Exchange differences, inflation accounting and Fair Value valuation |
(713) | |||||||||
| Profit (loss) before tax | 71,254 | |||||||||
| Profit (loss) before tax Adjusted (*) | 86,124 | |||||||||
| Tax | (18,708) | |||||||||
| Net profit (loss) | 52,546 | |||||||||
| Net profit (loss) Adjusted (*) | 63,389 | |||||||||
| Profit (loss) of minority interests | (383) | |||||||||
| Net profit (loss) attributable to the Group | 52,929 | |||||||||
| Net profit (loss) attributable to the Group Adjusted (*) | 63,772 |
(*) For details on the Alternative Performance Measures identified by the Group and how they were determined refer to the specific sections of the Preface and the Alternative Performance Measures in this Interim Financial Report.

Below is a summary reconciliation between EBITDA, EBIT, Profit before Tax, Net profit (loss), and the Net profit (loss) attributable to the Group.
| (€ thousands) | Second Quarter 2024 | |||||
|---|---|---|---|---|---|---|
| EBITDA | EBIT | Profit (loss) before tax |
Net profit (loss) |
Net profit (loss) attributable to the Group |
||
| Alternative Performance Measures | 158,078 | 84,314 | 71,254 | 52,546 | 52,929 | |
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out |
301 | 301 | 301 | 301 | 301 | |
| Charges and write-off related to back-office and network reorganization, as well as other efficiency projects and changes in Top management |
2,456 | 2,456 | 2,456 | 2,456 | 2,456 | |
| Gain and loss on disposal of assets and/or businesses, write-off and revaluation of fixed assets |
83 | 209 | 209 | 209 | 209 | |
| Amortization of fixed assets accounted in phase of Purchase Price Allocation | - | 12,122 | 12,122 | 12,122 | 12,122 | |
| Financial income (loss) related to inflation accounting (IAS 29) and Fair Value changes resulting from modifications and/or non-cash accretion of financial liabilities (IFRS 9) |
- | - | 688 | 688 | 688 | |
| Other unusual, infrequent or unrelated income and expenses above an amount of €1m in a quarter, or above €2m across multiple quarters |
412 | 412 | (906) | (906) | (906) | |
| Total adjustments before tax | 3,252 | 15,500 | 14,870 | 14,870 | 14,870 | |
| Fiscal effect on adjustments and other fiscal adjustments | (4,027) | (4,027) | ||||
| Total adjustments | 3,252 | 15,500 | 14,870 | 10,843 | 10,843 | |
| Adjusted Alternative Performance Measures | 161,330 | 99,814 | 86,124 | 63,389 | 63,772 |
Below is a summary reconciliation between EBITDA, EBIT by geographical with the same adjusted indicators.
| (€ thousands) | Second Quarter 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EMEA Americas |
Asia Pacific | Corporate | Total | |||||||
| EBITDA | EBIT | EBITDA | EBIT | EBITDA | EBIT | EBITDA | EBIT | EBITDA | EBIT | |
| Alternative Performance Measures |
117,006 | 75,610 | 35,471 | 26,055 | 22,993 | 7,423 | (17,392) | (24,774) | 158,078 | 84,314 |
| Transaction and integration costs for acquisitions and changes (positive or negative) in earn-out |
502 | 502 | (402) | (402) | 201 | 201 | - | - | 301 | 301 |
| Charges and write-off related to back-office and network reorganization, as well as other efficiency projects and changes in Top management |
718 | 718 | - | - | - | - | 1,738 | 1,738 | 2,456 | 2,456 |
| Gain and loss on disposal of assets and/or businesses, write-off and revaluation of fixed assets |
(32) | 78 | 40 | 40 | 74 | 90 | 1 | 1 | 83 | 209 |
| Amortization of fixed assets accounted in phase of Purchase Price Allocation |
- | 7,882 | - | 1,188 | - | 3,052 | - | - | - | 12,122 |
| Other unusual, infrequent or unrelated income and expenses above an amount of €1m in a quarter, or above €2m across multiple quarters |
- | - | - | - | - | - | 412 | 412 | 412 | 412 |
| Total adjustments | 1,188 | 9,180 | (362) | 826 | 275 | 3,343 | 2,151 | 2,151 | 3,252 | 15,500 |
| Adjusted Alternative Performance Measures |
118,194 | 84,790 | 35,109 | 26,881 | 23,268 | 10,766 | (15,241) | (22,623) | 161,330 | 99,814 |

| (€ thousands) | First Half 2025 | First Half 2024 | Change | Change % |
|---|---|---|---|---|
| Revenues from sales and services |
1,180,490 | 1,177,251 | 3,239 | 0.3% |
| (€ thousands) | Second Quarter 2025 | Second Quarter 2024 | Change | Change % |
| Revenues from sales and services |
592,700 | 604,143 | (11,443) | -1.9% |
Consolidated revenues from sales and services amounted to €1,180,490 thousand in the first six months of 2025, an increase of €3,239 thousand (+0.3%) compared to the first six months of 2024, explained for €27,773 thousand (+2.4%) by acquisitions and perimeter changes. Organic growth was negative for €9,504 thousand (-0.8%), while exchange differences were negative for €15,030 thousand (-1.3%).
The revenues of the Argentinian subsidiary reflect the inflation accounting used in accordance with IAS 29 (Inflation Accounting), which had a positive impact on organic growth (+0.1%).
Despite the weakness of the market, there was good organic growth in the Americas region, while the European area, although growing overall thanks to the acquisitions, recorded negative organic performance. The APAC region was affected by the depreciation of the New Zealand dollar and the Australian dollar and, in terms of organic growth, by the weakness of the Chinese market.
In the second quarter alone, consolidated revenues from sales and services amounted to €592,700 thousand, a decrease of €11,443 thousand (-1.9%) compared to the second quarter of 2024, explained mainly by the foreign exchange effect which was negative for €15,167 thousand (-2.5%) and organic growth which was negative for €10,002 thousand (-1.7%). Acquisitions and perimeter changes made a positive contribution of €13,726 thousand (+2.3%).
The revenues of the Argentinian subsidiary, in the second quarter alone, reflect the inflation accounting used in accordance with IAS 29 (Inflation Accounting), which had a positive impact on organic growth (+0.1%).

| (€ thousands) | H1 2025 |
% on Total | H1 2024 |
% on Total | Change | Change % | Exchange diff. | Change % in local currency |
|---|---|---|---|---|---|---|---|---|
| EMEA | 765,958 | 64.9% | 757,467 | 64.4% | 8,491 | 1.1% | 735 | 1.0% |
| Americas | 243,085 | 20.6% | 240,418 | 20.4% | 2,667 | 1.1% | (7,766) | 4.3% |
| Asia Pacific | 171,447 | 14.5% | 179,185 | 15.2% | (7,738) | -4.3% | (7,999) | 0.1% |
| Corporate | - | 0.0% | 181 | 0.0% | (181) | -100.0% | - | -100.0% |
| Total | 1,180,490 | 100.0% | 1,177,251 | 100.0% | 3,239 | 0.3% | (15,030) | 1.6% |
| Change % in | ||||||||
| (€ thousands) | Q2 2025 |
% on Total | Q2 2024 |
% on Total | Change | Change % | Exchange diff. | local currency |
| EMEA | 382,394 | 64.5% | 381,409 | 63.1% | 985 | 0.3% | 541 | 0.1% |
| Americas | 124,646 | 21.0% | 129,597 | 21.5% | (4,951) | -3.8% | (9,119) | 3.2% |
| Asia Pacific | 85,660 | 14.5% | 93,021 | 15.4% | (7,361) | -7.9% | (6,589) | -0.8% |
| Corporate | - | 0.0% | 116 | 0.0% | (116) | -100.0% | - | -100.0% |
| Period (€ thousand) | 2025 | 2024 | Change | Change % |
|---|---|---|---|---|
| I quarter | 383,564 | 376,058 | 7,506 | 2.0% |
| II quarter | 382,394 | 381,409 | 985 | 0.3% |
| I Half Year | 765,958 | 757,467 | 8,491 | 1.1% |
Consolidated revenues from sales and services amounted to €765,958 thousand in the first six months of 2025, an increase of €8,491 thousand (+1.1%) compared to the same period of the prior year.
The increase is attributable to acquisitions and perimeter changes which contributed €20,006 thousand (+2.6%), among them stands out the first-time consolidation of the Polish subsidiary Amplifon Aparaty Słuchowe Sp.zo.o. purchased at the beginning of March. The strong performance of the French and German markets, mainly in the second half of the semester, was not enough to offset the weakness of the Southern European markets and the organic performance had a negative impact on the European market of €12,250 thousand (-1.6%). The foreign exchange effect was slightly positive at €735 thousand (+0.1%).
In the second quarter alone, consolidated revenues from sales and services amounted to € 382,394 thousand, an increase of €985 thousand (+0.3%) with respect to the comparison period. This change is explained primarily by acquisitions and perimeter changes, for €10,025 thousand (+2.6%). Organic growth was negative for €9,581 thousand (-2.5%) while the foreign exchange effect was marginal at positive €541 thousand (+0.2%).

| Period (€ thousand) | 2025 | 2024 | Change | Change % |
|---|---|---|---|---|
| I quarter | 118,439 | 110,821 | 7,618 | 6.9% |
| II quarter | 124,646 | 129,597 | (4,951) | -3.8% |
| I Half Year | 243,085 | 240,418 | 2,667 | 1.1% |
Consolidated revenues from sales and services amounted to €243,085 thousand in the first six months of 2025, an increase of €2,667 thousand (+1.1%).
This increase is explained for €2,881 thousand (+1.2%) by organic growth which was fueled primarily by the above-market performance of Miracle-Ear Direct Retail. Acquisitions and perimeter changes contributed €7,552 thousand (+3.1%) and the foreign exchange effect which negatively contributed for €7,766 thousand (-3.2%).
The revenues of the Argentinian subsidiary reflect the inflation accounting used in accordance with IAS 29 (Inflation Accounting), which had a positive impact on organic growth (+0.2%).
In the second quarter alone, consolidated revenues from sales and services amounted to € 124,646 thousand, a drop of €4,951 thousand (-3.8%) with respect to the comparison period. This change is explained primarily by the weakening of the US dollar, the Argentine peso, and the Canadian dollar, which negatively contributed for €9,199 thousands (-7,0%), partially offset by the positive contributions made by acquisitions and perimeter changes for €4,053 thousand (+3.1%) and organic growth for €115 thousand (+0.1%).
The revenues of the Argentinian subsidiary, in the second quarter alone, reflect the inflation accounting used in accordance with IAS 29 (Inflation Accounting), which had a positive impact on organic growth (+0.4%) and a negative impact on exchange differences (-0.1%).
| Period (€ thousand) | 2025 | 2024 | Change | Change % |
|---|---|---|---|---|
| I quarter | 85,787 | 86,164 | (377) | -0.4% |
| II quarter | 85,660 | 93,021 | (7,361) | -7.9% |
| I Half Year | 171,447 | 179,185 | (7,738) | -4.3% |
Revenues from sales and services amounted to €171,447 thousand in the first six months of 2025, showing a decrease of €7,738 thousand (-4.3%) compared to the same period of 2024.
This change is explained primarily by negative exchange differences for €7,999 thousand (-4.4%), due to the weakening of the New Zealand and Australian dollars. Overall, the acquisitions and perimeter changes had a positive impact of €215 thousand (+0.1%): the contribution of acquisitions in China for €3,181 thousand (+1.8%) was partially offset by the disposal of the

indirect sales network of the Chinese subsidiary Hangzhou Amplifon Hearing Aid Co., Ltd. and from the closure of one first group of low-performing shops, for €2,966 thousand (-1.7%). Organic growth had a positive impact of €46 thousand.
In the second quarter alone, consolidated revenues from sales and services amounted to €85,660 thousand, a drop of €7,361 thousand (-7.9%) mainly attributable to negative exchange differences for €6,589 thousand (-7.1%). Acquisitions and perimeter changes were negative for €352 thousand (-0.4%) mostly due to the disposal of indirect sales channels described above. Organic growth had a negative impact of €420 thousand (-0.4%).

| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Gross operating profit (loss) (EBITDA) | 286,981 | 293,773 |
| Gross operating profit (loss) (EBITDA) Adjusted | 287,645 | 297,058 |
| (€ thousands) | Second Quarter 2025 | Second Quarter 2024 |
| Gross operating profit (loss) (EBITDA) | 146,185 | 158,078 |
| Gross operating profit (loss) (EBITDA) Adjusted | 147,289 | 161,330 |
Gross operating profit (EBITDA) amounted to €286,981 thousand in the first six months of 2025, a decline of €6,792 thousand (-2.3%) with respect to the comparison period. The EBITDA margin came to 24.3%, 0.7 p.p. lower than in the comparison period.
The change compared to the previous period is attributable to the effect of lower operating leverage, the unfavorable geographic mix with greater exposure to Southern European markets, which slowed more than others, the dilution resulting from the acceleration of growth of Miracle-Ear's direct network in the United States, and the performance in China.
The result for the reporting period was affected by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made) for €664 thousand. The result of 2024 was affected by these items for €3,285 thousand.
Net of these items, adjusted EBITDA came to €287,645 thousand in the first six months of 2025, a decrease of €9,413 thousand (-3.2%) against the comparison period. The EBITDA margin was 0.8 p.p. lower than in the comparison period, coming in at 24.4%.
In the second quarter alone, EBITDA was €11,893 thousand (-7.5%) lower than in the comparison period coming in at €146,185 thousand. The EBITDA margin was 24.7%, - 1.5 p.p. lower than in the comparison period.
The second quarter result was affected by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made) for € 1,104 thousand. The result of 2024 was affected by these items for €3,252 thousand.
Net of these items, Adjusted EBITDA came to €147,289 thousand in the second quarter of 2025, a decrease against the comparison period of €14,041 thousand (-8.7%). The EBITDA margin was 1.8 p.p. lower than in the comparison period, coming in at 24.9%.

| H1 | EBITDA | H1 | EBITDA | |||
|---|---|---|---|---|---|---|
| (€ thousands) | 2025 | Margin | 2024 | Margin | Change | Change % |
| EMEA | 222,948 | 29.1% | 225,739 | 29.8% | (2,791) | -1.2% |
| Americas | 58,290 | 24.0% | 61,711 | 25.7% | (3,421) | -5.5% |
| Asia Pacific | 43,311 | 25.3% | 47,155 | 26.3% | (3,844) | -8.2% |
| Corporate (*) | (37,568) | -3.2% | (40,832) | -3.5% | 3,264 | -8.0% |
| Total | 286,981 | 24.3% | 293,773 | 25.0% | (6,792) | -2.3% |
| Q2 | EBITDA | Q2 | EBITDA | |||
| (€ thousands) | 2025 | Margin | 2024 | Margin | Change | Change % |
| EMEA | 110,707 | 29.0% | 117,006 | 30.7% | (6,299) | -5.4% |
| Americas | 30,480 | 24.5% | 35,471 | 27.4% | (4,991) | -14.1% |
| Asia Pacific | 20,214 | 23.6% | 22,993 | 24.7% | (2,779) | -12.1% |
| Corporate (*) | (15,216) | -2.6% | (17,392) | -2.9% | 2,176 | -12.5% |
(*) Centralized costs are shown as a percentage of the Group's total sales
| H1 | EBITDA Adjusted |
H1 | EBITDA Adjusted |
|||
|---|---|---|---|---|---|---|
| (€ thousands) | 2025 | Margin | 2024 | Margin | Change | Change % |
| EMEA | 223,114 | 29.1% | 227,407 | 30.0% | (4,293) | -1.9% |
| Americas | 57,090 | 23.5% | 60,530 | 25.2% | (3,440) | -5.7% |
| Asia Pacific | 43,641 | 25.5% | 47,294 | 26.4% | (3,653) | -7.7% |
| Corporate (*) | (36,200) | -3.1% | (38,173) | -3.2% | 1,973 | -5.2% |
| Total | 287,645 | 24.4% | 297,058 | 25.2% | (9,413) | -3.2% |
| EBITDA | EBITDA | |||||
|---|---|---|---|---|---|---|
| Q2 | Adjusted | Q2 | Adjusted | |||
| (€ thousands) | 2025 | Margin | 2024 | Margin | Change | Change % |
| EMEA | 110,514 | 28.9% | 118,194 | 31.0% | (7,680) | -6.5% |
| Americas | 30,425 | 24.4% | 35,109 | 27.1% | (4,684) | -13.3% |
| Asia Pacific | 20,325 | 23.7% | 23,268 | 25.0% | (2,943) | -12.6% |
| Corporate (*) | (13,975) | -2.4% | (15,241) | -2.5% | 1,266 | -8.3% |
| Total | 147,289 | 24.9% | 161,330 | 26.7% | (14,041) | -8.7% |
(*) Centralized costs are shown as a percentage of the Group's total sales.

Gross operating profit (EBITDA) amounted to €222,948 thousand in the first six months of 2025, a decrease of €2,791 thousand (-1.2%) with respect to the comparison period. The EBITDA margin came to 29.1%, a decrease of 0.7 p.p. compared to the first half of 2024.
The result for the reporting period was affected by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made) for €166 thousand. The result of 2024 was affected by these items for €1,668 thousand.
Net of these items, the decrease in adjusted EBITDA came to €4,293 thousand (-1.9%) in the first six months of 2025. The EBITDA margin was 0.9 p.p. lower than in the comparison period, coming in at 29.1%.
In the second quarter alone, EBITDA was €6,299 thousand (-5.4%) lower than in the comparison period coming in at €110,707 thousand. The EBITDA margin was 29.0%, 1.7 p.p. lower than in the comparison period.
The second quarter result was affected by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made) for €193 thousand. The result of 2024 was affected by these items for €1,188 thousand.
Net of these items, adjusted EBITDA came to €110,514 thousand, a decrease of €7,680 thousand (-6.5%) against the comparison period. The EBITDA margin was 2.1 p.p. lower than in the comparison period, coming in at 28.9%.
Gross operating profit (EBITDA) amounted to €58,290 thousand in the first six months of 2025, a decrease of €3,421 thousand (-5.5%) with respect to the comparison period. The EBITDA margin came to 24.0%, a decrease of 1.7 p.p. compared to the first half of 2024.
The result for the reporting period benefited from items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made) for €1,200 thousand. The result of 2024 benefited from these items for €1,181 thousand.
Net of these items, the decrease in adjusted EBITDA came to €3,440 thousand (-5.7%) in the first six months of 2025. The EBITDA margin was 1.7 p.p. lower than in the comparison period, coming in at 23.5%.

In the second quarter alone, EBITDA was €4,991 thousand (-14.1%) lower than in the comparison period coming in at €30,480 thousand. The EBITDA margin was 24.5%, 2.9 p.p. lower than in the comparison period.
The result for the second quarter benefited from items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made) for €55 thousand. The result of 2024 benefited from these items amounted to €362 thousand.
Net of these items, adjusted EBITDA came to €30,425 thousand in the second quarter of 2025, a decrease of 4,684 thousand (-13.3%) against the comparison period. The EBITDA margin was 2.7 p.p. lower than in the comparison period, coming in at 24.4%.
Gross operating profit (EBITDA) amounted to €43,311 thousand in the first six months of 2025, a decrease of €3,844 thousand (-8.2%) with respect to the comparison period. The EBITDA margin came to 25.3%, a decrease of 1.0 p.p. compared to the first half of 2024.
The result for the reporting period was affected by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made) for €330 thousand. The result of 2024 was affected by these items for €139 thousand.
Net of these items, the decrease in adjusted EBITDA came to €3,653 thousand (-7.7%) in the first six months of 2025. The EBITDA margin was 0.9 p.p. lower than in the comparison period, coming in at 25.5%.
In the second quarter alone, EBITDA was €2,779 thousand (-12.1%) lower than in the comparison period coming in at €20,214 thousand. The EBITDA margin was 23.6%, 1.1 p.p. lower than in the comparison period.
The second quarter result was affected by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made) for € 111 thousand. The result of 2024 was affected by these items for €275 thousand.
Net of these items, adjusted EBITDA came to €20,325 thousand in the second quarter of 2025, a decrease of €2,943 thousand (-12.6%) against the comparison period. The EBITDA margin was 1.3 p.p. lower than in the comparison period, coming in at 23.7%.

In the first six months of 2025 the net cost of centralized corporate functions (corporate bodies, general management, business development, procurement, treasury, legal affairs, human resources, IT systems, global marketing and internal audit) which do not qualify as operating segments under IFRS 8 amounted to €37,568 thousand (3.2% of the Group's revenues from sales and services), a decrease of €3,264 thousand (-8.0%) with respect to the same period of the prior year. The EBITDA margin was 0.3 p.p. lower than in the comparison period.
The result for the reporting period was affected by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made) for €1,368 thousand. The result of 2024 was affected by these items for €2,659 thousand.
Net of these items, adjusted EBITDA was €1,973 thousand (+5.2%) higher in the first six months of 2024. The EBITDA margin improved by +0.1 p.p. against the comparison period, coming in at -3.1%.
In the second quarter alone, the net cost for corporate functions amounted to €15,216 thousand (-2.6% of the Group's revenues from sales and services), a decrease of € 2,176 thousand (-12.5%) compared to the second quarter of 2024.
The result for the reporting period was affected by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made) for €1,241 thousand. The result of 2024 was affected by these items for €2,151 thousand.
Net of these items, adjusted EBITDA was €1,266 thousand (-8.3%) lower than in the second quarter of 2024. The EBITDA margin improved by +0.1 p.p. against the comparison period, coming in at -2.4%.

| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Operating profit (loss) (EBIT) | 128,986 | 148,947 |
| Operating profit (loss) (EBIT) Adjusted | 156,328 | 176,795 |
| (€ thousands) | Second Quarter 2025 | Second Quarter 2024 |
| Operating profit (loss) (EBIT) | 67,546 | 84,314 |
| Operating profit (loss) (EBIT) Adjusted | 82,543 | 99,814 |
Operating profit (EBIT) amounted to €128,986 thousand in the first six months of 2025, a decrease of €19,961 thousand (-13.4%) with respect to the comparison period. The EBIT margin came to 10.9%, 1.8 p.p. lower than in the comparison period.
With respect to the gross operating profit (EBITDA), EBIT was also impacted by an increase in amortization and depreciation stemming from network expansion, the investments made in innovation and digital transformation, as well as higher amortization for the right of use assets and the initial recognition of assets in accordance with Purchase Price Allocation accounting.
The result for the reporting period was affected by €27,342 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance primarily attributable to, in addition to what was already described in the section on adjusted EBITDA, the amortization of intangible assets recognized during Purchase Price Allocation. For more information refer to the section on Alternative Performance Indicators. The result of 2024 was affected by these items for €27,848 thousand.
Net of these items, adjusted EBIT amounted to €156,328 thousand in the first six months of 2025, a decrease of €20,467 thousand (-11.6%) against the comparison period. The EBIT margin was 1.8 p.p. lower than in the comparison period, coming in at 13.2%.
In the second quarter alone operating profit (EBIT) amounted to €67,546 thousand, a decrease of €16,768 thousand (-19.9%) with respect to the comparison period. The EBIT margin came to 11.4%, 2.6 p.p. lower in the comparison period.
The result for the second quarter was affected for €14,997 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance detailed in the section on Alternative Performance Indicators to which reference should be made. The result of 2024 was affected by these items for €15,500 thousand.

Net of these items, adjusted EBIT amounted to €82,543 thousand in the second quarter of 2025, a decrease of €17,271 thousand (-17.3%) against the comparison period. The EBIT margin was 2.6 p.p. lower than in the comparison period, coming in at 13.9%.
| (€ thousands) | H1 2025 | EBIT Margin |
H1 2024 | EBIT Margin |
Change | Change % |
|---|---|---|---|---|---|---|
| EMEA | 132,586 | 17.3% | 143,566 | 19.0% | (10,980) | -7.6% |
| Americas | 37,963 | 15.6% | 43,651 | 18.2% | (5,688) | -13.0% |
| Asia Pacific | 11,827 | 6.9% | 17,192 | 9.6% | (5,365) | -31.2% |
| Corporate (*) | (53,390) | -4.5% | (55,462) | -4.7% | 2,072 | -3.7% |
| Total | 128,986 | 10.9% | 148,947 | 12.7% | (19,961) | -13.4% |
| (€ thousands) | Q2 2025 | EBIT Margin |
Q2 2024 | EBIT Margin |
Change | Change % |
| EMEA | 65,439 | 17.1% | 75,610 | 19.8% | (10,171) | -13.5% |
| Americas | 20,269 | 16.3% | 26,055 | 20.1% | (5,786) | -22.2% |
| Asia Pacific | 4,247 | 5.0% | 7,423 | 8.0% | (3,176) | -42.8% |
| Corporate (*) | (22,409) | -3.8% | (24,774) | -4.1% | 2,365 | -9.5% |
The breakdown of EBIT by geographic area is shown below.
(*) Centralized costs are shown as a percentage of the Group's total sales.
| EBIT | EBIT | |||||
|---|---|---|---|---|---|---|
| H1 2025 | Adjusted | H1 2024 | Adjusted | Change | Change % | |
| (€ thousands) | Margin | Margin | ||||
| EMEA | 149,784 | 19.6% | 161,605 | 21.3% | (11,821) | -7.3% |
| Americas | 39,245 | 16.1% | 44,603 | 18.6% | (5,358) | -12.0% |
| Asia Pacific | 19,321 | 11.3% | 23,390 | 13.1% | (4,069) | -17.4% |
| Corporate (*) | (52,022) | -4.4% | (52,803) | -4.5% | 781 | -1.5% |
| Total | 156,328 | 13.2% | 176,795 | 15.0% | (20,467) | -11.6% |
| EBIT | EBIT | |||||
| Q2 2025 | Adjusted | Q2 2024 | Adjusted | Change | Change % | |
| (€ thousands) | Margin | Margin | ||||
| EMEA | 73,626 | 19.3% | 84,790 | 22.2% | (11,164) | -13.2% |
| Americas | 21,537 | 17.3% | 26,881 | 20.7% | (5,344) | -19.9% |
| Asia Pacific | 8,548 | 10.0% | 10,766 | 11.6% | (2,218) | -20.6% |
| Corporate (*) | (21,168) | -3.6% | (22,623) | -3.7% | 1,455 | -6.4% |
| Total | 82,543 | 13.9% | 99,814 | 16.5% | (17,271) | -17.3% |
(*) Centralized costs are shown as a percentage of the Group's total sales.

Operating profit (EBIT) amounted to €132,586 thousand in the first six months of 2025, a decrease of €10,980 thousand (-7.6%) with respect to the comparison period. The EBIT margin came to 17.3%, 1.7 p.p. lower than in the first six months of 2024.
The result for the reporting period was affected for €17,198 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance detailed in the section on Alternative Performance Indicators to which reference should be made. The result of 2024 was affected by these items for €18,039 thousand.
Net of these items, adjusted EBIT was €11,821 thousand (-7.3%) lower in the first six months of 2025. The EBIT margin fell 1.7 p.p. against the comparison period to 19.6%.
In the second quarter alone operating profit (EBIT) amounted to €65,439 thousand, a decrease of €10,171 thousand (-13.5%) with respect to the comparison period. The EBIT margin came to 17.1%, 2.7 p.p. lower than in the comparison period.
The result for the second quarter was affected for €8,187 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance detailed in the section on Alternative Performance Indicators to which reference should be made. The result of 2024 was affected by these items for €9,180 thousand.
Net of these items, adjusted EBIT came to €73,626 thousand in the second quarter of 2025, a decrease of €11,164 thousand (-13.2%) against the comparison period. The EBIT margin fell 2.9 p.p. against the comparison period to 19.3%.
Operating profit (EBIT) amounted to €37,963 thousand in the first six months of 2025, a decrease of €5,688 thousand (-13.0%) with respect to the comparison period. The EBIT margin came to 15.6%, 2.6 p.p. lower than in the first six months of 2024.
The result for the reporting period was affected for €1,282 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance detailed in the section on Alternative Performance Indicators to which reference should be made. The result of 2024 was affected by these items for €952 thousand.
Net of these items, adjusted EBIT was €5,358 thousand (-12.0%) lower in the first six months of 2025. The EBIT margin fell 2.5 p.p. against the comparison period to 16.1%.
In the second quarter alone operating profit (EBIT) amounted to €20,269 thousand, a decrease of €5,786 thousand (-22.2%) with respect to the comparison period. The EBIT margin came to 16.3%, 3.8 p.p. lower than in the comparison period.

The result for the second quarter was affected for €1,268 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance detailed in the section on Alternative Performance Indicators to which reference should be made. The result of 2024 was affected by these items for €826 thousand.
Net of these items, adjusted EBIT came to €21,537 thousand in the second quarter of 2025, a decrease of €5,344 thousand (-19.9%) against the comparison period. The EBIT margin fell 3.4 p.p. against the comparison period to 17.3%.
Operating profit (EBIT) amounted to €11,827 thousand in the first six months of 2025, a decrease of €5,365 thousand (-31.2%) with respect to the comparison period. The EBIT margin came to 6.9%, 2.7 p.p. lower than in the first six months of 2024.
The result for the reporting period was affected for €7,494 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance detailed in the section on Alternative Performance Indicators to which reference should be made. The result of 2024 was affected by these items for €6,198 thousand.
Net of these items, adjusted EBIT was €4,069 thousand (-17.4%) lower in the first six months of 2025. The EBIT margin fell 1.8 p.p. against the comparison period to 11.3%.
In the second quarter alone operating profit (EBIT) amounted to €4,247 thousand, a decrease of €3,176 thousand (-42.8%) with respect to the comparison period. The EBIT margin came to 5.0%, 3.0 p.p. lower than in the comparison period.
The result for the second quarter was affected for €4,301 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance detailed in the section on Alternative Performance Indicators to which reference should be made. The result of 2024 was affected by these items for €3,343 thousand.
Net of these items, adjusted EBIT came to €8,548 thousand in the second quarter of 2025, a decrease of €2,218 thousand (-20.6%) against the comparison period. The EBIT margin fell 1.6 p.p. against the comparison period to 10.0%.

The net Corporate costs at the EBIT level amounted to €53,390 thousand in the first six months of 2025 (-4.5% of the revenues generated by the Group's sales and services), a decrease of €2,072 thousand against the first half of 2024 (-3.7%)
The result for the reporting period was affected for €1,368 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made). The result of 2024 was affected by these items for €2,659 thousand.
Net of these items, the net Corporate costs at the EBIT level amounted to €52,022 thousand (- 1.5%). The EBIT margin was 0.1 p.p. lower than in the comparison period, coming in at -4.4%.
In the second quarter alone, the net Corporate costs at the EBIT level amounted to €22,409 thousand in the second quarter of 2025 (-3.8% of the revenues generated by the Group's sales and services), a decrease of €2,365 thousand (-9.5%) against the second quarter of 2024.
The result for the second quarter was affected for €1,241 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance detailed in the section on Alternative Performance Indicators to which reference should be made. The result of 2024 was affected by these items for €2,151 thousand.
Net of these items, costs were €1,455 thousand (-6.4%) lower. The margin on sales came to -3.6%, showing an increase of +0.1 p.p. against the comparison period.

| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Profit before taxes | 98,280 | 121,432 |
| Profit before taxes Adjusted | 124,946 | 148,974 |
| (€ thousands) | Second Quarter 2025 | Second Quarter 2024 |
| Profit before taxes | 51,546 | 71,254 |
| Profit before taxes Adjusted | 66,222 | 86,124 |
Profit before tax amounted to €98,280 thousand in the first six months of 2025, a decrease of €23,152 thousand (-19.1%) against the comparison period, with a gross profit margin of 8.3% (- 2.0 p.p. with respect to the comparison period).
Total financial expenses were €3,191 thousand higher than in the first half of 2024 due mainly to the higher interest payable on leases and the impact of exchange differences caused by significant changes in currency exchange rates during the half.
The result for the reporting period was affected for €26.666 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made). In addition to what was described in the section on EBIT, financial expenses in the reporting period benefitted from the income generated by the purchase and use of superbonus credits in accordance with Articles 119 and 121 of Legislative Decree 34/2020, net hyper-inflation charges and the impact of changes in FV following non-monetary adjustment and/or revaluations of financial liabilities for a total negative impact of €676 thousand. The result of 2024 was affected by items (income and expenses) that are unusual, infrequent or not related to the operating performance for €27,542 thousand.
Net of these items, the adjusted profit before tax in the first six months of 2025 was €24,028 thousand (-16.1%) lower, coming in at €124,946 thousand. The gross profit margin came to 10.6%, a decrease of -2.1 p.p. against the comparison period.
In the second quarter alone, profit before tax amounted to €51,546 thousand, a decrease of €19,708 thousand (-27.7%) against the comparison period. The gross profit margin came to 8.7% (-3.1 p.p. compared to the comparison period). Net expenses for financial management were, overall, higher at €2,940 thousand.
The result for the quarter was affected for €14,676 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section

on Alternative Performance Indicators to which reference should be made). The result of 2024 was affected by these items for €14,870 thousand.
Net of these items, adjusted profit before tax was €19,902 thousand (-23,1%) lower. The gross profit margin was 3.1 p.p. lower than in the comparison period, coming in at 11.2%.
| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Net profit (loss) attributable to the Group | 68,120 | 87,793 |
| Net profit (loss) attributable to the Group Adjusted | 90,462 | 107,828 |
| (€ thousands) | Second Quarter 2025 | Second Quarter 2024 |
| Net profit (loss) attributable to the Group | 35,236 | 52,929 |
| Net profit (loss) attributable to the Group Adjusted | 48,824 | 63,772 |
The Group's portion of net profit came to €68,120 thousand in the first six months of 2025, a decrease of €19,673 thousand (-22.4%) against the comparison period with the profit margin down 1.7 p.p. at 5.8%.
The result for the reporting period was affected for €22,342 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made). In addition to the costs for €26,666 thousand already explained above in the section on Profit before tax, net the tax effect of €7,097 thousand, a reassessment of an estimation of deferred tax in Australia entailed a non-monetary charge for €2,773 thousand. The result of 2024 was affected by these items for €20,035 thousand net the tax effect of €7,507 thousand.
Net of these items, the Group's adjusted portion of net profit amounted to €90,462 thousand in the first six months of 2025, €17,366 thousand lower (-16.1%) than in the comparison period. The profit margin was 1.5 p.p. lower than in the comparison period and came in at 7.7%.
In the second quarter alone, the Group's portion of net profit was €35,236 thousand, €17,693 thousand (-33.4%) lower than in the comparison period. The profit margin came in at 5.9% (-2.9 p.p. against the comparison period).
The result for the quarter was affected for €13,588 thousand by items (income and expenses) that are unusual, infrequent or not related to the operating performance (detailed in the section on Alternative Performance Indicators to which reference should be made). In addition to the costs for €14,676 thousand already explained above in the section on Profit before tax, net the

tax effect of €3,861 thousand, a reassessment of an estimation of deferred tax in Australia entailed a non-monetary charge for €2,773 thousand. The result of 2024 was affected by these items for €10,843 thousand, net the tax effect of €4,027 thousand.
Net of these items, the adjusted portion of the profit before tax amounted to €14,948 thousand (-23.4%). The profit margin was 2.4 p.p. lower than in the comparison period, coming in at 8.2%.
The tax rate in the period came to 30.6% compared to 27.6% in the first six months of 2024.
The adjusted tax rate in the period came to 27.5% compared to 27.6% in the first six months of 2024.

| (€ thousands) | 06/30/2025 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | APAC | Eliminations | Total | |
| Goodwill | 1,065,711 | 292,120 | 561,617 | - | 1,919,448 |
| Non-competition agreements, trademarks, customer lists and lease rights |
169,781 | 30,554 | 44,198 | - | 244,533 |
| Software, licenses, other intangible fixed assets, fixed assets in progress and advances |
124,686 | 26,029 | 9,143 | - | 159,858 |
| Property, plant, and equipment | 172,063 | 41,412 | 38,534 | - | 252,009 |
| Right-of-use assets | 379,562 | 46,093 | 50,682 | - | 476,337 |
| Financial fixed assets | 6,200 | 5,885 | 238 | - | 12,323 |
| Other non-current financial assets | 37,065 | 2,490 | 1,563 | - | 41,118 |
| Non-current assets | 1,955,068 | 444,583 | 705,975 | - | 3,105,626 |
| Inventories | 73,200 | 11,566 | 8,871 | - | 93,637 |
| Trade receivables | 246,765 | 37,647 | 12,297 | (76,379) | 220,330 |
| Other receivables | 88,943 | 23,918 | 9,832 | (188) | 122,505 |
| Current assets (A) | 408,908 | 73,131 | 31,000 | (76,567) | 436,472 |
| Operating assets | 2,363,976 | 517,714 | 736,975 | (76,567) | 3,542,098 |
| Trade payables | (283,782) | (77,300) | (43,680) | 76,379 | (328,383) |
| Other payables | (276,218) | (41,165) | (34,439) | 188 | (351,634) |
| Provisions for risks and charges (current portion) |
(2,475) | (587) | - | - | (3,062) |
| Current liabilities (B) | (562,475) | (119,052) | (78,119) | 76,567 | (683,079) |
| Net working capital (A) - (B) | (153,567) | (45,921) | (47,119) | - | (246,607) |
| Derivative instruments | 1,059 | 1,059 | |||
| Deferred tax assets | 53,673 | 6,110 | 14,539 | 74,322 | |
| Deferred tax liabilities | (68,073) | (21,990) | (9,606) | (99,669) | |
| Provisions for risks and charges (non current portion) |
(14,802) | (1,092) | (810) | (16,704) | |
| Liabilities for employees' benefits (non current portion) |
(12,898) | (21) | (608) | (13,527) | |
| Loan fees | 3,720 | 3,720 | |||
| Other non-current liabilities | (169,154) | (12,983) | (2,701) | (184,838) | |
| NET INVESTED CAPITAL | 1,595,026 | 368,686 | 659,670 | 2,623,382 | |
| Group net equity | 1,013,559 | ||||
| Minority interests | 272 | ||||
| Total net equity | 1,013,831 | ||||
| Net medium and long-term financial indebtedness |
1,046,467 | ||||
| Net short-term financial indebtedness | 62,489 | ||||
| Total net financial indebtedness | 1,108,956 | ||||
| Lease liabilities | 398,176 | 49,868 | 52,551 | - | 500,595 |
| Total lease liabilities & net financial indebtedness |
1,609,551 | ||||
| NET EQUITY, LEASE LIABILITIES AND NET FINANCIAL INDEBTEDNESS |
2,623,382 |
(*) The balance sheet items are analyzed by geographical area without separation of the Corporate structures that are natively included in EMEA.

| 12/31/2024 (€ thousands) |
|||||
|---|---|---|---|---|---|
| EMEA | Americas | APAC | Eliminations | Total | |
| Goodwill | 1,031,163 | 313,631 | 600,701 | - | 1,945,495 |
| Non-competition agreements, trademarks, customer lists and lease rights |
176,203 | 31,101 | 52,143 | - | 259,447 |
| Software, licenses, other intangible fixed assets, fixed assets in progress and advances |
127,637 | 32,008 | 9,268 | - | 168,913 |
| Property, plant, and equipment | 168,319 | 41,075 | 44,530 | - | 253,924 |
| Right-of-use assets | 381,119 | 49,770 | 61,175 | - | 492,064 |
| Financial fixed assets | 17,326 | 6,890 | 256 | - | 24,472 |
| Other non-current financial assets | 36,942 | 2,640 | 1,850 | - | 41,432 |
| Non-current assets | 1,938,709 | 477,115 | 769,923 | - | 3,185,747 |
| Inventories | 71,792 | 11,777 | 9,611 | - | 93,180 |
| Trade receivables | 233,432 | 66,043 | 15,120 | (87,841) | 226,754 |
| Other receivables | 93,370 | 16,633 | 5,489 | (188) | 115,304 |
| Current assets (A) | 398,594 | 94,453 | 30,220 | (88,029) | 435,238 |
| Operating assets | 2,337,303 | 571,568 | 800,143 | (88,029) | 3,620,985 |
| Trade payables | (343,885) | (70,137) | (50,919) | 87,841 | (377,100) |
| Other payables | (287,489) | (45,154) | (41,817) | 188 | (374,272) |
| Provisions for risks and charges (current portion) |
(1,787) | (616) | - | - | (2,403) |
| Current liabilities (B) | (633,161) | (115,907) | (92,736) | 88,029 | (753,775) |
| Net working capital (A) - (B) | (234,567) | (21,454) | (62,516) | - | (318,537) |
| Derivative instruments | 3,680 | - | - | - | 3,680 |
| Deferred tax assets | 56,435 | 5,762 | 15,135 | - | 77,332 |
| Deferred tax liabilities | (66,211) | (23,234) | (10,048) | - | (99,493) |
| Provisions for risks and charges (non current portion) |
(18,896) | (1,158) | (871) | - | (20,925) |
| Liabilities for employees' benefits (non current portion) |
(14,753) | - | (704) | - | (15,457) |
| Loan fees | 3,452 | - | - | - | 3,452 |
| Other non-current liabilities | (171,840) | (14,740) | (2,853) | - | (189,433) |
| NET INVESTED CAPITAL | 1,496,008 | 422,291 | 708,067 | - | 2,626,366 |
| Group net equity | 1,150,002 | ||||
| Minority interests | 222 | ||||
| Total net equity | 1,150,224 | ||||
| Net medium and long-term financial indebtedness |
960,387 | ||||
| Net short-term financial indebtedness | 1,418 | ||||
| Total net financial indebtedness | 961,805 | ||||
| Lease liabilities | 398,120 | 53,845 | 62,372 | - | 514,337 |
| Total lease liabilities & net financial indebtedness |
1,476,142 | ||||
| NET EQUITY, LEASE LIABILITIES AND NET FINANCIAL INDEBTEDNESS |
2,626,366 |

Non-current assets amounted to €3,105,626 thousand as at 30 June 2025, a decrease of €80,121 thousand with respect to the €3,185,747 thousand recorded as at 31 December 2024.
The changes in the reporting period are explained (i) for €71,501 thousand by acquisitions; (ii) for €64,615 thousand by capex; (iii) for €61,615 thousand by right-of-use assets acquired in the reporting period for renewals of existing leases and network expansion; (iv) for €157,995 thousand, by amortization, depreciation and impairment, including amortization of the right-ofuse assets and the assets allocated as a result of business combinations; (v) for €103,975 by the negative impact of exchange differences, which had the largest impact on goodwill; (vi) for €15,882 thousand by other decreases stemming mainly from the reclass to the short term category of tax credit booked in 2024 and to the early lease terminations due to clinics' relocation and closure.
The breakdown of non-current assets by geographic area is shown below.
| (€ thousands) | 06/30/2025 | 12/31/2024 | Change | |
|---|---|---|---|---|
| Goodwill | 1,065,711 | 1,031,163 | 34,548 | |
| Non-competition agreements, trademarks, customer lists and lease rights |
169,781 | 176,203 | (6,422) | |
| Software, licenses, other intangible fixed assets, fixed assets in progress and advances |
124,686 | 127,637 | (2,951) | |
| EMEA (*) | Tangible assets | 172,063 | 168,319 | 3,744 |
| Right-of-use assets | 379,562 | 381,119 | (1,557) | |
| Financial fixed assets | 6,200 | 17,326 | (11,126) | |
| Other non-current financial assets | 37,065 | 36,942 | 123 | |
| Non-current assets | 1,955,068 | 1,938,709 | 16,359 | |
| Goodwill | 292,120 | 313,631 | (21,511) | |
| Americas | Non-competition agreements, trademarks, customer lists and lease rights |
30,554 | 31,101 | (547) |
| Software, licenses, other intangible fixed assets, fixed assets in progress and advances |
26,029 | 32,008 | (5,979) | |
| Tangible assets | 41,412 | 41,075 | 337 | |
| Right-of-use assets | 46,093 | 49,770 | (3,677) | |
| Financial fixed assets | 5,885 | 6,890 | (1,005) | |
| Other non-current financial assets | 2,490 | 2,640 | (150) | |
| Non-current assets | 444,583 | 477,115 | (32,532) | |
| Goodwill | 561,617 | 600,701 | (39,084) | |
| Asia Pacific | Non-competition agreements, trademarks, customer lists and lease rights |
44,198 | 52,143 | (7,945) |
| Software, licenses, other intangible fixed assets, fixed assets in progress and advances |
9,143 | 9,268 | (125) | |
| Tangible assets | 38,534 | 44,530 | (5,996) | |
| Right-of-use assets | 50,682 | 61,175 | (10,493) | |
| Financial fixed assets | 238 | 256 | (18) | |
| Other non-current financial assets | 1,563 | 1,850 | (287) | |
| Non-current assets | 705,975 | 769,923 | (63,948) | |
| Total | 3,105,626 | 3,185,747 | (80,121) |
(*) The balance sheet items are analyzed by geographical area without separation of the Corporate structures that are natively included in EMEA.

Non-current assets amounted to €1,955,068 thousand as at 30 June 2025, an increase of €16,359 thousand with respect to the €1,938,709 thousand recorded as at 31 December 2024.
This increase is explained:
Non-current assets amounted to €444,583 thousand as at 30 June 2025, a decrease of €32,532 thousand against the €477,115 thousand recorded as at 31 December 2024.
The change is explained:

Non-current assets amounted to €705,975 thousand as at 30 June 2025, a decrease of €63,948 thousand against the €769,923 thousand recorded as at 31 December 2024.
The change is explained:

Net invested capital amounted to €2,623,382 thousand as at 30 June 2025, a decrease of €2,984 thousand against the €2,626,366 thousand recorded as at 31 December 2024.
The decrease of the non-current assets beforementioned is broadly offset by the increase in working capital and by the decrease of the other medium/long-term payables.
The breakdown of net invested capital by geographic area is shown below.
| (€ thousands) | 06/30/2025 | 12/31/2024 | Change |
|---|---|---|---|
| EMEA (*) | 1,595,026 | 1,496,008 | 99,018 |
| Americas | 368,686 | 422,291 | (53,605) |
| Asia Pacific | 659,670 | 708,067 | (48,397) |
| Total | 2,623,382 | 2,626,366 | (2,984) |
(*) The balance sheet items are analyzed by geographical area without separation of the Corporate structures that are natively included in EMEA.
Net invested capital came to €1,595,026 thousand as at 30 June 2025, an increase of €99,018 thousand against the €1,496,008 thousand recorded as at 31 December 2024.
In addition to the change in non-current assets described above, there was an increase in working capital mostly linked to the decrease in trade payables.
Factoring without recourse in the reporting period, through premier factoring companies, involved trade receivables with a face value of €111,754 thousand (€112,516 thousand in the same period of the prior year) and VAT credits with a face value of €17,893 thousand (€10,111 thousand in the same period of the prior year).
Net invested capital came to €368,686 thousand as at 30 June 2025, a decrease of €53,605 thousand against the €422,291 thousand recorded as at 31 December 2024.
In addition to the decrease in non-current assets described above, there was a decrease in working capital, slightly offset by a decrease in other medium/long-term payables.
Factoring without recourse in the reporting period, through premier factoring companies, involved trade receivables with a face value of €2,936 thousand (€581 thousand in the same period of the prior year).

Net invested capital came to €659,670 thousand as at 30 June 2025, a decrease of €48,397 thousand against the €708,067 thousand recorded as at 31 December 2024.
The decrease in non-current assets described above was partially offset by an increase in working capital.
Factoring without recourse in the reporting period, through premier factoring companies, involved trade receivables with a face value of €6,679 thousand (€2,177 thousand in the same period of the prior year).
| (€ thousands) | 06/30/2025 | 12/31/2024 | Change | ||
|---|---|---|---|---|---|
| Net medium and long-term financial indebtedness | 1,046,467 | 960,386 | 86,081 | ||
| Net short-term financial indebtedness | 305,182 | 290,253 | 14,929 | ||
| Cash and cash equivalents | (242,693) | (288,834) | 46,141 | ||
| Net financial indebtedness excluding lease liabilities (A) | 1,108,956 | 961,805 | 147,151 | ||
| Lease liabilities – current portion | 127,269 | 126,740 | 529 | ||
| Lease liabilities – non-current portion | 373,326 | 387,597 | (14,271) | ||
| Lease liabilities (B) | 500,595 | 514,337 | (13,742) | ||
| Net financial indebtedness (A+B) (C) | 1,609,551 | 1,476,142 | 133,409 | ||
| Group net equity (D) | 1,013,559 | 1,150,002 | (136,443) | ||
| Minority interests | 272 | 222 | 50 | ||
| Net Equity (E) | 1,013,831 | 1,150,224 | (136,393) | ||
| Net financial indebtedness excluding lease liabilities /Group net equity (A/D) |
1.09 | 0.84 | |||
| Net financial indebtedness excluding lease liabilities /Net equity (A/E) |
1.09 | 0.84 | |||
| Net financial indebtedness excluding lease liabilities /EBITDA for leverage calculation (*) |
1.93 | 1.63 |
(*) Net financial indebtedness excluding lease liabilities /EBITDA for the leverage calculation is the ratio of net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to EBITDA for the last four quarters (determined with reference to usual, frequent or related to the operating performance operations only, based on pro forma figures in case of significant changes to the structure of the Group).
Net financial debt, excluding lease liabilities, amounted to €1,108,956 thousand as at 30 June 2025, an increase of €147,151 thousand compared to 31 December 2024 which reflects the significant outlays for the payment of dividends and share buybacks. In the first half of 2025, free cash flow reached a positive €37,476 thousand (€46,822 thousand as at 30 June 2024) after €64,433 thousand in capital expenditure (€65,338 thousand in the comparison period).
Net cash-outs for acquisitions (which amounted to €54,493 thousand versus €142,737 thousand in the first half of 2024), along with the purchase of treasury shares (€55,228 thousand) and the payment of dividends (€65,302 thousand versus €65,593 thousand in the comparison period), brought cash flow for the reporting period to negative €138,779 thousand versus negative €155,814 thousand in the first half of 2024.
In the first half of 2025 the last lines of credit subject to financial covenants expired or were repaid; consequently, the Group is no longer subject to any financial covenants.
During the semester, Amplifon refined the below mentioned operations which are not subject to financial covenants:

and a €75 million long term loan. The new financing was used to refinance, and increase, a pre-existing line expiring in 2026;
As at 30 June 2025, the Group had cash and cash equivalents of €242,693 thousand compared to a total net financial indebtedness of €1,351,649 thousand, net of lease liabilities.
Long-term debt, net of lease liabilities, amounts to €1,046,467 thousand as at 30 June 2025 (€ 960,386 thousand as at 31 December 2024), showing an increase of €86,081 thousand compared to 2024 explained by the new financing agreements signed in the reporting period, net of the reclassification of short-term portions of the existing debt.
Short-term debt amounts to €305,182 thousand, an increase of €14,929 thousand compared to the €290,253 thousand recorded at 31 December 2024. The short-term portion refers primarily to: the short-term portion of long-term bank debt (€103,606 thousand); bank borrowings linked to hot money accounts and other short-term credit lines (€188,314 thousand); the interest payable on the Eurobond (€1,478 thousand) and other bank loans (€3,417 thousand),short-term lines included, as well as the best estimate of the deferred payments for acquisitions (€8,043 thousand).
The chart below shows the debt maturities compared to:


The revocable credit lines amounted to €334 million, with an unutilized portion of €147 million as at 30 June 2025.
Interest payable on financial debt amounted to €19,135 thousand as at 30 June 2025 versus €18,247 thousand as at 30 June 2024.
Interest payable on leases recognized in accordance with IFRS 16 amounted to €10,321 thousand versus €8,916 thousand as at 30 June 2024.
Interest receivable on bank deposits came to €2,076 thousand as at 30 June 2025 versus €1,530 thousand as at 30 June 2024.
The reasons for the changes in net debt are described in the next section on the statement of cash flows.

The reclassified statement of cash flows shows the change in net financial indebtedness from the beginning to the end of the period. Pursuant to IAS 7, the consolidated financial statements include a statement of cash flows that shows the change in cash and cash equivalents from the beginning to the end of the period.
| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| OPERATING ACTIVITIES: | ||
| Net profit (loss) attributable to the Group | 68,120 | 87,793 |
| Minority interests | 99 | 81 |
| Amortization, depreciation and impairment: | ||
| - Intangible fixed assets | 55,708 | 50,153 |
| - Tangible fixed assets | 32,800 | 30,620 |
| - Right-of-use assets | 69,487 | 64,053 |
| Total amortization, depreciation and impairment | 157,995 | 144,826 |
| Provisions, other non-monetary items and gains/losses from disposals | 3,128 | 9,554 |
| Group's share of the result of associated companies | (90) | (283) |
| Financial income charges | 30,797 | 27,798 |
| Current and deferred income taxes | 30,060 | 33,558 |
| Change in assets and liabilities: | ||
| - Utilization of provisions | (5,612) | (2,126) |
| - (Increase) decrease in inventories | (1,201) | 8,943 |
| - Decrease (increase) in trade receivables | 3,101 | 8,449 |
| - Increase (decrease) in trade payables | (44,348) | (43,986) |
| - Changes in other receivables and other payables | (23,509) | (29,537) |
| Total change in assets and liabilities | (71,569) | (58,257) |
| Dividends received | 291 | - |
| Net interest charges | (28,429) | (25,134) |
| Taxes paid | (21,386) | (44,208) |
| Cash flow provided by (used in) operating activities before repayment of lease liabilities | 169,016 | 175,728 |
| Repayment of lease liabilities | (67,107) | (63,568) |
| Cash flow generated from (absorbed) by operating activities | 101,909 | 112,160 |
| INVESTING ACTIVITIES: | ||
| Purchase of intangible fixed assets | (31,460) | (26,404) |
| Purchase of property, plant and equipment | (33,155) | (39,254) |
| Consideration from sale of tangible fixed assets and businesses | 182 | 320 |
| Cash flow generated from (absorbed) by investing activities | (64,433) | (65,338) |
| Cash flow generated from operating and investing activities (Free cash flow) | 37,476 | 46,822 |
| Business combinations (*) | (54,493) | (142,737) |
| Net cash flow generated from acquisitions | (54,493) | (142,737) |
| Cash flow generated from (absorbed) by investing activities and acquisitions | (118,926) | (208,075) |

| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| FINANCING ACTIVITIES: | ||
| Treasury shares | (55,228) | - |
| Dividends | (65,302) | (65,593) |
| Fees paid on medium/long-term financing | (1,788) | (105) |
| Other non-current assets | 556 | 5,799 |
| Cash flow generated from (absorbed) by financing activities | (121,762) | (59,899) |
| Changes in net financial indebtedness net of lease liabilities | (138,779) | (155,814) |
| Net financial indebtedness at the beginning of the period net of lease liabilities | (961,805) | (852,130) |
| Effect of exchange rate fluctuations on net financial debt | (8,298) | (1,341) |
| Effect of discontinued operations on net financial debt | (74) | - |
| Changes in net financial debt | (138,779) | (155,814) |
| Net financial indebtedness at the end of the period net of lease liabilities | (1,108,956) | (1,009,285) |
(*) The item refers to the net cash flows used in the acquisition of businesses and equity investments.
The change in net financial indebtedness of €138,779 thousand is attributable to:

Items (income and expenses) that are unusual, infrequent or not related to the operating performance negative impacted on cash flow of €2,542 thousand in the first half of 2025, attributable for €1,239 related to transaction and integration costs for acquisitions and €1,303 thousand related to costs relative to corporate and network reorganization, as well as other efficiency projects and changes in top management.
The Group continued with external growth in the first half of 2025 acquiring 222 clinics for a total investment of €54,493 thousand, including the debt consolidated and the best estimate of the earn-out linked to sales and profitability targets payable over the next few years.
More in detail, in the first half of 2025:

In the first half of 2025, the markets in which the Group operates were characterized by a softer demand, reflecting the deterioration in the macroeconomic and geopolitical context, as well as in consumer confidence, which appears to have peaked in the second quarter.
The US market was slightly negative in the first half and below historical growth rates, though improving sequentially in the second quarter. The European market presented a two-speed dynamic, with an excellent performance in France supported by the RAC 0 regulatory reform, in line with expectations, and a positive momentum in Germany, while the rest of the area was impacted by soft consumer confidence and other temporary factors, above all in Southern European countries. There was also substantial softness in the Asia-Pacific markets, above all in China.
For the rest of 2025, the Group expects a progressive normalization of the global market. More specifically, the Group expects the gradual recovery of the US market to continue, thanks also to a more favorable comparison base, and a European market supported by the strong growth of the French market and the positive momentum in Germany, along with a gradual recovery in the rest of the area, particularly in Italy and Spain where the portfolio of returning customers is expected to show improvement over the second quarter of 2025, following the partial recovery from the Covid-19 outbreak in the second half of 2020.
In light of the second quarter performance and current market expectations, assuming there are no further slowdowns in global economic activity due to, among others, the well-known macroeconomic and geopolitical situation, for FY2025, also with regards to what was previously communicated, Amplifon expects:
In the medium term, the Group remains very positive about its prospects of sustainable growth in sales and profitability, thanks to the unchanged fundamentals of the hearing care market and its strong leadership position, as well as the full implementation of the Fit4Growth program to enhance profitability and reinforce the Group's competitive positioning.
Milan, July 29th, 2025
CEO
Enrico Vita


| (€ thousands) | 06/30/2025 | 12/31/2024 | Change | |
|---|---|---|---|---|
| ASSETS | ||||
| Non-current assets | ||||
| Goodwill | Note 3 | 1,919,448 | 1,945,495 | (26,047) |
| Intangible fixed assets with finite useful life | Note 4 | 404,391 | 428,360 | (23,969) |
| Property, plant, and equipment | Note 5 | 252,009 | 253,924 | (1,915) |
| Right-of-use assets | Note 6 | 476,337 | 492,064 | (15,727) |
| Equity-accounted investments | 2,323 | 2,527 | (204) | |
| Hedging instruments | 2,684 | 4,454 | (1,770) | |
| Deferred tax assets | 74,322 | 77,332 | (3,010) | |
| Contract costs | 10,246 | 10,494 | (248) | |
| Other assets | 40,871 | 52,884 | (12,013) | |
| Total non-current assets | 3,182,631 | 3,267,534 | (84,903) | |
| Current assets | ||||
| Inventories | 93,637 | 93,180 | 457 | |
| Trade receivables | 220,330 | 226,754 | (6,424) | |
| Contract costs | 7,863 | 7,734 | 129 | |
| Other receivables | 114,642 | 107,552 | 7,090 | |
| Hedging instruments | 747 | 878 | (131) | |
| Other financial assets | - | 296 | (296) | |
| Cash and cash equivalents | Note 9 | 242,693 | 288,834 | (46,141) |
| Total current assets | 679,912 | 725,228 | (45,316) | |
| Total assets |


| 06/30/2025 4,528 202,712 (78,653) (174,004) 990,856 68,120 1,013,559 272 1,013,831 |
12/31/2024 4,528 202,712 (29,358) (77,628) 904,374 145,374 1,150,002 222 1,150,224 |
Change - - (49,295) (96,376) 86,482 (77,254) (136,443) 50 |
|---|---|---|
| (136,393) | ||
| 1,040,596 | 952,283 | 88,313 |
| 373,326 | 387,597 | (14,271) |
| 16,704 | 20,925 | (4,221) |
| 13,527 | 15,457 | (1,930) |
| 1,625 | 1,157 | 468 |
| 99,669 | 99,493 | 176 |
| 3,511 | 5,885 | (2,374) |
| 154,399 | 153,766 | 633 |
| 30,438 | 35,667 | (5,229) |
| 1,733,795 | 1,672,230 | 61,565 |
| 328,383 | 377,100 | (48,717) |
| 8,043 | 11,510 | (3,467) |
| 120,289 | 122,914 | (2,625) |
| 51,424 | 49,830 | 1,594 |
| 176,882 | 197,460 | (20,578) |
| 281 | 739 | (458) |
| 3,062 | 2,403 | 659 |
| 3,860 | 4,094 | (234) |
| 295,424 | 277,518 | 17,906 |
| 127,269 | 126,740 | 529 |
| 1,114,917 | 1,170,308 | (55,391) |
| 3,862,543 | 3,992,762 | (130,219) |
(*) Transactions with related parties have not been reported separately because not material both at single entity and at consolidated level.
Please refer to note 17 for more details.

| (€ thousands) | First Half 2025 | First Half 2024 | Change | |
|---|---|---|---|---|
| Revenues from sales and services | Note 13 | 1,180,490 | 1,177,251 | 3,239 |
| Operating costs | Note 14 | (896,155) | (887,685) | (8,470) |
| Other income and costs | 2,646 | 4,207 | (1,561) | |
| Gross operating profit (EBITDA) | 286,981 | 293,773 | (6,792) | |
| Amortization, depreciation and impairment | ||||
| Amortization of intangible fixed assets | Note 4 | (55,650) | (50,053) | (5,597) |
| Depreciation of property, plant, and equipment | Note 5 | (32,248) | (30,075) | (2,173) |
| Right-of-use depreciation | Note 6 | (68,670) | (64,053) | (4,617) |
| Impairment losses and reversals of non-current assets | (1,427) | (645) | (782) | |
| (157,995) | (144,826) | (13,169) | ||
| Operating result | 128,986 | 148,947 | (19,961) | |
| Financial income, expenses and value adjustments to financial assets |
||||
| Group's share of the result of associated companies valued at equity and gains/losses on disposals of equity investments |
90 | 283 | (193) | |
| Interest income and expenses | (17,056) | (16,717) | (339) | |
| Interest expenses on lease liabilities | (10,321) | (8,916) | (1,405) | |
| Other financial income and expenses | (1,477) | (707) | (770) | |
| Exchange gains and losses, and inflation accounting | (2,650) | (1,308) | (1,342) | |
| Gain (loss) on assets accounted at fair value | 708 | (150) | 858 | |
| (30,706) | (27,515) | (3,191) | ||
| Profit (loss) before tax | 98,280 | 121,432 | (23,152) | |
| Current and deferred income tax | ||||
| Current tax | (25,685) | (27,957) | 2,272 | |
| Deferred tax | (4,376) | (5,601) | 1,225 | |
| (30,061) | (33,558) | 3,497 | ||
| Net profit (loss) | 68,219 | 87,874 | (19,655) | |
| Net profit (loss) attributable to Minority interests | 99 | 81 | 18 | |
| Net profit (loss) attributable to the Group | 68,120 | 87,793 | (19,673) |
(*) Transactions with related parties have not been reported separately because not material both at single entity and at consolidated level. Please refer to note 17 for more details.
| Earnings per share (€ per share) | Note 16 | First Half 2025 | First Half 2024 | |
|---|---|---|---|---|
| Earnings per share | ||||
| - | Basic | 0.30300 | 0.38850 | |
| - | Diluted | 0.30090 | 0.38547 | |


| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Net income (loss) for the period | 68,219 | 87,874 |
| Other comprehensive income (loss) that will not be reclassified subsequently to profit or loss: |
||
| Remeasurement of defined benefit plans | 2,736 | (51) |
| Tax effect on components of other comprehensive income that will not be reclassified subsequently to profit or loss |
(444) | 2 |
| Total other comprehensive income (loss) that will not be reclassified subsequently to profit or loss after the tax effect (A) |
2,292 | (49) |
| Other comprehensive income (loss) that will be reclassified subsequently to profit or loss: | ||
| Gains/(losses) on cash flow hedging instruments | (2,621) | (2,452) |
| Gains/(losses) on exchange differences from translation of financial statements of foreign entities |
(91,768) | 9,384 |
| Tax effect on components of other comprehensive income that will be reclassified subsequently to profit or loss |
629 | 588 |
| Total other comprehensive income (loss) that will be reclassified subsequently to profit or loss after the tax effect (B) |
(93,760) | 7,520 |
| Total other comprehensive income (loss) (A)+(B) | (91,468) | 7,471 |
| Comprehensive income (loss) for the period | (23,249) | 95,345 |
| Attributable to the Group | (23,299) | 95,436 |
| Attributable to Minority interests | 50 | (91) |

| (€ thousands) | Share capital |
Share premium reserve |
Legal reserve |
Other reserves |
Treasury shares reserve |
Stock grant reserve |
|---|---|---|---|---|---|---|
| Balance as at 01/01/2024 | 4,528 | 202,712 | 934 | 3,636 | (17,495) | 41,299 |
| Allocation of profit (loss) for 2023 | ||||||
| Share capital increase | ||||||
| Treasury shares | ||||||
| Dividend distribution | ||||||
| Notional cost of stock grants | 9,373 | |||||
| Other changes | 11,888 | (15,921) | ||||
| - Stock Grant | 11,888 | (15,921) | ||||
| - Inflation accounting | ||||||
| - Other changes | ||||||
| Total comprehensive income (loss) for the period | ||||||
| - Hedge accounting | ||||||
| - Actuarial gains (losses) | ||||||
| - Translation differences | ||||||
| - Profit for the first six months of 2024 | ||||||
| Balance as at 30 June 2024 | 4,528 | 202,712 | 934 | 3,636 | (5,607) | 34,751 |
| (€ thousands) | Share capital | Share premium reserve |
Legal reserve |
Other reserves |
Treasury shares reserve |
Stock grant reserve |
|---|---|---|---|---|---|---|
| Balance at 01/01/2025 | 4,528 | 202,712 | 934 | 3,636 | (29,358) | 41,307 |
| Allocation of profit (loss) for 2024 | ||||||
| Share capital increase | ||||||
| Treasury shares | (55,228) | |||||
| Dividend distribution | ||||||
| Notional cost of stock grants | 3,439 | |||||
| Other changes | 5,933 | (8,396) | ||||
| - Stock Grant | 5,933 | (8,396) | ||||
| - Inflation accounting | ||||||
| - Other changes | ||||||
| Total comprehensive income (loss) for the period |
||||||
| - Hedge accounting | ||||||
| - Actuarial gains (losses) | ||||||
| - Translation differences | ||||||
| - Profit for the first six months of 2025 | ||||||
| Balance at 30 June 2025 | 4,528 | 202,712 | 934 | 3,636 | (78,653) | 36,350 |

| Cash flow hedge reserve |
Actuarial gains and losses |
Retained earnings |
Translation differences |
Profit (loss) for the period |
Total Shareholders' equity |
Minority interests |
Total net equity |
|---|---|---|---|---|---|---|---|
| 9,888 | (957) | 809,643 | (108,408) | 155,139 | 1,100,919 | 759 | 1,101,678 |
| 155,139 | (155,139) | - | - | ||||
| - | - | ||||||
| - | - | ||||||
| (65,593) | (65,593) | (65,593) | |||||
| 9,373 | 9,373 | ||||||
| 2,252 | (1,781) | (434) | (2,215) | ||||
| 2,731 | (1,302) | (1,302) | |||||
| 13,158 | 13,158 | 13,158 | |||||
| (13,637) | (13,637) | (434) | (14,071) | ||||
| (1,864) | (49) | 9,556 | 87,793 | 95,436 | (91) | 95,345 | |
| (1,864) | (1,864) | (1,864) | |||||
| (49) | (49) | (49) | |||||
| 9,556 | 9,556 | (172) | 9,384 | ||||
| 87,793 | 87,793 | 81 | 87,874 | ||||
| 8,024 | (1,006) | 901,441 | (98,852) | 87,793 | 1,138,354 | 234 | 1,138,588 |
| Cash flow hedge reserve |
Actuarial gains and losses |
Retained earnings |
Translation differences |
Profit (loss) for the period |
Total Shareholders' equity |
Minority interests |
Total net equity |
|---|---|---|---|---|---|---|---|
| 2,856 | (3,071) | 904,374 | (123,290) | 145,374 | 1,150,002 | 222 | 1,150,224 |
| 145,374 | (145,374) | - | - | ||||
| - | - | ||||||
| (55,228) | (55,228) | ||||||
| (65,302) | (65,302) | (65,302) | |||||
| 3,439 | 3,439 | ||||||
| 6,410 | 3,947 | 3,947 | |||||
| 2,793 | 330 | 330 | |||||
| 3,831 | 3,831 | 3,831 | |||||
| (214) | (214) | (214) | |||||
| (1,992) | 2,292 | (91,719) | 68,120 | (23,299) | 50 | (23,249) | |
| (1,992) | (1,992) | (1,992) | |||||
| 2,292 | 2,292 | 2,292 | |||||
| (91,719) | (91,719) | (49) | (91,768) | ||||
| 68,120 | 68,120 | 99 | 68,219 | ||||
| 864 | (779) | 990,856 | (215,009) | 68,120 | 1,013,559 | 272 | 1,013,831 |

| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net profit (loss) | 68,219 | 87,874 |
| Amortization, depreciation and impairment: | ||
| - intangible fixed assets | 55,708 | 50,153 |
| - property, plant, and equipment | 32,800 | 30,620 |
| - right-of-use assets | 69,487 | 64,053 |
| Provisions, other non-monetary items and gain/losses from disposals | 3,128 | 9,553 |
| Group's share of the result of associated companies | (90) | (283) |
| Financial income and expenses | 30,797 | 27,798 |
| Current and deferred taxes | 30,060 | 33,558 |
| Cash flow from operating activities before change in net working capital | 290,109 | 303,326 |
| Utilization of provisions | (5,612) | (2,126) |
| (Increase) decrease in inventories | (1,201) | 8,943 |
| Decrease (increase) in trade receivables | 3,101 | 8,449 |
| Increase (decrease) in trade payables | (44,348) | (43,986) |
| Changes in other receivables and other payables | (23,509) | (29,537) |
| Total change in assets and liabilities | (71,569) | (58,257) |
| Dividends earned | 291 | - |
| Interest received (paid) | (30,953) | (25,980) |
| Taxes paid | (21,386) | (44,208) |
| Cash flow generated from (absorbed by) operating activities (A) | 166,492 | 174,881 |
| INVESTING ACTIVITIES: | ||
| Purchase of intangible fixed assets | (31,460) | (26,404) |
| Purchase of tangible fixed assets | (33,155) | (39,254) |
| Consideration from sale of non-current assets | 182 | 320 |
| Cash flow generated from (absorbed by) operating investing activities (B) | (64,433) | (65,338) |
| Purchase of subsidiaries and business units net of cash and cash equivalents acquired or dismissed |
(54,493) | (142,737) |
| Increase (decrease) in payables for business acquisitions | (4,992) | 7,043 |
| Cash flow generated from (absorbed by) acquisition activities (C) | (59,485) | (135,694) |
| Cash flow generated from (absorbed by) investing activities (B)+(C) | (123,918) | (201,032) |
| FINANCING ACTIVITIES: | ||
| Increase (decrease) in financial payables | 104,570 | 112,478 |
| (Increase) decrease in financial receivables | - | 16 |
| Fees paid on medium and long-term loans | (1,788) | (104) |
| Principal portion of lease payments | (67,107) | (63,568) |
| Other non-current assets and liabilities | 556 | 5,799 |
| Dividend distributed | (65,302) | (65,593) |
| Treasury shares purchase | (55,228) | - |
| Cash flow generated from (absorbed by) financing activities (D) | (84,299) | (10,972) |
| Net increase in cash and cash equivalents (A)+(B)+(C)+(D) | (41,725) | (37,123) |

| emul ket sdir storage |
|
|---|---|
| CERTIFIED | |
| Stater | |
| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| Cash and cash equivalents at beginning of period | 288,834 | 193,148 |
| Effect of exchange rate fluctuations on cash & cash equivalents | (4,342) | (1,033) |
| Effect of asset disposals on cash & cash equivalents | (74) | - |
| Flows of cash and cash equivalents | (41,725) | (37,123) |
| Cash and cash equivalents at end of period | 242,693 | 154,992 |
Related-party transactions relate to lease of the main office and certain stores, to recharges of maintenance costs and general services of the above-mentioned buildings and to commercial transactions, personnel costs and loans. Such operations are detailed in Note 17 "Transactions with parents and other related parties".
| (€ thousands) | First Half 2025 | First Half 2024 |
|---|---|---|
| - Goodwill | 46,120 | 103,774 |
| - Customer lists | 10,821 | 35,720 |
| - Trademarks and non-competition agreements | 1,319 | 1,308 |
| - Other intangible fixed assets | 2,035 | 2,141 |
| - Property, plant, and equipment | 2,442 | 5,632 |
| - Right-of-use assets | 7,520 | 6,339 |
| - Current assets | 5,342 | 13,357 |
| - Provision for risks and charges | (10) | (1,629) |
| - Current liabilities | (8,812) | (17,831) |
| - Other non-current assets and liabilities | (12,980) | (16,191) |
| - Third parties' equity | - | 14,073 |
| Total investments | 53,797 | 146,693 |
| Net financial debt acquired | 3,290 | 1,698 |
| Total business combinations | 57,087 | 148,391 |
| (Increase) decrease in payables through business acquisition | 4,992 | (7,043) |
| Cash flow absorbed by (generated from) acquisitions | 62,079 | 141,348 |
| (Cash and cash equivalents acquired) | (2,594) | (5,654) |
| Net cash flow absorbed by (generated from) acquisitions | 59,485 | 135,694 |


The Amplifon Group is global leader in the distribution of hearing solutions and the fitting of customized products.
The parent company Amplifon S.p.A. is based in Via Ripamonti 133, Milan, Italy. The Group is controlled directly by Ampliter S.r.l. (42.01% of share capital and 68.36% of voting rights as at 30 June 2025), held by Amplifin S.r.l at 100%, which is owned at 88% by Susan Carol Holland.
The Condensed Consolidated Financial Statements as at 30 June 2025 was prepared in accordance with International Accounting Standards, as well as the implementation regulations set out in Article 9 of Legislative Decree no. 38 of 28 February 2005. These standards include the IAS and IFRS issued by the International Accounting Standard Board, as well as the SIC and IFRIC interpretations issued by the International Financial Reporting Interpretations Committee, which were endorsed in accordance with the procedure set out in Article 6 of Regulation (EC) no. 1606 of 19 July 2002 by 30 June 2025. The International Accounting Standards endorsed after that date and before the preparation of this report were adopted in the preparation of the condensed interim consolidated financial report only if early adoption is allowed by the Endorsing Regulation and the standard itself and if the Group had elected to do so.
The condensed interim consolidated financial statements as at 30 June 2025 does not include all the additional information required by the annual financial statements and must be read together with the annual consolidated financial statements of the Group as at 31 December 2024.
The publication of the Condensed Consolidated Financial Statements of the Amplifon Group as at 30 June 2025 was authorized by a resolution of the Board of Directors of 29 July 2025 which approved their publication.
According to the Consob Communication of 28 July 2006, it is specified that during the first half of 2025 the Group did not carry out atypical and/or unusual transactions, as defined by the Communication itself.
The current macroeconomic and geopolitical environment worsened progressively during the second quarter, which was characterized by uncertainty and volatility, due to conflicts and recent political developments related to the trade tariffs introduced by the United States that could also affect a few of the Group's suppliers. Toward this end, Amplifon continues to monitor changes in the business environment constantly and can also rely on negotiating leverage, supplier diversification, on the flexibility of suppliers in production logistics and, last by not least, the Group's geographic diversification.
The conflict in the Middle East has witnessed a period of severe escalation, with devastating consequences for civilians and a growing risk of regional destabilization. In the last weeks, the situation appearsslightly quieter, but a lasting solution still seems far off. In this region, however, the Group only has about 24 points of sale in Israel which generate sales equal to less than 1% of annual consolidated revenues and limited activities in nearby countries (Egypt) and does not have any direct or indirect business activities in Lebanon and Iran.
As for the conflict between Ukraine and Russia, the situation continues to be characterized by intense attacks on civil infrastructure, while new sanctions have intensified the pressure on the complex diplomatic efforts. The Group has no business activities, direct or indirect, in either Ukraine, Russia or Byelorussia.
While inflation decreased in the reporting period, fueled by lower energy prices and a more accommodating monetary policy, economic growth remains modest as a result of external factors including trade tensions and reduced consumer confidence which could continue to impact demand and different cost items including, for example, the cost of labor and debt. Generally, the hearing aid market has shown great resilience even in times of economic crisis. This resilience is ascribed to the importance and non-discretional nature of hearing care, which remains a priority for consumers regardless of the economic conditions, along with the use of public/private insurances and consumer loans, which facilitate access to services and hearing aids, contributing to stable demand even in periods of economic uncertainty. However, the progressive deterioration of the macroeconomic and geopolitical environment, characterized by growing levels of uncertainty and volatility, impacts consumer confidence in general and cause consumers to postpone hearing aid purchases which would, however, still be needed at a later point in time.
With regard to climate change, the Amplifon Group's business model is based on providing retail hearing solutions. The goals, therefore, connected to transitioning to alternative sources of energy and the actions needed to address climate change are pursued through the steps taken by the Group to improve the energy efficiency of its business activities, as well as report on the greenhouse gas emissions generated along the value chain. Toward this end, the Group is committed to defining and presenting short-term targets for reducing emissions aligned with the Science-Based Target Initiative (SBTi) by 2025. As a result of its activities and business model, the Group has no significant exposure to the environmental risks connected to climate change.

In the first half of 2025 the Group continued with its strategy to balance external and internal growth and acquired 222 clinics, comprising 175 in Europe, 25 in North America and 22 in China.
The total investment, including the indebtedness consolidated and the best estimate of the net change in the earn-out linked to sales and profitability targets payable over the next few years, amounted to €54,493 thousand.
The changes in goodwill and amounts recognized as a result of the acquisitions made in the period are reported in the table below and shown by groups of Cash Generating Units.
| (€ thousands) | Net carrying value at 12/31/2024 |
Business combinations |
Disposals | Impairment | Other net changes | Net carrying value at 06/30/2025 |
|---|---|---|---|---|---|---|
| EMEA | 1,031,163 | 35,062 | - | - | (514) | 1,065,711 |
| AMERICAS | 313,631 | 9,101 | - | - | (30,612) | 292,120 |
| APAC | 600,701 | 1,957 | - | - | (41,041) | 561,617 |
| Total | 1,945,495 | 46,120 | - | - | (72,167) | 1,919,448 |
"Business combination" refers to the temporary allocation to goodwill of the portion of the purchase price paid, including deferments and contingent consideration (earn-outs), which is not directly attributable to the fair value of assets and liabilities, but is based on the positive contribution to cash flows that is expected to be made for an indefinite period of time. "Other net changes" refers almost entirely to foreign exchange differences.
For the purpose of monitoring recoverable value, the total goodwill stemming from the cost incurred for a business combination is allocated to groups of Cash Generating Units; these groups of Cash Generating Units are identified by region and benefit from synergies, as well as shared policies, and are autonomous in the management and use of resources.
The assets allocated to the groups of Cash Generating Units and the methods used to determine these groups are the same as those applied to the financial Statements as at 31 December 2024.
The groups of Cash Generating Units recognized for the purposes of impairment test include:
The recoverable value of goodwill is determined based on the value in use or, if the latter is less than book value, on fair value. No impairment loss was identified as a result of the impairment tests conducted on 31 December 2024.

The Group tests for impairment of goodwill once a year and in the event of any impairment indicators.
In the first half of 2025, the Group's revenues were slightly higher despite a particularly challenging comparison base and increased market volatility as the worsening of the macroeconomic and geopolitical environment continued in the second quarter.
The performance of the US private market was slightly negative in the first half and the European markets, with the exception of France and Germany, remain weak.
Moreover, the adverse exchange effect intensified for the Group in the first half as the Euro strengthened against the US, Australian and New Zealand dollar.
Profitability came in at 24.4%, compared to 25.2% in the first half of 2024 due to a decreased operating leverage, an unfavorable geographical mix with greater exposure to southern Europe's markets which slowed more than others, the dilution stemming from the accelerated growth in Miracle-Ear's direct store network in the United States, as well as the performance in China.
This trend was also reflected in comparison with the budget, as both the Group and the Regions reported significant gaps with respect to the latter.
The sensitivity analyses carried out during impairment testing on 31 December 2024 showed that all the Groups of Cash Generating Units had ample headroom capable of absorbing significant changes in the basic parameters and future cash flows.
In order to understand if the headrooms recorded at year-end 2024 were maintained, the impairment tests were reperformed for all the groups of cash-generating units, implementing both new discount rates (WACC) and growth rates, updated based on data available at 30 June 2025, to the same business plan used as at 31 December 2024 whose total cash flows were adjusted prudentially, decreasing them by a percentage equal to the negative budget gap reported in June 2025.
No indicators of impairment emerged and, therefore, for the purposes of measuring the recoverable value of goodwill, reference should be made to the impairment tests reported in the Annual Report 2024.

A summary of the book value and the fair value of assets and liabilities, deriving from the temporary allocation of the purchase price made as a result of business combinations and the purchase of minority interests in subsidiaries, is provided in the following table.
| (€ thousands) | EMEA | Americas | APAC | Total |
|---|---|---|---|---|
| Cost of acquisitions of the period | 41,568 | 8,191 | 4,038 | 53,797 |
| Assets and liabilities acquired – Book value | ||||
| Current assets | 2,193 | 544 | 11 | 2,748 |
| Current liabilities | (3,839) | (2,612) | (226) | (6,677) |
| Net working capital | (1,646) | (2,068) | (215) | (3,929) |
| Other intangible, tangible and right-of-use assets | 7,024 | 3,704 | 1,269 | 11,997 |
| Provision for risks and charges | (10) | - | - | (10) |
| Other non-current assets and liabilities | (3,929) | (1,052) | (546) | (5,527) |
| Non-current assets and liabilities | 3,085 | 2,652 | 723 | 6,460 |
| Net invested capital | 1,439 | 584 | 508 | 2,531 |
| Net financial position | 1,027 | (1,723) | - | (696) |
| NET EQUITY ACQUIRED - BOOK VALUE | 2,466 | (1,139) | 508 | 1,835 |
| DIFFERENCE TO BE ALLOCATED | 39,102 | 9,330 | 3,530 | 51,962 |
| ALLOCATIONS | ||||
| Trademarks and licenses | 13 | - | - | 13 |
| Non-compete agreements | - | 776 | 530 | 1,306 |
| Customer lists | 8,646 | 864 | 1,311 | 10,821 |
| Contract liabilities - Short and long-term | (4,086) | (1,411) | (172) | (5,669) |
| Deferred tax assets | 838 | 840 | 37 | 1,715 |
| Deferred tax liabilities | (1,371) | (840) | (133) | (2,344) |
| ALLOCATIONS | 4,040 | 229 | 1,573 | 5,842 |
| GOODWILL | 35,062 | 9,101 | 1,957 | 46,120 |

The following table shows the changes in intangible assets.
| (€ thousands) | Historical cost at 12/31/2024 |
Accumulated amortization and write downs at 12/31/2024 |
Net book value at 12/31/2024 |
Historical cost at 06/30/2025 |
Accumulated amortization and write downs at 06/30/2025 |
Net book value at 06/30/2025 |
|---|---|---|---|---|---|---|
| Software | 356,982 | (220,799) | 136,183 | 366,877 | (237,289) | 129,588 |
| Licenses | 35,392 | (26,093) | 9,299 | 38,319 | (29,317) | 9,002 |
| Non-competition agreements | 23,601 | (19,300) | 4,301 | 24,757 | (18,190) | 6,567 |
| Customer lists | 524,674 | (316,879) | 207,795 | 521,644 | (329,997) | 191,647 |
| Trademarks and concessions | 94,720 | (56,145) | 38,575 | 92,446 | (57,872) | 34,574 |
| Other | 18,378 | (6,113) | 12,265 | 22,922 | (9,621) | 13,301 |
| Fixed assets in progress and advances |
19,942 | - | 19,942 | 19,712 | - | 19,712 |
| Total | 1,073,689 | (645,329) | 428,360 | 1,086,677 | (682,286) | 404,391 |
| (€ thousands) | Net book value at 12/31/2024 |
Investments | Disposals | Amortization | Business combinations |
Impairment | Other net changes |
Net book value at 06/30/2025 |
|---|---|---|---|---|---|---|---|---|
| Software | 136,183 | 6,260 | - | (24,535) | - | - | 11,680 | 129,588 |
| Licenses | 9,299 | 1,841 | - | (3,146) | 13 | - | 995 | 9,002 |
| Non-competition agreements |
4,301 | 2,803 | - | (2,917) | 1,306 | (27) | 1,101 | 6,567 |
| Customer lists | 207,795 | - | - | (20,804) | 10,821 | (37) | (6,128) | 191,647 |
| Trademarks and concessions |
38,575 | - | - | (3,544) | - | - | (457) | 34,574 |
| Other | 12,265 | 360 | - | (704) | 2,027 | - | (647) | 13,301 |
| Fixed assets in progress and advances |
19,942 | 20,196 | - | - | 8 | 6 | (20,440) | 19,712 |
| Total | 428,360 | 31,460 | - | (55,650) | 14,175 | (58) | (13,896) | 404,391 |
The investments in intangible assets (€31,460 thousand) are related to investments in digital technology and information technology. The constant focus on the customer and the desire to increase control of operations fueled the significant work done on both technological infrastructures through the Symphony project, focused on providing customers with a highly personalized experience, as well as on the optimization of in-store systems and tools to support the Amplifon Product Experience, which has redefined Amplifon's entire customer journey, including through clinics' renovation. At the same time substantial work was also done on operating and back-office processes, with a high focus on systems used to streamline and centralize Group procurement.
The change in "Business combinations" comprises:

The item "impairment" includes for €37 thousand the impairment of customer lists, resulting in the closure of a first group of low-performing clinics, as part of a broad program to strengthen margins and reinforce company's competitiveness thanks to initiatives to enhance the efficiency of the distribution network and back-office processes, reduce costs and focus on the investments with the highest returns, which will be effective in the second half of 2025 and throughout 2026.
The item "Other net changes" is explained almost entirely by foreign exchange differences and the reclassification of work in progress completed in the period.
The following table shows the changes in property, plant, and equipment.
| (€ thousands) | Historical cost at 12/31/2024 |
Accumulated amortization and write downs at 12/31/2024 |
Net book value at 12/31/2024 |
Historical cost at 06/30/2025 |
Accumulated amortization and write downs at 06/30/2025 |
Net book value at 06/30/2025 |
|---|---|---|---|---|---|---|
| Land | 165 | - | 165 | 165 | - | 165 |
| Buildings, constructions and leasehold improvements |
371,383 | (242,117) | 129,266 | 381,548 | (251,461) | 130,087 |
| Plant and machines | 47,495 | (37,922) | 9,573 | 47,843 | (38,968) | 8,875 |
| Industrial and commercial equipment |
97,332 | (74,844) | 22,488 | 101,891 | (78,010) | 23,881 |
| Motor vehicles | 1,416 | (765) | 651 | 1,529 | (921) | 608 |
| Computers and office machinery |
103,003 | (78,749) | 24,254 | 102,910 | (81,984) | 20,926 |
| Furniture and fittings | 154,918 | (109,838) | 45,080 | 161,115 | (113,598) | 47,517 |
| Other tangible fixed assets | 6,439 | (4,618) | 1,821 | 7,728 | (5,833) | 1,895 |
| Fixed assets in progress and advances |
20,626 | - | 20,626 | 18,055 | - | 18,055 |
| Total | 802,777 | (548,853) | 253,924 | 822,784 | (570,775) | 252,009 |
| (€ thousands) | Net book value at 12/31/2024 |
Investments | Disposals | Amortization | Business combinations |
Impairment | Other net changes |
Net book value at 06/30/2025 |
|---|---|---|---|---|---|---|---|---|
| Land | 165 | - | - | - | - | - | - | 165 |
| Buildings, constructions and leasehold improvements |
129,266 | 9,221 | (69) | (14,064) | 470 | (482) | 5,745 | 130,087 |
| Plant and machines | 9,573 | 97 | (2) | (1,424) | 223 | - | 408 | 8,875 |
| Industrial and commercial equipment |
22,488 | 2,001 | (8) | (3,691) | 395 | (8) | 2,704 | 23,881 |
| Motor vehicles | 651 | - | (31) | (75) | 38 | - | 25 | 608 |
| Computers and office machinery |
24,254 | 2,249 | (20) | (6,387) | 358 | (32) | 504 | 20,926 |
| Furniture and fittings | 45,080 | 2,915 | (21) | (6,281) | 495 | (29) | 5,358 | 47,517 |
| Other tangible fixed assets | 1,821 | 12 | - | (326) | 440 | (1) | (51) | 1,895 |
| Fixed assets in progress and advances |
20,626 | 16,660 | - | - | 23 | - | (19,254) | 18,055 |
| Total | 253,924 | 33,155 | (151) | (32,248) | 2,442 | (552) | (4,561) | 252,009 |
The investments of the reporting period (€33,155 thousand) refer primarily to the opening of new clinics and renewal of existing ones, as well as to the purchase of hardware needed for the implementation of Group Information Technology projects previously described.


The change in "Business combinations" comprises:
The item "impairment" includes the impairment of buildings, constructions and leasehold improvements (for €442 thousand), computers and office machinery (for €30 thousand), furniture and fittings (for €28 thousand), resulting in the closure of a first group of lowperforming clinics, as part of a broad program to strengthen margins and reinforce company's competitiveness thanks to initiatives to enhance the efficiency of the distribution network and back-office processes, reduce costs and focus on the investments with the highest returns, which will be effective in the second half of 2025 and throughout 2026.
"Other net changes" is explained primarily by foreign exchange differences recorded in the reporting period and the reclassification of work in progress completed in the period.
Right-of-use assets are reported here below:
| (€ thousands) | Historical cost at 12/31/2024 |
Accumulated amortization and write downs at 12/31/2024 |
Net book value at 12/31/2024 |
Historical cost at 06/30/2025 |
Accumulated amortization and write downs at 06/30/2025 |
Net book value at 06/30/2025 |
|---|---|---|---|---|---|---|
| Stores and offices | 955,892 | (483,899) | 471,993 | 979,011 | (520,560) | 458,451 |
| Motor vehicles | 35,504 | (17,687) | 17,817 | 34,956 | (19,684) | 15,272 |
| Electronic machinery | 4,368 | (2,114) | 2,254 | 5,313 | (2,699) | 2,614 |
| Total | 995,764 | (503,700) | 492,064 | 1,019,280 | (542,943) | 476,337 |
| (€ thousands) | Net book value at 12/31/2024 |
Increase | Decrease | Depreciation | Business combinations |
Impairment | Other net changes |
Net book value at 06/30/2025 |
|---|---|---|---|---|---|---|---|---|
| Stores and offices | 471,993 | 57,593 | (5,421) | (63,849) | 7,380 | (817) | (8,428) | 458,451 |
| Motor vehicles | 17,817 | 2,847 | (1,198) | (4,146) | 136 | - | (184) | 15,272 |
| Electronic machinery | 2,254 | 1,203 | (14) | (675) | 4 | - | (158) | 2,614 |
| Total | 492,064 | 61,643 | (6,633) | (68,670) | 7,520 | (817) | (8,770) | 476,337 |
The increase in right of use assets (€61,643 thousand) acquired in the period is explained by the renewal of existing leases and the network expansion.
The change in "business combinations" comprises:
The item "impairment" fully includes the impairment of right-of-use assets of a first group of low-performing clinics that have been closed as part of a broad program to strengthen margins and reinforce company's competitiveness thanks to initiatives to enhance the efficiency of the distribution network and back-office processes, reduce costs and focus on the investments with the highest returns, which will be effective in the second half of 2025 and throughout 2026.
"Other changes" refers mainly to foreign exchange differences recorded in the reporting period.


| (€ thousands) | Balance at 06/30/2025 | Balance at 12/31/2024 | Change |
|---|---|---|---|
| Long-term financial receivables | 5,145 | 6,120 | (975) |
| Asset Plans and other restricted amounts | 1,563 | 1,637 | (74) |
| Other non-current assets | 34,163 | 45,127 | (10,964) |
| Total | 40,871 | 52,884 | (12,013) |
"Other non-current assets" amounted to €40,871 thousand on 30 June 2025 (€52,884 thousand on 31 December 2024).
The change in "Other non-current assets" compared to the prior reporting period is explained mainly by the reclassification of the super-bonus tax credits, granted in accordance with Articles 119 and 121 of Law Decree 34/2020, purchased and recognized in 2024, as current assets. These credits (and the related payments) are recognized at amortized cost and when utilized any remaining difference between the value at amortized cost and the nominal offsetting amount is recognized as financial income.
In the first six months of 2025:
The amount of these credits recognized in "Other non-current assets" amounted to €2,734 thousand on 30 June 2025. The current portion of the credits is recognized in "Other receivables" for €12,651 thousand, while the payables for the settlement of these receivables are classified under "Other payables" for €28,622 thousand and the non-current portion is recognized in "Other long-term liabilities" for €8,600 thousand.
Based on the joint agreements with a top-tier financial institution, signed on December 20, 2024, and subsequent amendments, Amplifon S.p.A. and Amplifon Italia S.p.A. jointly got involved in the purchase of an additional €24.7 million in Superbonus tax credits for the period 2026-2027 (respectively €16.9 million in 2026 and €7.8 million in 2027), at a total consideration of €23.2 million. According to the contractual conditions, these credits will be transferred to Amplifon (and paid to the transferring bank) at the time of use and, therefore, are not recorded in the balance sheet as of June 30, 2025.

As at 30 June 2025, the share capital comprised 226,388,620 ordinary shares with a par value of €0.02 fully subscribed and paid in, unchanged with respect to 31 December 2024.
A total of 2,732,804 treasury shares was purchased in 2025, for a total cash-out of €55,228 thousand, of which 400,000 (cash-out of €8,164 thousand) were purchased as resolved by the Shareholders' Meeting on 30 April 2024 and 2,332,804 thousand (cash-out of €47,064 thousand) as resolved by the Shareholders' Meeting on 23 April 2025 and the Board of Directors on 6 May 2025.
During the first half of 2025, a total of 266,664 shares were transferred following the exercise of performance stock grants.
As at 30 June 2025, a total of 3,534,389 treasury shares, equal to 1.56% of the Company's share capital, was held.
Information on the treasury shares held is provided in the following table.
| No. of treasury shares |
Average purchase price (Euro) | Total amount | |
|---|---|---|---|
| FV of transferred rights (Euro) | (€ thousands) | ||
| Held at 12/31/2024 | 1,068,249 | 27.482 | 29,358 |
| Purchases | 2,732,804 | 20.209 | 55,228 |
| Transfers due to exercise of performance stock grants | (266,664) | 22.247 | (5,933) |
| Held at 06/30/2025 | 3,534,389 | 22.254 | 78,653 |
The Group's net financial indebtedness, including lease liabilities, prepared in accordance with the ESMA guideline 32-382-1138 of 4 March 2021 and CONSOB's Warning Notice n. 5/21 of 29 April 2021, is shown below.
| (€ thousands) | 06/30/2025 | 12/31/2024 | Change |
|---|---|---|---|
| A Cash |
242,693 | 288,834 | (46,141) |
| B Cash equivalent |
- | - | - |
| C Short term investments |
- | - | - |
| D Total Cash, Cash Equivalents and Short-Term Investments (A+B+C) |
242,693 | 288,834 | (46,141) |
| Current financial payables (including bonds, but excluding current E portion of medium/long-term debt) |
188,670 | 140,008 | 48,662 |
| - Other financial payables and bank overdrafts | 189,136 | 139,765 | 49,371 |
| - Hedging derivatives | (466) | 243 | (709) |
| F Current portion of medium/long-term financial debt |
243,781 | 276,985 | (33,204) |
| - Financial accruals and deferred income | 4,863 | 6,771 | (1,908) |
| - Payables for business acquisitions | 8,043 | 11,510 | (3,467) |
| - Bank borrowings | 103,606 | 131,964 | (28,358) |
| - Lease Liability – current portion | 127,269 | 126,740 | 529 |
| G Current Financial Indebtedness (E+F) |
432,451 | 416,993 | 15,458 |
| H Net Current Financial Indebtedness (G-D) |
189,758 | 128,159 | 61,599 |
| I Non current financial payables |
1,069,793 | 997,983 | 71,810 |
| - Bank borrowings – Non current portion | 692,956 | 604,501 | 88,455 |
| - Payables for business acquisitions – Non current portion | 3,511 | 5,885 | (2,374) |
| - Lease Liability – Non current portion | 373,326 | 387,597 | (14,271) |
| J Bonds |
350,000 | 350,000 | - |
| - Eurobond 2020-2027 | 350,000 | 350,000 | - |
| K Trade and other non current payables |
- | - | - |
| L Non Current Financial Indebtedness (I+J+K) |
1,419,793 | 1,347,983 | 71,810 |
| M Total Financial Indebtedness (H+L) | 1,609,551 | 1,476,142 | 133,409 |
Excluding lease liabilities (€500,595 thousand as at 30 June 2025), net financial debt amounted to €1,108,956 thousand as at 30 June 2025, broken down as follows:
| (€ thousands) | 06/30/2025 | 12/31/2024 | Change |
|---|---|---|---|
| Cash and Cash Equivalents | 242,693 | 288,834 | (46,141) |
| Cash and Cash Equivalents | 242,693 | 288,834 | (46,141) |
| Current Financial Indebtedness (excluding lease liabilities) |
305,182 | 290,253 | 14,929 |
| Net Current Financial Indebtedness (excluding lease liabilities) |
62,489 | 1,419 | 61,070 |
| Non-current Financial Indebtedness (excluding lease liabilities) |
1,046,467 | 960,386 | 86,081 |
| Total Financial Indebtedness (excluding lease liabilities) | 1,108,956 | 961,805 | 147,151 |
In the first half of 2025 the last lines of credit subject to financial covenants expired or were repaid; consequently, the Group is no longer subject to any financial covenants.
In the first half of 2025, Amplifon also finalized the following transactions which are not subject to financial covenants:
The remaining lines, subject to financial covenants, expired by 30 June 2025: at this date there are no more credit facilities subject to financial covenants.
Long-term debt, net of lease liabilities, amounted to €1,046,467 thousand on 30 June 2025 (€ 960,386 thousand at 31 December 2024), showing an increase of €86,081 thousand explained by the new financing agreements signed in the reporting period, net of the reclassification of short-term portions of the existing debt.

Short-term debt, excluding lease liabilities, increased by €61,070 thousand, going from €1,419 thousand on 31 December 2024 to €62,489 thousand on 30 June 2025 as a result of the increase in total net debt.
More in detail, short-term debt comprises primarily other bank debt for €188,314 thousand including the hot money accounts and the utilization of other short-term credit lines, the shortterm portion of long-term debt (€103,606 thousand), the interest payable on the Eurobond (€1,478 thousand) on other bank loans (€3,417 thousand), comprehensive of the short-term lines, and, lastly, the best estimate of the deferred payments for acquisitions (€8,043 thousand), net of €242,693 thousand in total liquidity.
The Group has €480 million in unutilized irrevocable credit lines which, along with the unutilized portion of the loan signed with the European Investment Bank amounting to €225 million, €147 million in other available uncommitted credit lines, and the cash generation expected for 2025, make it possible to maintain the liquidity needed to satisfy current obligations, support business needs, as well as take advantage of any investment opportunities that might materialize.
Bank loans and the Eurobond 2020-2027 are shown in the statement of financial position as follows:
a. under the item "medium/long-term financial liabilities":
| (€ thousands) | Balance at 06/30/2025 |
|---|---|
| Eurobond 2020-2027 | 350,000 |
| Loan with the European Investment Bank | 125,000 |
| Other medium/long-term debt | 567,956 |
| Fees on Eurobond 2020-2027 and bank loans | (2,360) |
| Medium/long-term financial liabilities | 1,040,596 |
| (€ thousands) | Balance at 06/30/2025 |
|---|---|
| Bank overdraft and other short-term debt (including current portion of other long-term debt) | 291,920 |
| Other financial payables | 4,863 |
| Fees on bank loans | (1,359) |
| Short-term financial liabilities | 295,424 |
All the other items in the net financial position table can be easily referred to in the financial consolidated statements.

The financial liabilities breakdown is as follows:
| (€ thousands) | Balance at 06/30/2025 |
Balance at 12/31/2024 |
Change |
|---|---|---|---|
| Eurobond 2020-2027 | 350,000 | 350,000 | - |
| Loan with European Bank of Investments | 125,000 | 125,000 | - |
| Other medium long-term bank loans | 567,956 | 479,501 | 88,455 |
| Fees on Eurobond 2020-2027 and bank loans | (2,360) | (2,218) | (142) |
| Total long-term financial liabilities | 1,040,596 | 952,283 | 88,313 |
| Short term debt | 295,424 | 277,518 | 17,906 |
| - of which current portion of short-term bank loans | 103,606 | 131,964 | (28,358) |
| - of which debts for account overdrafts and other short-term liabilities | 188,314 | 139,765 | 48,549 |
| - of which fees on bank loans | (1,359) | (1,233) | (126) |
| Total short-term financial liabilities | 295,424 | 277,518 | 17,906 |
| Total financial liabilities | 1,336,020 | 1,229,801 | 106,219 |
The main financial liabilities are detailed below.
This is a €350,000 thousand 7-year non-convertible bond with a fixed annual coupon of 1.125% that is listed on the Luxembourg Stock Exchange's unregulated market.
| Issue Date | Debtor | Maturity | Nominal value (€/000) |
Nominal interest rate (*) | Euro interest rate after hedging |
|---|---|---|---|---|---|
| 02/13/2020 | Amplifon S.p.A. | 02/13/2027 | 350,000 | 1.125% | N/A |
| Total in Euro | 350,000 |
(*) The nominal interest rate is equal to the mid swap plus a spread.
These are the main bilateral and pooled loans which are detailed below:
| Issue Date | Debtor | Type | Maturity | Nominal value (€/000) |
Oustanding debt (€/000) |
Rate in use (*) |
Debt hedged (€/000) |
Swap rate + applicable margin (**) |
Fixed rate |
Final rate in use |
|---|---|---|---|---|---|---|---|---|---|---|
| 12/23/2021 | Amplifon S.p.A. |
Amortizing | 12/23/2026 | 210,000 | 126,000 | 2.84% | 126,000 | 0.96% | 0.96% | |
| 12/15/2023 | Amplifon S.p.A. |
Amortizing | 12/15/2032 | 75,000 | 75,000 | 3.65% | 3.65% | 3.65% | ||
| 06/27/2024 | Amplifon S.p.A. |
Amortizing | 06/27/2033 | 50,000 | 50,000 | 3.90% | 3.90% | 3.90% | ||
| 06/30/2024 | Amplifon S.p.A. |
Amortizing | 09/30/2029 | 50,000 | 50,000 | 3.66% | 50,000 | 3.25% | 3.25% | |
| 10/15/2024 | Amplifon S.p.A. |
Amortizing | 10/15/2029 | 200,000 | 200,000 | 3.28% | 100,000 | 3.43% | 3.28% | (***) |
| 12/19/2024 | Amplifon S.p.A. |
Amortizing | 12/19/2029 | 75,000 | 75,000 | 3.70% | 75,000 | 3.28% | 3.28% | |
| 03/12/2025 | Amplifon S.p.A. |
Amortizing | 03/12/2030 | 75,000 | 75,000 | 3.39% | 3.33% | |||
| 04/01/2025 | Amplifon S.p.A. |
Amortizing | 03/31/2030 | 50,000 | 50,000 | 3.40% | 3.40% | |||
| 06/18/2025 | Amplifon S.p.A. |
Amortizing | 06/12/2030 | 75,000 | 75,000 | 2.94% | 2.94% | |||
| 06/27/2025 | Amplifon S.p.A. |
Amortizing | 06/30/2030 | 20,000 | 20,000 | 3.04% | 3.04% | |||
| Total | 880,000 | 796,000 | 351,000 |
(*) The nominal interest rate comprises the benchmark rate (Euribor) plus the applicable spread.
(**) An Interest Rate Swap was used to hedge these loans against interest rate risk at the IRS rate plus a spread.
(***) The rate for the €100 million tranche of this loan is 3.43% and 3.28% for the remainder.

Provisions for risks and charges amounted to €19,766 thousand, compared to €23,328 thousand recorded on 31 December 2024.
The provisions for risks as at 30 June 2025 are detailed below:
| (€ thousands) | 06/30/2025 | 12/31/2024 | Change |
|---|---|---|---|
| Product warranty provision | - | 1,416 | (1,416) |
| Contractual risk provision | 140 | 3,399 | (3,259) |
| Agents' leaving indemnity | 13,931 | 13,515 | 416 |
| Other risk provisions | 2,633 | 2,595 | 38 |
| Total Long-term provision for risks and charges | 16,704 | 20,925 | (4,221) |
| Product warranty provision | 950 | 215 | 735 |
| Other provisions for risks | 2,112 | 2,188 | (75) |
| Total Short-term provision for risks and charges | 3,062 | 2,403 | 660 |
| Total provision for risks and charges | 19,766 | 23,328 | (3,561) |
The lease liabilities stem from long-term leases and rental agreements. These liabilities are equal to the present value of future installments payable over the lease term.
The finance lease liabilities are shown in the statement of financial position as follows:
| (€ thousands) | 06/30/2025 | 12/31/2024 | Change |
|---|---|---|---|
| Short term lease liabilities | 127,269 | 126,740 | 529 |
| Long term lease liabilities | 373,326 | 387,597 | (14,271) |
| Total lease liabilities | 500,595 | 514,337 | (13,742) |
During the reporting period, the following costs have been booked in profit and loss.
| First Half | |
|---|---|
| (€ thousands) | 2025 |
| Interest charges on leased assets | (10,321) |
| Right-of-use depreciation | (68,670) |
| Costs for short-term leases and leases for low value assets | (9,838) |

| (€ thousands) | First Half 2025 |
First Half 2024 |
Change |
|---|---|---|---|
| Revenues from sale of products | 1,021,476 | 1,028,228 | (6,752) |
| Revenues from services | 159,014 | 149,023 | 9,991 |
| Total revenues from sales and services | 1,180,490 | 1,177,251 | 3,239 |
| Goods and services provided at a point in time | 1,021,476 | 1,028,228 | (6,752) |
| Goods and services provided over time | 159,014 | 149,023 | 9,991 |
| Total revenues from sales and services | 1,180,490 | 1,177,251 | 3,239 |
Consolidated revenues from sales and services amounted to €1,180,490 thousand in the first six months of 2025, an increase of €3,239 thousand (+0.3%) with respect to the comparison period, attributable essentially to acquisitions for €27,984 thousand (+2.4%). Organic growth was negative for €9,715 thousand (-0.8%), while exchange differences were negative for €15,030 thousand (-1.3%).
Operating costs amounted to €896,155 thousand in the first half of 2025 (€887,685 thousand in the first half of 2024), an increase of €8,470 thousand (+1%) against the comparison period.
"Amortization, depreciation and impairment" amounted to €157,995 thousand as at 30 June 2025, higher than the €144,826 thousand recorded in the first half of 2024.
As part of a broad program to strengthen margins and reinforce company's competitiveness thanks to initiatives to enhance the efficiency of the distribution network and back-office processes, reduce costs and focus on the investments with the highest returns, which will be effective in the second half of 2025 and throughout 2026, in the first half of 2025 the following costs were incurred:
"Financial income, expenses and value adjustments to financial assets" came to €30,706 thousand in the first half of 2025 (€27,515 thousand in the first half of 2024).
Financial expenses increased of €3,191 thousands compared to the first half of 2024 because of higher interest expenses on leases and the exchange rate impact as a result of the strong variations occurred in the semester.

Current and deferred tax amounted to €30,061 thousand in the first half of 2025, compared to €33,558 thousand in the first half of 2024. This figure is affected by the effects of a deferred taxation reassessment in Australia that resulted in an expense for deferred tax assets reduction of €2,773 thousand.
The tax rate was 30.6% in the reporting period versus 27.6% as at 30 June 2024.
On 7 May 2025, Amplifon S.p.A.'s Board of Directors resolved, as recommended by the Remuneration and Appointments Committee, pursuant to Art. 84 bis, paragraph 5 of Consob Regulation n. 11971/99, as amended, to assign 931,950 rights under the first cycle of Stock Grant Plan 2025-2027 at the end of the three-year vesting period.
The stock grants assigned in the reporting period had a unit fair value of €17.34.
The fair value was determined based on the following assumptions:
| Valuation model | Binomial Tree (Cox-Ross-Rubinstein method) |
|---|---|
| Price at grant date | €17.86 |
| KPI | - € |
| Exercise price | 0.00 |
| Volatility (3 years) | 33.00% |
| Risk-free interest rate | 1.974% |
| Maturity (in years) | 3 |
| Vesting date | 3 months after the Board of Directors approves the draft consolidated financial statements at 31.12.28. |
| Dividend yield expected | 1.0122% |
The notional cost of this assignment cycle recognized in the income statement at 30 June 2025 amounted to €848 thousand.
Amplifon S.p.A.'s Board of Directors resolved, as recommended by the Remuneration and Appointments Committee, pursuant to Art. 84 bis, paragraph 5 of Consob Regulation n. 11971/99, as amended, to assign 46,200 rights under the Sustainable Value Sharing Plan 2022- 2027, reserved for the Chief Executive Officer and Group Executives with Strategic Responsibilities (the Beneficiaries), as described in the Informational Document approved during the Shareholders' Meeting held on 21 April 2023.
The Scheme is a composite incentive instrument comprising two distinct phases, "Phase A" and "Phase B". The second phase ("Phase B") is dependent on the outcome of "Phase A":
• Phase A: if the MBO Target established under the MBO Plan, applicable in the prior year (the 2025 assignment refers to the MBO target for 2024) is achieved, the beneficiaries receive a certain number of rights (the Co-Invested Rights) which allow the beneficiaries

to receive shares at the end of the vesting period of Phase B referred to below, or at an earlier time in the event that Phase B does not reach maturity;
• Fase B: if, in a given year, the beneficiaries receive Co-invested Rights by virtue of the mechanism described above, the beneficiaries will participate in an additional and separate incentive tool based on financial instruments, under which the Company assigns additional rights, equal in number to the Co-invested Rights. This will allow the beneficiaries to receive shares (the "Matched Rights") provided that certain performance targets, linked to value creation and the Group's sustainable success, are achieved.
With regard to the Sustainable Value Sharing Plan 2022-2027 reserved for the Chief Executive Officer and Group Executives with Strategic Responsibilities, the conversion of the vested MBO resulted in the assignment of 23,100 Co-Invested Rights and 23,100 Matched Rights.
| PHASE A | PHASE B | |
|---|---|---|
| Valuation model | Binomial Tree (Cox-Ross-Rubinstein method) | Binomial Tree (Cox-Ross-Rubinstein method) |
| FV | €17.86 | 6.92 € |
| KPI | - € | ESG/TSR |
| Exercise price | 0.00 | 0.00 |
| Volatility (3 years) | 33.00% | 33.00% |
| Risk-free interest rate | 1.974% | 1.974% |
| Maturity (in years) | 3 | 3 |
| Vesting date | 3 months after the Board of Directors approves the draft consolidated financial statements at 31.12.28. |
3 months after the Board of Directors approves the draft consolidated financial statements at 31.12.28. |
| Dividend yield expected | 1.0122% | 1.0122% |
The fair value was determined based on the following assumptions:

Basic earnings (loss) per share is obtained by dividing the net profit for the year attributable to the ordinary shareholders of the parent company by the weighted average number of shares outstanding in the period, considering purchases and disposals of own shares as cancellations and issues of shares.
Earnings per share are determined as follows:
| Earnings per share | First Half 2025 |
First Half 2024 |
|---|---|---|
| Net profit (loss) attributable to ordinary shareholders (€ thousand) | 68,120 | 87,793 |
| Average number of shares outstanding in the period | 224,820,026 | 225,979,292 |
| Average number per share (€ per share) | 0.30300 | 0.38850 |
Diluted earnings (loss) per share
Diluted earnings (loss) per share is obtained by dividing the net profit for the period attributable to the ordinary shareholders of the parent by the weighted average number of shares outstanding during the year adjusted by the diluting effects of potential shares. In the calculation of shares outstanding, purchases and sales of treasury shares are considered as cancellation or issue of shares.
The potential ordinary share categories stems exclusively from the Group's treasury shares.
| Weighted average diluted number of shares outstanding | First Half 2025 |
First Half 2024 |
|---|---|---|
| Average number of shares outstanding in the period | 224,820,026 | 225,979,292 |
| Weighted average of potential and diluting ordinary shares | 1,568,594 | 1,777,512 |
| Weighted average of shares potentially subject to options in the period | 226,388,620 | 227,756,804 |
The diluted earnings per share were determined as follows:
| Diluted earnings per share | First Half 2025 |
First Half 2024 |
|---|---|---|
| Net profit attributable to ordinary shareholders (€ thousand) | 68,120 | 87,793 |
| Average number of shares outstanding in the period | 226,388,620 | 227,756,804 |
| Average diluted earnings per share (€) | 0.30090 | 0.38547 |
The parent company, Amplifon S.p.A. is based in Via Ripamonti 133, Milan, Italy and it's controlled directly by Ampliter S.r.l. (42.01% of share capital and 68.36% of voting rights), held for a 100.0% by Amplifin S.r.l., which is owned at 88% by Susan Carol Holland.
The transactions with related parties, including intercompany transactions, do not qualify as atypical or unusual, and fall within the Group's normal course of business and are conducted at arm's length as dictated by the nature of the goods and services provided.
The following table details transactions with related parties:
| First Half 2025 | |||||||
|---|---|---|---|---|---|---|---|
| (€ thousands) | Trade receivables | Trade payables | Other receivables |
Other assets |
Revenues for sales and services |
Operating (costs)/revenues |
Interest income and expense |
| Amplifin S.r.l. | 14 | 35 | - | - | - | (38) | - |
| Totale – Società controllante | 14 | 35 | - | - | - | (38) | - |
| Comfoor BV (The Netherlands) | 43 | 1,764 | - | - | - | (838) | - |
| Ruti Levinson Institute Ltd (Israel) | 28 | - | - | 13 | - | - | - |
| Afik - Test Diagnosis & Hearing Aids Ltd (Israel) |
40 | - | - | - | - | - | |
| Total – Other related parties | 111 | 1,764 | - | 13 | - | (838) | - |
| Total related parties | 125 | 1,799 | - | 13 | - | (876) | - |
| Total as per financial statements | 220,330 | 328,383 | 114,642 | 40,871 | 1,180,490 | (896,155) | (17,056) |
| % of financial statements total | 0.06% | 0.55% | 0.00% | 0.03% | 0.00% | 0.10% | 0.00% |
The trade and other receivables refer primarily to the trade receivables due by associates (mainly in Israel) who act as resellers and to which the Group supplies hearing aids and other related products.
The trade payables and operating costs refer primarily to commercial transactions with Comfoor BV, a joint venture from which hearing protection devices are purchased and then distributed in Group clinics.
The lease for the Milan headquarters (leased to Amplifon S.p.A. by the parent company Amplifin S.r.l.) is recognized under right-of-use depreciation for per €920 thousand, interest on leases for €199 thousand, lease liabilities of €9,411 thousand, and right-of-use asset of €8,280 thousand.

Currently the Group is not exposed to any particular risks, uncertainties or legal disputes in excess of the provisions already made in the financial statements, shown in Note 11 "Provision for risk and charges". The usual tax audits are currently underway, and no findings of note have been reported so far and the Group is, at any rate, confident in the adequacy of the measures implemented.
As this condensed consolidated interim financial report does not include all the additional information that is mandatorily included in the Annual Report relating to the management of financial risk, for a detailed analysis of financial risk management reference should be made to the Group's 2024 Annual Report.

The exchange rates used to translate non-Euro zone companies' financial statements are as follows:
| 30 June 2025 | 2024 | 30 June 2024 | |||||
|---|---|---|---|---|---|---|---|
| Average exchange rate | As at 30 June |
As at 31 December |
Average exchange rate |
As at 30 June | |||
| Panamanian balboa | 1.0927 | 1.1720 | 1.0389 | 1.0705 | 1.0813 | ||
| Australian dollar | 1.7229 | 1.7948 | 1.6772 | 1.6079 | 1.6422 | ||
| Canadian dollar | 1.5400 | 1.6027 | 1.4948 | 1.4670 | 1.4685 | ||
| New Zealand dollar | 1.8827 | 1.9334 | 1.8532 | 1.7601 | 1.7752 | ||
| Singapore dollar | 1.4461 | 1.4941 | 1.4164 | 1.4513 | 1.4561 | ||
| US dollar | 1.0927 | 1.1720 | 1.0389 | 1.0705 | 1.0813 | ||
| Hungarian forint | 404.5700 | 399.8000 | 411.3500 | 395.1000 | 389.7600 | ||
| Swiss franc | 0.9414 | 0.9347 | 0.9412 | 0.9634 | 0.9615 | ||
| Egyptian pound | 55.1248 | 58.3194 | 52.8202 | 51.4080 | 44.8310 | ||
| Israeli New shekel | 3.9291 | 3.9492 | 3.7885 | 4.0200 | 3.9951 | ||
| Argentinian peso (*) | 1391.4393 | 1391.4393 | 1070.8061 | 975.3883 | 975.3883 | ||
| Chilean peso | 1043.2800 | 1100.9700 | 1033.7600 | 1021.5400 | 1016.2400 | ||
| Colombian peso | 4579.6600 | 4790.8500 | 4577.5500 | 4463.0000 | 4238.8300 | ||
| Mexican peso | 21.8035 | 22.0899 | 21.5504 | 19.5654 | 18.5089 | ||
| Uruguayan peso | 46.2883 | 47.0360 | 45.4668 | 42.3314 | 41.9655 | ||
| Chinese renminbi | 7.9238 | 8.3970 | 7.5833 | 7.7748 | 7.8011 | ||
| Indian rupee | 94.0693 | 100.5605 | 88.9335 | 89.2495 | 89.9862 | ||
| British pound | 0.8423 | 0.8555 | 0.8292 | 0.8464 | 0.8546 | ||
| Polish zloty | 4.2313 | 4.2423 | 4.2750 | 4.3090 | 4.3169 |
(*) Argentina is a highly inflationary country. As requested by IAS 29, profit and loss items have been converted at the closing exchange rate.
The average Argentine peso exchange rate as at 30 June 2025 is 1205.9751 and as at 30 June 2024 is 929.0128.

In accordance with IFRS 8 "Operating Segments", the schedules related to each operating segment are shown below.
The Amplifon Group's business (distribution and customization of hearing solutions) is organized into three specific geographical areas which comprise the Group's operating segments: Europe, Middle-East and Africa - EMEA - (Italy, France, The Netherlands, Germany, the United Kingdom, Spain, Portugal, Switzerland, Belgium, Hungary, Egypt, Poland, and Israel), Americas (USA, Canada, Chile, Argentina, Ecuador, Colombia, Panama, Mexico and Uruguay) and Asia-Pacific (Australia, New Zealand, India, and China).
The Group also operates via centralized Corporate functions (Corporate bodies, general management, business development, procurement, treasury, legal affairs, human resources, IT systems, global marketing and internal audit) which do not qualify as operating segments under IFRS 8.
These areas of responsibility, which coincide with the geographical areas (the Corporate functions are recognized under EMEA), represent the organizational structure used by management to run the Group's operations. The reports periodically analyzed by the Chief Executive Officer and Top Management are divided up accordingly, by geographical area.
Performances are monitored and measured for each operating segment/geographical area, through operating profit including amortization and depreciation (EBIT), along with the portion of the results of equity investments in associated companies valued by using the equity method. Financial expenses are not monitored insofar as they are based on corporate decisions regarding the financing of each region (own funds versus borrowings) and, consequently, neither are taxes. Items in the statement of financial position are analyzed by the geographical area without being separated from the Corporate functions which remain part of EMEA. All the information relating to the income statement and the statement of financial position is determined using the same criteria and accounting standards used to prepare the consolidated financial statements.


| (€ thousands) | EMEA | AMERICAS | APAC | ELIM. | CONSOLIDATED |
|---|---|---|---|---|---|
| ASSETS | |||||
| Non-current assets | |||||
| Goodwill | 1,065,711 | 292,120 | 561,617 | - | 1,919,448 |
| Intangible fixed assets with finite useful life | 294,467 | 56,583 | 53,341 | - | 404,391 |
| Property, plant, and equipment | 172,063 | 41,412 | 38,534 | - | 252,009 |
| Right-of-use assets | 379,562 | 46,093 | 50,682 | - | 476,337 |
| Equity-accounted investments | 2,323 | - | - | - | 2,323 |
| Hedging instruments | 2,684 | - | - | - | 2,684 |
| Deferred tax assets | 53,673 | 6,110 | 14,539 | - | 74,322 |
| Deferred contract costs | 9,036 | 1,136 | 74 | - | 10,246 |
| Other assets | 31,906 | 7,240 | 1,725 | - | 40,871 |
| Total non-current assets | 3,182,631 | ||||
| Current assets | |||||
| Inventories | 73,200 | 11,566 | 8,871 | - | 93,637 |
| Receivables | 328,865 | 60,656 | 22,018 | (76,567) | 334,972 |
| Deferred contract costs | 6,843 | 909 | 111 | - | 7,863 |
| Hedging instruments | 747 | - | - | - | 747 |
| Cash and cash equivalents | 242,693 | ||||
| Total current assets | 679,912 | ||||
| TOTAL ASSETS | 3,862,543 | ||||
| LIABILITIES | |||||
| Net Equity | 1,013,831 | ||||
| Non-current liabilities | |||||
| Medium/long-term financial liabilities | 1,040,596 | ||||
| Lease liabilities | 305,115 | 36,361 | 31,850 | - | 373,326 |
| Provisions for risks and charges | 14,802 | 1,092 | 810 | - | 16,704 |
| Liabilities for employees' benefits | 12,898 | 21 | 608 | - | 13,527 |
| Hedging instruments | 1,625 | - | - | - | 1,625 |
| Deferred tax liabilities | 68,073 | 21,990 | 9,606 | - | 99,669 |
| Payables for business acquisitions | 1,723 | 1,788 | - | - | 3,511 |
| Contract liabilities | 139,442 | 12,256 | 2,701 | - | 154,399 |
| Other long-term liabilities | 29,712 | 726 | - | - | 30,438 |
| Total non-current liabilities | 1,733,795 | ||||
| Current assets | |||||
| Trade payables | 283,782 | 77,300 | 43,680 | (76,379) | 328,383 |
| Payables for business acquisitions | 4,420 | 3,522 | 101 | - | 8,043 |
| Contract liabilities | 96,900 | 16,421 | 6,968 | - | 120,289 |
| Other payables and tax payables | 179,006 | 24,339 | 25,149 | (188) | 228,306 |
| Hedging instruments | 281 | - | - | - | 281 |
| Provisions for risks and charges | 2,475 | 587 | - | - | 3,062 |
| Liabilities for employees' benefits | 1,132 | 405 | 2,323 | - | 3,860 |
| Short-term financial liabilities | 295,424 | ||||
| Lease liabilities | 93,061 | 13,507 | 20,701 | - | 127,269 |
| Total current liabilities | 1,114,917 | ||||
| TOTAL LIABILITIES | 3,862,543 |
(*) The items in the statement of financial position are analyzed by geographic area without being separated from the Corporate functions which are included in EMEA.

| (€ thousands) | EMEA | AMERICAS | APAC | ELIM. | CONSOLIDATED |
|---|---|---|---|---|---|
| ASSETS | |||||
| Non-current assets | |||||
| Goodwill | 1,031,163 | 313,631 | 600,701 | - | 1,945,495 |
| Intangible fixed assets with finite useful life | 303,840 | 63,109 | 61,411 | - | 428,360 |
| Property, plant, and equipment | 168,319 | 41,075 | 44,530 | - | 253,924 |
| Right-of-use assets | 381,119 | 49,770 | 61,175 | - | 492,064 |
| Equity-accounted investments | 2,527 | - | - | - | 2,527 |
| Hedging instruments | 4,454 | - | - | - | 4,454 |
| Deferred tax assets | 56,435 | 5,762 | 15,135 | - | 77,332 |
| Deferred contract costs | 9,165 | 1,254 | 75 | - | 10,494 |
| Other assets | 42,576 | 8,277 | 2,031 | - | 52,884 |
| Total non-current assets | 3,267,534 | ||||
| Current assets | |||||
| Inventories | 71,792 | 11,777 | 9,611 | - | 93,180 |
| Receivables | 320,174 | 81,671 | 20,490 | (88,029) | 334,306 |
| Deferred contract costs | 6,612 | 1,003 | 119 | - | 7,734 |
| Hedging instruments | 878 | - | - | - | 878 |
| Other financial assets | 296 | ||||
| Cash and cash equivalents | 288,834 | ||||
| Total current assets | 725,228 | ||||
| TOTAL ASSETS | 3,992,762 | ||||
| LIABILITIES | |||||
| Net Equity | 1,150,224 | ||||
| Non-current liabilities | |||||
| Medium/long-term financial liabilities | 952,283 | ||||
| Lease liabilities | 308,004 | 40,119 | 39,474 | - | 387,597 |
| Provisions for risks and charges | 18,896 | 1,158 | 871 | - | 20,925 |
| Liabilities for employees' benefits | 14,753 | - | 704 | - | 15,457 |
| Hedging instruments | 1,157 | - | - | - | 1,157 |
| Deferred tax liabilities | 66,211 | 23,234 | 10,048 | - | 99,493 |
| Payables for business acquisitions | 2,136 | 3,749 | - | - | 5,885 |
| Contract liabilities | 137,096 | 13,865 | 2,805 | - | 153,766 |
| Other long-term liabilities | 34,743 | 875 | 49 | - | 35,667 |
| Total non-current liabilities | 1,672,230 | ||||
| Current liabilities | |||||
| Trade payables | 343,885 | 70,137 | 50,919 | (87,841) | 377,100 |
| Payables for business acquisitions | 5,143 | 6,107 | 260 | - | 11,510 |
| Contract liabilities | 97,435 | 17,796 | 7,683 | - | 122,914 |
| Other payables and tax payables | 188,954 | 26,910 | 31,614 | (188) | 247,290 |
| Hedging instruments | 739 | - | - | - | 739 |
| Provisions for risks and charges | 1,787 | 616 | - | - | 2,403 |
| Liabilities for employees' benefits | 1,128 | 447 | 2,519 | - | 4,094 |
| Short-term financial liabilities | 277,518 | ||||
| Lease liabilities | 90,116 | 13,726 | 22,898 | - | 126,740 |
| Total current liabilities | 1,170,308 | ||||
| TOTAL LIABILITIES | 3,992,762 |
(*) The items in the statement of financial position are analyzed by geographic area without being separated from the Corporate functions which are included in EMEA.
| (€ thousands) | EMEA | AMERICAS | APAC | CORPORATE | ELIM. | CONSOLIDATED |
|---|---|---|---|---|---|---|
| Revenues from sales and services | 765,958 | 243,085 | 171,447 | - | - | 1,180,490 |
| Operating costs | (544,554) | (185,535) | (128,390) | (37,676) | - | (896,155) |
| Other income and costs | 1,544 | 740 | 254 | 108 | - | 2,646 |
| Gross operating profit by segment (EBITDA) |
222,948 | 58,290 | 43,311 | (37,568) | - | 286,981 |
| Amortization, depreciation and | ||||||
| impairment Intangible assets amortization |
(26,452) | (7,892) | (7,493) | (13,813) | - | (55,650) |
| Property, plant, and equipment depreciation |
(19,322) | (4,717) | (7,429) | (780) | - | (32,248) |
| Right-of-use depreciation | (44,484) | (7,718) | (15,239) | (1,229) | - | (68,670) |
| Impairment losses and reversals of non-current assets |
(104) | - | (1,323) | - | - | (1,427) |
| (90,362) | (20,327) | (31,484) | (15,822) | - | (157,995) | |
| Operating result by segment | 132,586 | 37,963 | 11,827 | (53,390) | - | 128,986 |
| Financial income, expenses and value adjustments to financial assets |
||||||
| Share of interests held in associated companies valued at equity and gains/losses on disposals of equity investments |
90 | - | - | - | - | 90 |
| Interest income and expenses | (17,056) | |||||
| Interest expenses on lease liabilities | (10,321) | |||||
| Other financial income and expenses | (1,477) | |||||
| Exchange gains and losses, and inflation accounting |
(2,650) | |||||
| Gain (loss) on assets accounted at fair value |
708 | |||||
| (30,706) | ||||||
| Net profit (loss) before tax | 98,280 | |||||
| Current and deferred income tax | ||||||
| Current income tax | (25,685) | |||||
| Deferred tax | (4,376) | |||||
| (30,061) | ||||||
| Net profit (loss) | 68,219 | |||||
| Net profit (loss) attributable to Minority interests |
99 | |||||
| Net profit (loss) attributable to the Group |
68,120 |
(*) The figures of the operating segments are net of the intercompany eliminations.

| (€ thousands) | EMEA | AMERICAS | APAC | CORPORATE | ELIM. | CONSOLIDATED |
|---|---|---|---|---|---|---|
| Revenues from sales and services | 757,467 | 240,418 | 179,185 | 181 | - | 1,177,251 |
| Operating costs | (533,912) | (180,528) | (131,935) | (41,310) | - | (887,685) |
| Other income and costs | 2,184 | 1,821 | (95) | 297 | - | 4,207 |
| Gross operating profit by segment (EBITDA) |
225,739 | 61,711 | 47,155 | (40,832) | - | 293,773 |
| Amortization, depreciation and impairment |
||||||
| Intangible assets amortization | (22,525) | (7,216) | (7,631) | (12,681) | - | (50,053) |
| Property, plant, and equipment depreciation |
(17,584) | (3,859) | (7,859) | (773) | - | (30,075) |
| Right-of-use depreciation | (41,455) | (6,985) | (14,437) | (1,176) | - | (64,053) |
| Impairment losses and reversals of non current assets |
(609) | - | (36) | - | - | (645) |
| (82,173) | (18,060) | (29,963) | (14,630) | - | (144,826) | |
| Operating result by segment | 143,566 | 43,651 | 17,192 | (55,462) | - | 148,947 |
| Financial income, expenses and value adjustments to financial assets |
||||||
| Group's share of the result of associated companies valued at equity and gains/losses on disposals of equity investments |
283 | - | - | - | - | 283 |
| Interest income and expenses | (16,717) | |||||
| Interest expenses on lease liabilities | (8,916) | |||||
| Other financial income and expenses | (707) | |||||
| Exchange gains and losses, and inflation accounting |
(1,308) | |||||
| Gain (loss) on assets accounted at fair | (150) | |||||
| value | (27,515) | |||||
| Net profit (loss) before tax | 121,432 | |||||
| Current and deferred income tax | ||||||
| Current income tax | (27,957) | |||||
| Deferred tax | (5,601) | |||||
| (33,558) | ||||||
| Net profit (loss) | 87,874 | |||||
| Net profit (loss) attributable to Minority interests |
81 | |||||
| Net profit (loss) attributable to the Group | 87,793 |
(*) The figures of the operating segments are net of the intercompany eliminations.

The consolidated financial statements as at June 30, 2025 were prepared in accordance with the historical cost method with the exception of derivatives, a few financial investments measured at fair value and assets and liabilities hedged against changes in fair value, as explained in more detail in this report, as well as on a going concern basis.
With regard to the financial statements, the following is specified:
The preparation of the financial statements and explanatory notes requires the use of estimates and assumptions particularly with regard to the following items:

Estimates and assumptions are periodically reviewed, and any changes made, following the change of the circumstances or the availability of better information, are recognized in the income statement. The use of reasonable estimates is essential to the preparation of the financial statements and does not affect their overall reliability.
The Group verifies the existence of a loss in value of goodwill regularly once a year or in the event of impairment indicators.
The impairment test is conducted for the groups of cash generating units to which the goodwill refers and based on which the Group values, directly or indirectly, the return on the investment that includes the goodwill.
The following table lists the IFRS/interpretations approved by the IASB, endorsed in Europe and applied for the first time this year.
| Description | Endorsement date |
Publication in the G.U.C.E. |
Effective date | Effective date for Amplifon |
|---|---|---|---|---|
| Amendments to IAS 21 "The Effects of Changes in Foreign Exchange Rates: Lack of Exchangeability" (issued on 15 August 2023) |
12 Nov '24 | 13 Nov '24 | 1 Jan '25 | 1 Jan '25 |
The amendments to IAS 21 proposed by IASB provide clarification as to exchange whether a currency is exchangeable and which exchange rate to be used if it is not.
The adoption of the standards and interpretations described above did not have a material impact on the measurement of the Group's assets, liabilities, costs, and revenues.

The following table shows the future IFRS standards interpretation approved by us and endorsed in Europe.
| Descrizione | Endorsement date |
Publication in the G.U.C.E. |
Effective date | Effective date for Amplifon |
|---|---|---|---|---|
| Amendments to IFRS 9 e IFRS7 | 27 May '25 | 28 May '25 | 1 Jan '26 | 1 Jan '26 |
| "Classification and Measurement of | ||||
| Financial Instruments" (issued on 30 | ||||
| May 2024) |
The amendments to IFRS9 and IFRS7 proposed by IASB are related to the classification and measurement of financial instruments. The amendments aim to reduce diversity in practice and improve the consistency and understandability of the requirements.
The following are the international accounting standards, interpretations, amendments to existing accounting standards and interpretations, or specific provisions contained in the standards and interpretations approved by the IASB which, at 30 June 2025, have yet to be endorsed for adoption in Europe.
| Description | Effective date |
|---|---|
| Annual improvements volume 11 (issued on 18 July 2024) | Periods beginning on or after 1 Jan '26 |
| Contracts Referencing Nature-dependent Electricity – Amendments to IFRS 9 and IFRS 7 (issued on 18 December 2024) |
Periods beginning on or after 1 Jan '26 |
| IFRS 18 Presentation and Disclosure in Financial Statements | Periods beginning on or after 1 Jan '27 |
| IFRS 19 Subsidiaries without Public Accountability | Periods beginning on or after 1 Jan '27 |
The adoption of the standards and interpretations approved and not endorsed above is not expected to have a material impact on the measurement of the Group's assets and liabilities. The document Annual improvement. Volume 11 lists improvements limited to changes that either clarify the wording in an IFRS Accounting Standard, or correct relatively minor unintended consequences, oversights or conflicts between requirements of the Accounting Standards. In particular, the amendments relate to IFRS1, IFRS7, IFRS9, IFRS10 and IAS7.
The objective of the Amendments to IFRS 9 and IFRS 7 Contract Referencing Nature-dependent Electricity is to better reflect the effects of physical and virtual nature-dependent electricity contracts in the financial statements through narrow-scope amendments to the own-use, hedge accounting and disclosure requirements.
The IFRS 18 principle, 'Presentation and Disclosure in Financial Statements,' will supersede IAS 1 and provides a more detailed definition of the financial statement formats, with particular emphasis on the income statement, where minimum and mandatory subtotals are stipulated. It also introduces new disclosure requirements concerning 'Management Defined Performance

Measures' and offers guidelines for the aggregation of information in the financial statements and accompanying notes.
The IFRS 19 principle, 'Subsidiaries without Public Accountability,' establishes reduced reporting obligations for the financial statements of subsidiaries that are not required to prepare public IFRS financial statements.
The adoption of the standards and interpretations described above did not have a material impact on the measurement of the Group's assets, liabilities, costs, and revenues.
On July 1 st , 2025, the European Investment Bank granted €75 million to Amplifon S.p.A., as part of the loan for a total amount of €350 million, subscribed in two instalments in July 2023 and in June 2024. As of today, the unutilized portion of the loan amounts to €150 million.
After the 30th of June 2025, n. 6,200 shares were transferred following the exercise of performance stock grants.
The treasury shares buy back activity proceeded after the half-year closing and up to July 28th , 2025. The Company bought on the Euronext Milano stock market and on multilateral trading facilities 1,795,701 Amplifon S.p.A. ordinary shares, equal to 0.793% of the Company's share capital, for a total cash-out of €35,513 thousand.
As of today, a total of 5,323,890 treasury shares, equal to 2.352% of the Company's share capital, is held.
Moreover, in the month of July, Amplifon undertook the acquisition of 5 clinics in Australia and 8 clinics in Italy.
Milan, July 29th, 2025
CEO
Enrico Vita

As required by articles 38 and 39 of Law 127/91 and article 126 of Consob's resolution 11971 dated 14 May 1999, as amended by resolution 12475 dated 6 April 2000, the following is the list of companies included in the consolidation scope of Amplifon S.p.A. as at 30 June 2025.
| Company name | Head office | Currency | Share capital |
|---|---|---|---|
| Amplifon S.p.A. | Milan (Italy) | EUR | 4,527,772 |
| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 06/30/2025 |
|---|---|---|---|---|---|
| Amplifon Rete | Milan (Italy) | I | EUR | 19,250 | 2.6% |
| Amplifon Italia S.p.A. | Milan (Italy) | D | EUR | 100,000 | 100.0% |
| Magicson S.r.l. | Turin (Italy) | I | EUR | 46,800 | 100.0% |
| Sonar S.r.l. | Turin (Italy) | I | EUR | 50,000 | 100.0% |
| Amplifon France S.A.S. | Parigi (France) | D | EUR | 173,550,898 | 100.0% |
| SCI Eliot Leslie (*) | Lione (France) | I | EUR | - | 100.0% |
| Nadov Audition S.A.S. | Juvisy (France) | I | EUR | 5,000 | 100.0% |
| Pastel Audiologie S.A.S. | VilleFranche-de Lauragais (France) |
I | EUR | 818,000 | 100.0% |
| Pastel Audition S.A.S. | Castanet-Tolosan (France) |
I | EUR | 10,000 | 100.0% |
| Acoustiques des Halles S.A.S. | Bayonne (France) | I | EUR | 80,000 | 100.0% |
| Audition Détente S.A.S. | Montpellier (France) | I | EUR | 2,222 | 100.0% |
| Belletente S.A.S. | Saint-Étienne (France) |
I | EUR | 6,000 | 100.0% |
| Audiloire S.A.S. | Tours (France) | I | EUR | 1,000 | 100.0% |
| L'Oreillette Du Mans S.A.S. | Le Mans (France) | I | EUR | 10,800 | 100.0% |
| Aurissimans S.A.S. | Savigné l'Eveque (France) |
I | EUR | 6,000 | 100.0% |
| L'Effet L'Arsene S.A.S. | Tours (France) | I | EUR | 1,000 | 100.0% |
| François Audition S.A.S. | Ballan-Mire (France) | I | EUR | 3,000 | 100.0% |
| Audition Freres François S.A.S. | Tours (France) | I | EUR | 6,000 | 100.0% |
| FFF Audio S.A.S. | Chambray-Lès-Tours (France) |
I | EUR | 6,000 | 100.0% |
| Vouvray Audition S.A.S. | Vouvray (France) | I | EUR | 6,000 | 100.0% |
| Audioconseil S.A.S. | Redon (France) | I | EUR | 102,800 | 100.0% |
| Audition Oscar Thuaire S.A.S. | Mont-de-Marsan (France) |
I | EUR | 5,000 | 100.0% |
| Clarté Audition Sanguinet S.A.S. | Sanguinet (France) | I | EUR | 1,000 | 100.0% |
| Clarté Audition Nord Landes S.A.S. | Biscarrosse (France) | I | EUR | 1,000 | 100.0% |
| LCA Bagnols sur Cèze S.A.S. | Bagnols-Sur-Ceze (France) |
I | EUR | 1,524 | 100.0% |
| emarke sdir storage |
|---|
| CERTIFIED |
| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 06/30/2025 |
|---|---|---|---|---|---|
| Amplifon Ibérica, S.A.U. | Barcelona (Spain) | D | EUR | 26,578,809 | 100.0% |
| Microson S.A. | Barcelona (Spain) | D | EUR | 61,752 | 100.0% |
| Amplifon LATAM Holding, S.L.U. | Barcelona (Spain) | I | EUR | 3,000 | 100.0% |
| Audifonos factory, S.L. | Malaga (Spain) | I | EUR | 3,000 | 100.0% |
| Audifonos sevillaudio, S.L. | Malaga (Spain) | I | EUR | 10,000 | 100.0% |
| Audio diagnostics, S.L. | Malaga (Spain) | I | EUR | 30,000 | 100.0% |
| Audio elite sur, S.L. | Malaga (Spain) | I | EUR | 20,000 | 100.0% |
| Audiolmenes, S.L. | Malaga (Spain) | I | EUR | 3,000 | 100.0% |
| Corbaudio centros auditivos, S.L. | Cordoba (Spain) | I | EUR | 3,000 | 100.0% |
| Talayoaudio, S.L.U. | Marbella (Spain) | I | EUR | 3,000 | 100.0% |
| Tecnoaudifonos, S.L.U. (*) | Malaga (Spain) | I | EUR | 6,000 | 100.0% |
| Audio nevada, S.L. | Malaga (Spain) | I | EUR | 10,000 | 100.0% |
| Audioliva, S.L. | Jaen (Spain) | I | EUR | 3,000 | 100.0% |
| Centro audio granada, S.L. | Granada (Spain) | I | EUR | 36,000 | 100.0% |
| Futurooigo, S.L. | Malaga (Spain) | I | EUR | 3,000 | 100.0% |
| Centro auditivo sent, S.L. | Granada (Spain) | I | EUR | 3,000 | 100.0% |
| Esteponaudio, S.L. | Estepona (Spain) | I | EUR | 3,000 | 100.0% |
| Recimetal cordoba, S.L. (*) | Marbella (Spain) | I | EUR | 23,095 | 100.0% |
| Soluciones auditivas de la subbetica, S.L. |
Rute (Spain) | I | EUR | 3,000 | 100.0% |
| Soluciones auditivas y visuales gonzales, S.L. |
Malaga (Spain) | I | EUR | 29,000 | 100.0% |
| Soluciones profesionales de audiologia, S.L. |
Malaga (Spain) | I | EUR | 23,408 | 100.0% |
| Sonic technology españa, S.L. | Fuengirola (Spain) | I | EUR | 9,015 | 100.0% |
| Sontec centros auditivos, S.L. | Mijas (Spain) | I | EUR | 3,000 | 100.0% |
| Amplifon Portugal SA | Lisboa (Portugal) | I | EUR | 15,520,187 | 100.0% |
| Amplifon Magyarország Kft | Budapest (Hungary) | D | HUF | 723,500,000 | 100.0% |
| Amplibus Magyarország Kft | Budaörs (Hungary) | I | HUF | 3,000,000 | 100.0% |
| Amplifon AG | Baar (Switzerland) | D | CHF | 1,000,000 | 100.0% |
| Amplifon Nederland B.V. | Utrecht (The Netherlands) |
D | EUR | 74,212,052 | 100.0% |
| Auditech B.V. | Utrecht (The Netherlands) |
I | EUR | 22,500 | 100.0% |
| Electro Medical Instruments B.V. | Utrecht (The Netherlands) |
I | EUR | 16,650 | 100.0% |
| Beter Horen B.V. | Utrecht (The Netherlands) |
I | EUR | 18,000 | 100.0% |
| Amplifon Customer Care Service B.V. | Elst (The Netherlands) |
I | EUR | 18,000 | 100.0% |
| Amplifon Belgium N.V. | Bruxelles (Belgium) | D | EUR | 495,800 | 100.0% |
| Amplifon RE SA | Luxembourg (Luxembourg) |
D | EUR | 3,700,000 | 100.0% |
| Amplifon Deutschland GmbH | Hamburg (Germany) | D | EUR | 6,026,000 | 100.0% |
| Focus Hören AG | Bonn (Germany) | I | EUR | 485,555 | 100.0% |
| Focus hören Deutschland GmbH | Bonn (Germany) | I | EUR | 25,000 | 100.0% |
| Hörhaus Wagenknecht GmbH | Söhrewald (Germany) |
I | EUR | 25,000 | 100.0% |
| Amplifon Poland Sp. z o.o. | Lodz (Poland) | D | PLN | 3,349,200 | 100.0% |
| Amplifon Aparaty Słuchowe Sp. z o.o. | Poznań (Poland) | I | PLN | 8,050,000 | 100.0% |
| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 06/30/2025 |
|---|---|---|---|---|---|
| Amplifon UK Ltd | Manchester (United Kingdom) |
D | GBP | 130,951,168 | 100.0% |
| Amplifon Ltd | Manchester (United Kingdom) |
I | GBP | 1,800,000 | 100.0% |
| Ultra Finance Ltd (*) | Manchester (United Kingdom) |
I | GBP | 75 | 100.0% |
| Medtechnica Ortophone Ltd (**) | Tel Aviv (Israel) | D | ILS | 1,100 | 90.0% |
| Amplifon Middle East SAE | Cairo (Egypt) | D | EGP | 3,000,000 | 51.0% |
| Miracle Ear Inc. | St. Paul (United States) |
I | USD | 5 | 100.0% |
| ME Pivot Holdings, LLC | Minneapolis (United States) |
I | USD | 2,000,000 | 100.0% |
| Amplifon Hearing Health Care. Corp. | St. Paul (United States) |
I | USD | 10 | 100.0% |
| Ampifon IPA, LLC | New York (United States) |
I | USD | - | 100.0% |
| Amplifon USA Inc. | Dover (United States) |
D | USD | 52,500,010 | 100.0% |
| ME Flagship, LLC | Wilmington (United States) |
I | USD | - | 100.0% |
| METX, LLC | Waco (United States) | I | USD | - | 100.0% |
| MEFL, LLC | Waco (United States) | I | USD | - | 100.0% |
| METampa, LLC | Waco (United States) | I | USD | - | 100.0% |
| MENM, LLC | Waco (United States) | I | USD | - | 100.0% |
| MEOH, LLC | Minneapolis (United States) |
I | USD | - | 100.0% |
| Safe in Sound Hearing, LLC (*) | Phoenix (United States) |
I | USD | - | 100,0% |
| SISH Tucson, LLC (*) | Tucson (United States) |
I | USD | - | 100,0% |
| Miracle Ear Canada Ltd. | Vancouver (Canada) | I | CAD | 178,701,200 | 100.0% |
| Great to Hear, Inc. (*) | Manitoba (Canada) | I | CAD | - | 100.0% |
| Living Sounds Hearing Centre Ltd. (*) | Alberta (Canada) | I | CAD | - | 100.0% |
| Sackville Hearing Centre Limited (*) | Nova Scotia (Canada) | I | CAD | - | 100.0% |
| Hometown Hearing Centre Inc (*) | Bancroft (Canada) | I | CAD | - | 100.0% |
| Newlife Hearing Inc. (*) | St. John's (Canada) | I | CAD | - | 100.0% |
| Provincial Hearing Aid Service (Halifax) Ltd. (*) |
Halifax (Canada) | I | CAD | - | 100.0% |
| Audia Hearing Aid Centre Inc. (*) | Ontario (Canada) | I | CAD | - | 100.0% |
| The Hearing Institute of Ontario, Inc. (*) |
Ontario (Canada) | I | CAD | - | 100.0% |
| Pure Audiology & Hearing Aid Services, Inc. (*) |
Oakville (Canada) | I | CAD | - | 100.0% |
| St. Thomas Hearing Clinic Inc. (*) | St. Thomas (Canada) | I | CAD | - | 100.0% |
| Sunnybank Enterprises Ltd. (*) | Parksville (Canada) | I | CAD | - | 100.0% |
| GAES S.A. (Chile) | Santiago de Chile (Chile) |
I | CLP | 1,901,686,034 | 100.0% |
| GAES Servicios Corporativo de Latinoamerica SpA |
Santiago de Chile (Chile) |
I | CLP | 10,000,000 | 100.0% |
| Audiosonic Chile S.A. | Santiago de Chile (Chile) |
I | CLP | - | 99.0% |
| GAES S.A. (Argentina) | Buenos Aires (Argentina) |
I | ARS | 120,542,331 | 100.0% |
| GAES Colombia S.A.S. | Bogotà (Colombia) | I | COP | 22,000,000,000 | 100.0% |
| Audiovital Cìa. Ltda. | Quito (Ecuador) | I | USD | 430,337 | 100.0% |
| CITICITY sdir scorage |
|---|
| CERTIFIED |
| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 06/30/2025 |
|---|---|---|---|---|---|
| Centros Auditivos GAES Mexico sa de cv |
Ciudad de México (Mexico) |
I | MXN | 276,477,133 | 100.0% |
| Compañía de Audiologia y Servicios Medicos sa de cv |
Aguascalientes (Mexico) |
I | MXN | 43,306,212 | 100.0% |
| GAES Panama S.A. | Panama (Panama) | I | PAB | 510,000 | 100.0% |
| Audical S.A.S | Montevideo (Uruguay) |
D | UYU | 500,000 | 100.0% |
| Centro Auditivo S.A.S | Montevideo (Uruguay) |
D | UYU | 500,000 | 100.0% |
| Ikako S.A. | Montevideo (Uruguay) |
D | UYU | 100,000 | 100.0% |
| Amplifon Australia Holding Pty Ltd | Sydney (Australia) | D | AUD | 392,000,000 | 100.0% |
| National Hearing Centres Pty Ltd | Sydney (Australia) | I | AUD | 100 | 100.0% |
| National Hearing Centres Unit Trust | Sydney (Australia) | I | AUD | - | 100.0% |
| Otohub Unit Trust (in liquidation) | Sydney (Australia) | D | AUD | - | 100.0% |
| Otohub Australasia Pty Ltd | Sydney (Australia) | D | AUD | 10 | 100.0% |
| Attune Hearing Pty Ltd | Sydney (Australia) | D | AUD | 14,771,093 | 100.0% |
| Attune Workplace Hearing Pty Ltd | Sydney (Australia) | I | AUD | 1 | 100.0% |
| Ear Deals Pty Ltd | Sydney (Australia) | I | AUD | 300,000 | 100.0% |
| Bay Audio Pty Ltd | Sydney (Australia) | D | AUD | 10,000 | 100.0% |
| Amplifon Asia Pacific Pte Limited | Singapore (Singapore) |
I | SGD | 7,425,000 | 100.0% |
| Amplifon NZ Ltd | Takapuna (New Zealand) |
I | NZD | 130,411,317 | 100.0% |
| Auckland Hearing Ltd (*) | Auckland (New Zealand) |
I | NZD | - | 100.0% |
| Bay Audiology Ltd (*) | Takapuna (New Zealand) |
I | NZD | - | 100.0% |
| Dilworth Hearing Ltd (*) | Auckland (New Zealand) |
I | NZD | - | 100.0% |
| Hearing Health Limited (*) | Auckland (New Zealand) |
I | NZD | - | 100.0% |
| Amplifon India Pvt Ltd | Gurgaon (India) | I | INR | 2,050,000,000 | 100.0% |
| Beijing Amplifon Hearing Technology Center Co., Ltd |
Běijīng (China) | D | CNY | 2,143,685 | 100.0% |
| Tianjin Amplifon Hearing Technology Co., Ltd |
Tianjin (China) | I | CNY | 3,500,000 | 100.0% |
| Shijiazhuang Amplifon Hearing Technology Center Co. Ltd |
Shijiazhuang (China) | I | CNY | 100,000 | 100.0% |
| Amplifon (China) Investment Co., Ltd | Shanghai (China) | D | CNY | 638,574,561 | 100.0% |
| Hangzhou Amplifon Hearing Aid Co., Ltd |
Hangzhou (China) | D | CNY | 11,000,000 | 100.0% |
| Zhengzhou Yuanjin Hearing Technology Co., Ltd. (*) |
Zhengzhou (China) | I | CNY | - | 100.0% |
| Wuhan Amplifon Hearing Aid Co., Ltd | Wuhan (China) | I | CNY | 40,000,000 | 100.0% |
| Shanghai Amplifon Hearing Technology Co. Ltd, |
Shanghai (China) | I | CNY | 50,000,000 | 100.0% |
| Nanjing Amplifon Hearing Aid Co., Ltd |
Nanjing (China) | I | CNY | 37,500,000 | 100.0% |
| Shanxi Amplifon Hearing Aid Co., Ltd. | Taiyuan (China) | I | CNY | 30,000,000 | 100.0% |
| Henan Amplifon Hearing Aid Co., Ltd. | Zhengzhou (Cina) | I | CNY | 1,000,000 | 100.0% |
| Fuzhou Tingan Medical Device Co., Ltd |
Fuzhou (China) | I | CNY | 20,000,000 | 100.0% |
| Chongqing Amplifon Hearing Aids Co., Ltd. |
Chongqing (China) | I | CNY | 10,000,000 | 100.0% |
| Sichuan Amplifon Hearing Aid Co., Ltd. |
Chengdu (China) | I | CNY | 24,000,000 | 100.0% |
| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 06/30/2025 |
|---|---|---|---|---|---|
| Xi'an Ansheng Medical Equipment Co., Ltd. |
Xi'an (China) | I | CNY | 16,000,000 | 100.0% |
| Ningxia Amplifon hearing aid Business Co., Ltd |
Yinchuan (China) | I | CNY | 16,000,000 | 100.0% |
| Yunnan Amplifon Hearing Aid Co., Ltd. |
Kunming (China) | I | CNY | 16,000,000 | 100.0% |
| Shanxi Amplifon Hearing Aid Business Co., Ltd |
Xi'an (China) | I | CNY | 18,000,000 | 100.0% |
| Anhui Amplifon Hearing Aid business Co., Ltd. |
Hefei (China) | I | CNY | 30,000,000 | 100.0% |
| AnLaiSheng (Inner Mongolia) Medical Equipment Co.Ltd |
Hohhot (China) | I | CNY | 47,000,000 | 100.0% |
| Amplifon International Trade (Hangzhou) Co., Ltd. |
Hangzhou (China) | I | CNY | 34,000,000 | 100.0% |
(*) Dormant companies
(**) Medtechnica Ortophone Ltd, despite being 90% owned by Amplifon, is consolidated at 100% without exposure of non-controlling interests due to the put-call option exercisable from 2019 and related to the purchase of the remaining 10%.
| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital |
% held as at 06/30/2025 |
|---|---|---|---|---|---|
| Comfoor BV (*) | Utrecht (The Netherlands) |
I | EUR | 18,000 | 50.0% |
| Ruti Levinson Institute Ltd (**) | Ramat HaSharon (Israel) |
I | ILS | 105 | 20.0% |
| Afik - Test Diagnosis & Hearing Aids Ltd (**) |
Jerusalem (Israel) | I | ILS | 100 | 20.0% |
| Lakeside Specialist Centre Ltd (**) | Mairangi Bay (New Zealand) |
I | NZD | - | 50.0% |
(*) Joint Venture
(**) Related companies


We, the undersigned, Enrico Vita, Chief Executive Officer and Gabriele Galli, Executive Responsible for Corporate Accounting Information for Amplifon S.p.A., taking into account the provisions of article § 154-bis, paragraphs 3 and 4 of Law no. 58/98, certify:
We also certify that the condensed interim consolidated financial statements as at 30 June 2025:
The report on operations includes a reliable operating and financial review of the Company and all of the companies included in the consolidation area.
Milan, July 29th, 2025
CEO Executive Responsible for Corporate Accounting Information
Enrico Vita Gabriele Galli


KPMG S.p.A. Revisione e organizzazione contabile Via Vittor Pisani, 25 20124 MILANO MI Telefono +39 02 6763.1 Email [email protected] PEC [email protected]
(This independent auditors' report has been translated into English solely for the convenience of international readers. Accordingly, only the original Italian version is authoritative)
To the shareholders of Amplifon S.p.A.
We have reviewed the accompanying condensed interim consolidated financial statements of the Amplifon Group, comprising the statement of financial position, the income statement and the statements of comprehensive income, changes in equity and cash flows and notes thereto, as at and for the six months ended 30 June 2025. The parent's directors are responsible for the preparation of these condensed interim consolidated financial statements in accordance with the IFRS Accounting Standard applicable to interim financial reporting (IAS 34) as issued by the International Accounting Standards Board and endorsed by the European Union. Our responsibility is to express a conclusion on these condensed interim consolidated financial statements based on our review.
We conducted our review in accordance with Consob (the Italian Commission for Listed Companies and the Stock Exchange) guidelines set out in Consob resolution no. 10867 dated 31 July 1997. A review of condensed interim consolidated financial statements consists of making inquiries, primarily of persons responsible for financial and accounting matters, applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (ISA Italia) and, consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion on the condensed interim consolidated financial statements.

Report on review of condensed interim consolidated financial statements 30 June 2025
Based on our review, nothing has come to our attention that causes us to believe that the condensed interim consolidated financial statements of the Amplifon Group as at and for the six months ended 30 June 2025 have not been prepared, in all material respects, in accordance with the IFRS Accounting Standard applicable to interim financial reporting (IAS 34) as issued by the International Accounting Standards Board and endorsed by the European Union.
Milan, 31 July 2025
KPMG S.p.A.
(signed on the original)
Paolo Bruno Director of Audit
Have a question? We'll get back to you promptly.